level_0,index,Unnamed: 0,pmid,rpsid,pmidlink,components_type,rna_id,rna_id_interface,rnas,rna_length,rna_sequence,rna_classification,source,protein_sequence,protein_name,protein_region,protein_modification,protein_sequence_length,Uniprot ID,mark,link,IDR,low complexity domain,In_vitrovivo,solute_concentration,salt_concentration,buffer,temperature,incubation_time,other_requirement,detection_method,morphology,description,rna_length_num,A_ratio,U_ratio,G_ratio,C_ratio,GC_ratio,AU_ratio,kolmogorov_complexity,shannon_entropy,SW_kernel_result,SW_kernel_avg,SW_kernel_var,SW_pooling_result,SW_pooling_avg,SW_pooling_var,mfe_energy,fc_energy,mea_score,cen_distance,cen_energy,mfe_freq,ensemble_diver,mean_bp_distance,poly_rna,repeat_rna,else_rna,label,score
0,0,0,PMID: 16081698,RNAPS0000001,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406881,https://www.ncbi.nlm.nih.gov/gene/406881,hsa-let-7a-1,80nt(1-80),UGGGAUGAGGUAGUAGGUUGUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAACUAUACAAUCUACUGUCUUUCCUA,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",80,0.2625,0.3125,0.2375,0.1875,1.2666666666666666,0.8400000000000001,14.615384615384615,0.4575806390475432,"[1.97724987 1.72475733 1.72475733 0.97724987 0.25249254 0.97724987
 0.25249254 0.         0.         1.         2.72475733 2.72475733
 2.72475733 2.45948481 2.72475733 2.72475733 0.         0.
 0.         0.         0.74750746 0.97724987 1.49501492 0.
 0.        ]",1.1275717223756854,1.1212246003049144,[1 1 0 1 0 0 1 1 1 1 0 0 0 1 1 1],0.625,0.234375,-34.200000762939446,-35.21200561523437,73.8904037475586,3.712982291367569,-34.200000762939446,0.19359106947082105,13.091995921159803,6.071951764436013,0,0,1,1,0.1595483026546355
1,1,1,PMID: 16081698,RNAPS0000002,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406882,https://www.ncbi.nlm.nih.gov/gene/406882,hsa-let-7a-2,72nt(1-72),AGGUUGAGGUAGUAGGUUGUAUAGUUUAGAAUUACAUCAAGGGAGAUAACUGUACAGCCUCCUAGCUUUCCU,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",72,0.2777777777777778,0.3194444444444444,0.25,0.1527777777777778,1.6363636363636362,0.8695652173913044,14.0,0.4499308148111609,"[1.72475733 1.72475733 1.72475733 0.97724987 0.25249254 0.97724987
 0.25249254 0.         0.         0.         0.         0.97724987
 1.72475733 2.72475733 0.         0.         0.74750746 1.22974241
 2.72475733 3.44951466 2.72475733 0.         0.        ]",1.0407304574715308,1.1401323318854495,[1 1 1 0 0 0 0 1 1 0 1 1 1 1],0.6428571428571429,0.22959183673469385,-25.20000076293945,-26.3896598815918,66.35356903076172,2.9795501448296684,-25.0,0.14511037399980356,8.798105093452863,5.067810895609556,0,0,1,1,0.1645286757094842
2,2,2,PMID: 16081698,RNAPS0000003,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406883,https://www.ncbi.nlm.nih.gov/gene/406883,hsa-let-7a-3,74nt(1-74),GGGUGAGGUAGUAGGUUGUAUAGUUUGGGGCUCUGCCCUGCUAUGGGAUAACUAUACAAUCUACUGUCUUUCCU,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",74,0.1891891891891892,0.35135135135135137,0.28378378378378377,0.17567567567567569,1.6153846153846152,0.5384615384615384,14.666666666666664,0.4532054953049521,"[2.72475733 1.22974241 0.97724987 1.72475733 1.72475733 0.
 0.         1.         4.44951466 2.47226479 2.47226479 3.95449974
 1.22974241 1.         1.         0.25249254 0.         0.
 0.74750746 0.97724987 0.74750746 0.74750746 1.        ]",1.3231224107283197,1.3671268940998298,[1 1 1 0 1 1 1 1 1 0 0 0 1 1],0.7142857142857143,0.20408163265306128,-34.09999847412109,-34.83078384399414,70.61786651611328,2.066996011110854,-34.09999847412109,0.3055250429373341,21.87631229756456,3.514352742777312,0,0,1,1,0.15711818281231393
3,3,3,PMID: 16081698,RNAPS0000004,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406884,https://www.ncbi.nlm.nih.gov/gene/406884,hsa-let-7b,83nt(1-83),CGGGGUGAGGUAGUAGGUUGUGUGGUUUCAGGGCAGUGAUGUUGCCCCUCGGAAGAUAACUAUACAACCUACUGCCUUCCCUG,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",83,0.1927710843373494,0.27710843373493976,0.3132530120481928,0.21686746987951808,1.4444444444444444,0.6956521739130435,14.538461538461535,0.4629201390275727,"[3.95449974 2.72475733 1.72475733 0.97724987 0.25249254 1.22974241
 2.72475733 0.         0.         3.95449974 2.47226479 0.74750746
 0.97724987 1.97724987 4.44951466 4.44951466 1.97724987 0.
 0.         0.         0.         1.72475733 1.72475733 2.47226479
 1.97724987 1.        ]",1.6727821837894294,1.9573007173988013,[1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1],0.875,0.109375,-46.70000076293945,-48.3931999206543,74.47447967529297,5.292431559937089,-46.20000076293945,0.06410284195072374,9.311380182229613,7.676371495864428,0,0,1,1,0.15015676761790453
4,4,4,PMID: 16081698,RNAPS0000005,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406885,https://www.ncbi.nlm.nih.gov/gene/406885,hsa-let-7c,84nt(1-84),GCAUCCGGGUUGAGGUAGUAGGUUGUAUGGUUUAGAGUUACACCCUGGGAGUUAACUGUACAACCUUCUAGCUUUCCUUGGAGC,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",84,0.2023809523809524,0.32142857142857145,0.2857142857142857,0.19047619047619047,1.5,0.6296296296296295,14.0,0.4635893725104475,"[2.72475733 4.44951466 1.97724987 1.72475733 1.72475733 0.97724987
 0.25249254 0.97724987 1.         0.         0.         0.74750746
 0.74750746 2.47226479 4.44951466 2.72475733 0.         0.
 0.74750746 0.97724987 1.72475733 1.72475733 1.72475733 0.
 0.         2.72475733 3.44951466]",1.4823289561903696,1.6645185127319608,[1 1 1 1 0 1 1 0 1 1 0 1 1 1 1 1],0.8125,0.15234375,-31.60000038146973,-33.15946578979492,75.70369720458984,4.990408125588886,-31.20000076293945,0.07963632372242828,10.100892513658053,7.722054448100691,0,0,1,1,0.15688405191788152
5,5,5,PMID: 16081698,RNAPS0000006,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406886,https://www.ncbi.nlm.nih.gov/gene/406886,hsa-let-7d,87nt(1-87),CCUAGGAAGAGGUAGUAGGUUGCAUAGUUUUAGGGCAGGGAUUUUGCCCACAAGGAGGUAACUAUACGACCUGCUGCCUUUCUUAGG,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",87,0.2413793103448276,0.27586206896551724,0.2988505747126437,0.1839080459770115,1.6250000000000002,0.875,14.785714285714285,0.4574821393756846,"[2.72475733 1.72475733 1.72475733 1.72475733 0.97724987 0.25249254
 1.72475733 1.         0.         0.         1.97724987 4.44951466
 1.         0.         0.         3.95449974 1.22974241 1.22974241
 1.22974241 0.74750746 0.         0.         3.44951466 3.44951466
 4.44951466 0.         0.         1.        ]",1.429288285198828,1.9349935579816893,[1 1 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1],0.8235294117647058,0.1453287197231834,-42.70000076293945,-44.5587158203125,80.61927795410156,3.7761631285584736,-42.70000076293945,0.04900548734363015,13.633420692266407,5.8090858100792016,0,0,1,1,0.1517417427174863
6,6,6,PMID: 16081698,RNAPS0000007,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406887,https://www.ncbi.nlm.nih.gov/gene/406887,hsa-let-7e,79nt(1-79),CCCGGGCUGAGGUAGGAGGUUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",79,0.2278481012658228,0.20253164556962025,0.3164556962025317,0.2531645569620253,1.25,1.125,14.0,0.4656336994818744,"[6.42676453 3.95449974 2.72475733 1.72475733 1.22974241 1.22974241
 0.97724987 0.25249254 0.97724987 1.72475733 3.44951466 1.72475733
 2.47226479 1.97724987 1.22974241 1.22974241 0.74750746 0.
 0.         4.44951466 3.44951466 2.72475733 0.         0.
 3.95449974]",1.945243146253248,2.5581139418677243,[1 1 1 1 0 1 1 1 1 1 0 1 1 1 1],0.8666666666666667,0.11555555555555555,-36.70000076293945,-38.36194610595703,70.32704162597656,5.181832954293069,-36.20000076293945,0.06743720500790785,8.535371188852602,7.63707002611376,0,0,1,1,0.15240635482064868
7,7,7,PMID: 16081698,RNAPS0000008,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406888,https://www.ncbi.nlm.nih.gov/gene/406888,hsa-let-7f-1,87nt(1-87),UCAGAGUGAGGUAGUAGAUUGUAUAGUUGUGGGGUAGUGAUUUUACCCUGUUCAGGAGAUAACUAUACAAUCUAUUGCCUUCCCUGA,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",87,0.25287356321839083,0.3448275862068966,0.25287356321839083,0.14942528735632185,1.6923076923076923,0.7333333333333334,14.785714285714285,0.4585182674332594,"[1.49501492 1.49501492 1.72475733 1.72475733 0.97724987 0.74750746
 0.         0.         0.97724987 2.47226479 1.97724987 1.22974241
 0.         0.         0.         2.47226479 0.97724987 1.72475733
 1.72475733 0.25249254 0.         0.         0.74750746 0.
 0.         1.         1.97724987 2.47226479]",1.0060483128220268,0.7408385758800601,[1 1 0 1 0 1 1 1 0 1 1 0 0 0 0 1 1],0.5882352941176471,0.2422145328719723,-42.29999923706055,-42.99283218383789,84.49996948242188,1.455974787546936,-42.29999923706055,0.32493059045498746,34.79211030221498,2.395385008818631,0,0,1,1,0.13961160123689842
8,8,8,PMID: 16081698,RNAPS0000009,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406889,https://www.ncbi.nlm.nih.gov/gene/406889,hsa-let-7f-2,83nt(1-83),UGUGGGAUGAGGUAGUAGAUUGUAUAGUUUUAGGGUCAUACCCCAUCUUGGAGAUAACUAUACAGUCUACUGUCUUUCCCACG,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",83,0.24096385542168675,0.3373493975903614,0.24096385542168675,0.18072289156626506,1.3333333333333333,0.7142857142857143,15.0,0.4515519766467379,"[2.72475733 1.72475733 1.72475733 1.72475733 0.97724987 0.74750746
 0.         0.         0.         0.         2.72475733 0.
 0.         1.97724987 0.97724987 1.72475733 1.72475733 0.25249254
 0.         0.         1.49501492 1.22974241 0.74750746 0.74750746
 1.         2.72475733]",1.0365223270617576,0.8276902784487837,[1 1 1 0 0 0 1 1 1 1 0 0 1 1 1 1],0.6875,0.21484375,-39.0,-40.61410140991211,69.04484558105469,7.973415965270956,-34.900001525878906,0.07288091328492499,4.798470804070055,10.93459301075842,0,0,1,1,0.1561111248278429
9,9,9,PMID: 16081698,RNAPS0000010,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406890,https://www.ncbi.nlm.nih.gov/gene/406890,hsa-let-7g,84nt(1-84),AGGCUGAGGUAGUAGUUUGUACAGUUUGAGGGUCUAUGAUACCACCCGGUACAGGAGAUAACUGUACAGGCCACUGCCUUGCCA,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",84,0.25,0.25,0.2857142857142857,0.21428571428571427,1.3333333333333333,1.0,14.0,0.4481044568925476,"[2.72475733 2.72475733 1.72475733 0.97724987 0.         0.
 1.22974241 0.         0.         2.72475733 1.72475733 0.74750746
 0.74750746 1.22974241 3.95449974 1.97724987 1.22974241 2.45948481
 0.         0.         0.74750746 1.22974241 3.95449974 2.47226479
 2.47226479 1.97724987 1.        ]",1.4825941531761064,1.3304808971787083,[1 1 0 1 0 1 0 1 1 1 1 0 1 1 1 1],0.75,0.1875,-39.29999923706055,-39.90167617797852,80.19678497314453,2.32223309348237,-39.29999923706055,0.3767243355485453,22.082221072109537,3.8060246022741593,0,0,1,1,0.16203311726880887
10,10,10,PMID: 16081698,RNAPS0000011,https://pubmed.ncbi.nlm.nih.gov/16081698,Undefined,NCBI ID:406891,https://www.ncbi.nlm.nih.gov/gene/406891,hsa-let-7i,84nt(1-84),CUGGCUGAGGUAGUAGUUUGUGCUGUUGGUCGGGUUGUGACAUUGCCCGCUGUGGAGAUAACUGCGCAAGCUACUGCCUUGCUA,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"ISH,Immunofluorescence microscopy",-,"Besides, all four AGO proteins, GW182, miRNAs and targeted mRNAs were consistently detected in P-bodies.",84,0.15476190476190474,0.30952380952380953,0.3333333333333333,0.2023809523809524,1.6470588235294117,0.5,14.0,0.4577773735607358,"[2.72475733 2.72475733 1.22974241 0.97724987 0.97724987 0.74750746
 1.72475733 1.72475733 1.72475733 4.44951466 1.97724987 1.22974241
 1.49501492 0.74750746 1.97724987 4.44951466 2.72475733 2.45948481
 0.         0.         2.47226479 1.97724987 1.72475733 1.72475733
 2.47226479 1.97724987 0.25249254]",1.8024669914829567,1.1587221010230406,[1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1],0.9375,0.05859375,-39.70000076293945,-41.02776336669922,77.7789077758789,3.5402670148886166,-37.099998474121094,0.11598027726929833,13.442780127048106,5.278301266194305,0,0,1,1,0.16394670525448107
11,11,11,PMID: 22398450,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/22398450,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,136 µM [PTBP1];|80 µM RNA,"170 mM NaCl, 30 mM KCl, 1 mM MgCl2","170 mM NaCl, 30 mM KCl, 1 mM MgCl2",RT,"imme diately,> 2day s",other_molecular:1 mM ATP,Differential interference contrast microscopy,liquid,"Analogous droplets were also observed for an unrelated SH35-ligand5 pair and for the tetravalent RNA binding protein PTB interacting with an RNA oligonucleotide. Thus, liquid-liquiddemixing phase transitions may occur in many multivalent intracellular systems.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
12,12,12,PMID: 22579282,RNAPS0000052,https://pubmed.ncbi.nlm.nih.gov/22579282,RNA + protein,-;|-,-;|-,"MS2 hairpin RNA (Han,2012);|Saccharomyces cerevisiae tRNA",31nt;|-,UAGAAAACAUGAGGAUCACCCAUGUCUGCAG;|-,irregular RNA;|tRNA,-;|Saccharomyces cerevisiae,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,1 µM[RNA];|2.5 µM yeast tRNA,"50 mM KCl, 5 mM MgCl2","50 mM KCl, 5 mM MgCl2",0˚C,30 min,"other_molecular:0.5% NP-40, 20 mM BME, 1:500 Rnasin",Confocal microscopy,gel,"Gel retention assay performed with both CFP tagged protein and Cy5.5-labeled hairpin RNA. The MS2 RNA hairpin is only recruited into the hydrogel when incubated with CFP-FUS214-MS2, which contains both the capacity for binding RNA as well as LC elements required for gel retention.",31,0.3548387096774194,0.1935483870967742,0.2258064516129032,0.2258064516129032,1.0,1.8333333333333333,16.4,0.4375507903583668,"[0.         0.         0.97724987 1.72475733 1.72475733 2.47226479
 1.97724987 0.74750746 1.72475733]",1.2609493314477096,0.6833132841473479,[0 0 1 1 1 1],0.6666666666666666,0.22222222222222224,-6.0,-6.637636184692383,30.6340446472168,1.8373985838207665,-6.0,0.3553738993806704,10.099811925096727,2.780202470891168,0,0,1,1,0.1796403177811785
13,13,13,PMID: 24577897,RNAPS0000182,https://pubmed.ncbi.nlm.nih.gov/24577897,RNA,-,-,"15-mer oligonucleotides RNA (Jia,2014)",15nt,CCAGUCAGUCUACGC,irregular RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,5µMRNA,100 mM NaCl,50 mM Tris-Cl pH 8,RT,-,"crowding agent:16%dextran-sulfate 9-20 kDa,10%PEG 8 kDa",FRAP,liquid,"We acquired and analyzed fluorescence recovery data for fluorescently labeled RNA in droplets from four systems: 16% dextran/10% PEG ,25% DEAE?dextran/25 % PEG,16 % dextran-sulfate/10 % PEG,and 30mM ATP/2 % pLys(all percentages w/v).The sizes of droplets ranged from 1 to 5 μm in diameter, similar in size to proposed fatty acid vesicle based protocell model systems(Adamala and Szostak 2013a), up to 50–75 μm in diameter,similar in size to giant unilamellar vesicles.",15,0.2,0.2,0.2,0.4,0.5,1.0,19.5,0.3974937501201927,[2.72475733 1.49501492 0.74750746 1.97724987],1.7361323964789876,0.5177584476377061,[1 1 1],1.0,0.0,0.0,-0.1023302599787712,14.44109058380127,0.2794547608359385,0.0,0.8470173528265572,26.837975411709234,0.5340991483310975,0,0,1,1,0.1477215927386175
14,14,14,PMID: 26015579,RNAPS0000090,https://pubmed.ncbi.nlm.nih.gov/26015579,RNA + protein,-,-,polyU(50),50nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-8 µM [laf-1];|5 µM polyU,100-400 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",20˚C,> 1 h,-,FRAP,"solute, liquid","RNA is recruited to droplets but does not shift the phase boundary. Addition of 5 µM RNA has no effect on the phase diagram of LAF-1. RNA concentration in the dilute phase vs. total LAF-1 concentration at 250 mM NaCl. Unlike LAF-1, which is in equilibrium with a constant saturation concentration in the dilute phase (Fig. 2D), the RNA concentration in the dilute phase decreases as total protein concentration increases. RNA concentration was directly measured using absorbance at A260 in the bulk phase after centrifugation of droplets.",50,0.0,1.0,0.0,0.0,,,12.25,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,50.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.11598025653561128
15,15,15,PMID: 26406374,RNAPS0000173,https://pubmed.ncbi.nlm.nih.gov/26406374,RNA + protein,-,-,"a random oligonucleotide RNA (Molliex,2015)",44nt,GGGCCCCCGGGUACCGAGCUGCUAAUCAAAACAAAACAAAAGCU,irregular RNA,-,"sp|P09651-2|ROA1_HUMAN Isoform A1-A of Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1|length=135aa|residues=186-320
MASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYN
GFGNDGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGY
GGSSSSSSYGSGRRF",HNRNPA1,LCD,-,135aa(186-320),P09651,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/P09651,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2438","[186-196],[197-208],[309-318]",[190-320],In vitro,100 µM [HNRNPA1 LCD];|100 µM RNA,150 mM NaCl,"50 mM HEPES(pH 7.5), 5 mM DTT",10˚C,-,crowding agent:150 mg/ml Ficoll,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"The two RRM domains and multiple binding motifs for RRMs on the RNA likely mediate weak multivalent interactions that lead to LLPS. Droplets formed by A1-LCD also recruited RNA (Figure 4C), indicating that the LCD of hnRNPA1 binds RNA, as shown previously.",44,0.3636363636363637,0.11363636363636365,0.2272727272727273,0.2954545454545455,0.7692307692307692,3.2,14.857142857142858,0.4337098699522758,"[6.42676453 6.42676453 1.97724987 1.97724987 4.44951466 3.44951466
 0.         0.         0.         0.         0.25249254 0.
 0.        ]",1.919965434907184,5.712711444300942,[1 1 1 1 0 0 0 0],0.5,0.25,-5.699999809265138,-6.314586639404298,36.75864791870117,4.662024582909852,-5.699999809265138,0.3689159396118303,6.0752558488036295,7.006788413415331,0,0,1,1,0.07968639906790376
16,16,16,PMID: 26412307,RNAPS0000175,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P39936|IF4F2_YEAST Eukaryotic initiation factor 4F subunit p130 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TIF4632 PE=1 SV=1|length=85aa|residues=13-97
QQANGYKKFPPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRN
NSQGNAQYYNNRFNNGYRLNNNDYN",elF4GII,IDR,-,85aa(13-97),P39936,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","[14-15],[17-19],[32-44],[64-66],[86-97]",-,In vitro,30 µM [elF4GII IDR];|0.1-4 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,liquid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
17,17,17,PMID: 26412307,RNAPS0000176,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=237aa|residues=1-237
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",FUS,IDR,-,237aa(1-237),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[1-237],"[17-104],[106-237]",In vitro,30 µM [FUS IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,solid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
18,18,18,PMID: 26412307,RNAPS0000177,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P09651-2|ROA1_HUMAN Isoform A1-A of Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1|length=135aa|residues=186-320
MASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYN
GFGNDGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGY
GGSSSSSSYGSGRRF",HNRNPA1,IDR,-,135aa(186-320),P09651,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/P09651,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2438","[186-196],[197-208],[309-318]",[190-320],In vitro,10 µM [HNRNPA1 IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,liquid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
19,19,19,PMID: 26412307,RNAPS0000179,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P40070|LSM4_YEAST U6 snRNA-associated Sm-like protein LSm4 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=LSM4 PE=1 SV=1|length=97aa|residues=91-187
QQINSNNNSNSNGPGHKRYYNNRDSNNNRGNYNRRNNNNGNSNRRPYSQNRQYNNSNSSN
INNSINSINSNNQNMNNGLGGSVQHHFNSSSPQKVEF",LSM4,IDR,-,97aa(91-187),P40070,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0005,http://db.phasep.pro/browse/",-,"[94-102],[108-135],[138-167]",In vitro,30 µM [Lsm4 IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Electron microscopy,solid,"A range of RNA concentrations (0.1–10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10–30 uM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 uM).",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
20,20,20,PMID: 26412307,RNAPS0000180,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI;
tr|C5MKY7|C5MKY7_HCMV Enhanced green fluorescent protein OS=Human cytomegalovirus OX=10359 GN=egfp PE=4 SV=1|length=239aa|residues=1-239|mutation=A207K,L222K,F224K
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPT
LVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTL
VNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLA
DHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLKEKVTAAGITLGMDELYK",PTBP1;|EGFP,-;|-,"protein_mutation:-;|protein_mutation:A207K,L222K,F224K",531aa(1-531);|239aa(1-239),P26599;C5MKY7,"DrLLPS,LLPSDB,PhaSepDB;LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;http://bio-comp.org.cn/llpsdb/protein.php?protein=p0009,http://db.phasep.pro/browse/","-;|[1-7],[24-30],[116-120],[122-122],[180-198],[209-223]","[32-44],[162-179],[306-335];|-",In vitro,10 µM [PTBP1];|100 nM [EGFP];|3.2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
21,21,21,PMID: 26412307,RNAPS0000181,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI;
sp|P39936|IF4F2_YEAST Eukaryotic initiation factor 4F subunit p130 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TIF4632 PE=1 SV=1|length=85aa|residues=13-97
QQANGYKKFPPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRN
NSQGNAQYYNNRFNNGYRLNNNDYN",PTBP1;|TIF4632,[PTBP1]:-;|[TIF4632]:IDR,-;|-,531aa(1-531);|85aa(13-97),P26599;P39936,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","-;|[14-15],[17-19],[32-44],[64-66],[86-97]","[32-44],[162-179],[306-335];|-",In vitro,10 µM [PTBP1];|100 nM [TIF4632 IDR];|3.2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
22,22,22,PMID: 26412307,RNAPS0000259,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI;
sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=237aa|residues=1-237
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1;|FUS,[PTBP1]:-;|[FUS]:IDR,-;|-,531aa(1-531);|237aa(1-237),P26599;P35637,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,10 µM [PTBP1];|100 nM [FUS IDR];|3.2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
23,23,23,PMID: 26412307,RNAPS0000309,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI;
sp|P31483|hTIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=hTIA1 PE=1 SV=3|length=97aa|residues=290-386
MINPVQQQNQIGYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQS
SAPWMGPNYGVQPPQGQNGSMLPNQPSGYRVAGYETQ",PTBP1;|hTIA1,[PTBP1]:-;|[hTIA1]:IDR,-;|-,531aa(1-531);|97aa(290-386),P26599;P31483,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",-;|[354-386],"[32-44],[162-179],[306-335];|-",In vitro,10 µM [PTBP1];|100 nM [hTIA1 IDR];|3.2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
24,24,24,PMID: 26412307,RNAPS0000310,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI;
sp|P40070|LSM4_YEAST U6 snRNA-associated Sm-like protein LSm4 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=LSM4 PE=1 SV=1|length=97aa|residues=91-187
QQINSNNNSNSNGPGHKRYYNNRDSNNNRGNYNRRNNNNGNSNRRPYSQNRQYNNSNSSN
INNSINSINSNNQNMNNGLGGSVQHHFNSSSPQKVEF",PTBP1;|Lsm4,[PTBP1]:-;|[Lsm4]:IDR,-;|-,531aa(1-531);|97aa(91-187),P26599;P40070,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0005,http://db.phasep.pro/browse/",-;|-,"[32-44],[162-179],[306-335];|[94-102],[108-135],[138-167]",In vitro,10 µM [PTBP1];|100 nM [Lsm4 IDR];|3.2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
25,25,25,PMID: 26412307,RNAPS0000366,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI;
sp|P32588|PUB1_YEAST Nuclear and cytoplasmic polyadenylated RNA-binding protein PUB1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PUB1 PE=1 SV=4|length=85aa|residues=243-327
NNNNNNYQQRRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIG
AMPLPSQGQPQQSQTIGLPPQVNPQ",PTBP1;|Pub1,[PTBP1]:-;|[Pub1]:IDR,-;|-,531aa(1-531);|85aa(243-327),P26599;P32588,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",-;|[243-262],"[32-44],[162-179],[306-335];|[243-297],[307-316]",In vitro,10 µM [PTBP1];|100 nM [Pub1 IDR];|3.2 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
26,26,26,PMID: 26412307,RNAPS0000367,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[elF4GII IDR] with PTB residues 1-531 fused to elF4GII residues 13-97|Linker is missing|length=616aa|residues=1-531/13-97
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIQQANGYKKF
PPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRNNSQGNAQYY
NNRFNNGYRLNNNDYN",PTBP1-TIF4632,IDR,-,"616aa(1-531,13-97)","P26599,P39936","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
TIF4632:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","-;|[14-15],[17-19],[32-44],[64-66],[86-97]","[32-44],[162-179],[306-335];|-",In vitro,1.25 µM [PTBP1]-[TIF4632 IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h;24 h,-,Electron microscopy,liquid,"All six PTB-IDR fusions phase separated upon addition of RNA, producing droplets that concentrated both molecules. At 1 hr after RNA addition, droplets formed by the eIF4GII IDR, Pub1 IDR, and Fus IDR fusions were relatively large, round, and separated into discrete structures. By contrast, the Lsm4 IDR, Tia1 IDR, and hnRNPA1 IDR fusions created droplets that were smaller, and often attached to each other in long irregular chains, as though coalescence into larger structures had been aborted.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
27,27,27,PMID: 26412307,RNAPS0000368,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG;
tr|C5MKY7|C5MKY7_HCMV Enhanced green fluorescent protein OS=Human cytomegalovirus OX=10359 GN=egfp PE=4 SV=1|length=239aa|residues=1-239|mutation=A207K,L222K,F224K
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPT
LVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTL
VNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLA
DHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLKEKVTAAGITLGMDELYK",PTBP1-FUS;|EGFP,-;|-,"protein_mutation:-;|protein_mutation:A207K,L222K,F224K","768aa(1-531,1-237);|239aa(1-239)","P26599,P35637;C5MKY7","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB;LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;http://bio-comp.org.cn/llpsdb/protein.php?protein=p0009,http://db.phasep.pro/browse/","-;|[1-237];|[1-7],[24-30],[116-120],[122-122],[180-198],[209-223]","[32-44],[162-179],[306-335];|-",In vitro,1.25 µM [PTBP1]-[FUS IDR];|100 nM [EGFP];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
28,28,28,PMID: 26412307,RNAPS0000369,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS,IDR,-,"768aa(1-531,1-237)","P26599,P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237]",In vitro,≥125 nM [PTBP1]-[FUS IDR];|≥20 nM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 12 h,-,Electron microscopy,liquid,"Adding BSA can greatly reduce the concentration threshold of proteins and RNA for phase transition.Performing the experiment in the presence of 100 mg/ml BSA to mimic protein-crowding effects within the cell allowed the detection of RNA-driven LLPS of the SNAP-PTB-FusIDR at concentrations below 10 nM (Figure 2D), which is below the cellular concentration of many of the abundant components of mRNP granules.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
29,29,29,PMID: 26412307,RNAPS0000370,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG;
sp|P39936|IF4F2_YEAST Eukaryotic initiation factor 4F subunit p130 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TIF4632 PE=1 SV=1|length=85aa|residues=13-97
QQANGYKKFPPHDNQYSGANNSQPNNHYNENLYSAREPHNNKQYQSKNGKYGTNKYNNRN
NSQGNAQYYNNRFNNGYRLNNNDYN",PTBP1-FUS;|elF4GII,[PTBP1-FUS]:IDR;|[elF4GII]:IDR,-;|-,"768aa(1-531,1-237);|85aa(13-97)","P26599,P35637;P39936","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P39936,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0420,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0006,http://db.phasep.pro/browse/","-;|[1-237];|[14-15],[17-19],[32-44],[64-66],[86-97]","[32-44],[162-179],[306-335];|-",In vitro,1.25 µM [PTBP1]-[FUS IDR];|100 nM [elF4GII IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
30,30,30,PMID: 26412307,RNAPS0000371,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG;
sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=237aa|residues=1-237
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG",PTBP1-FUS;|FUS,[PTBP1-FUS]:IDR;|[FUS]:IDR,-;|-,"768aa(1-531,1-237);|237aa(1-237)","P26599,P35637;P35637","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",-;|[1-237];|[1-237],"[32-44],[162-179],[306-335];|[17-104],[106-237];|[17-104],[106-237]",In vitro,1.25 µM [PTBP1]-[FUS IDR];|100 nM [FUS IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
31,31,31,PMID: 26412307,RNAPS0000372,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG;
sp|P31483|hTIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=hTIA1 PE=1 SV=3|length=97aa|residues=290-386
MINPVQQQNQIGYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQS
SAPWMGPNYGVQPPQGQNGSMLPNQPSGYRVAGYETQ",PTBP1-FUS;|hTIA1,[PTBP1-FUS]:IDR;|[hTIA1]:IDR,-;|-,"768aa(1-531,1-237);|97aa(290-386)","P26599,P35637;P31483","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",-;|[1-237];|[354-386],"[32-44],[162-179],[306-335];|-",In vitro,1.25 µM [PTBP1]-[FUS IDR];|100 nM [hTIA1 IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
32,32,32,PMID: 26412307,RNAPS0000046,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG;
sp|P40070|LSM4_YEAST U6 snRNA-associated Sm-like protein LSm4 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=LSM4 PE=1 SV=1|length=97aa|residues=91-187
QQINSNNNSNSNGPGHKRYYNNRDSNNNRGNYNRRNNNNGNSNRRPYSQNRQYNNSNSSN
INNSINSINSNNQNMNNGLGGSVQHHFNSSSPQKVEF",PTBP1-FUS;|Lsm4,[PTBP1-FUS]:IDR;|[Lsm4]:IDR,-;|-,"768aa(1-531,1-237);|97aa(91-187)","P26599,P35637;P40070","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/,https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0005,http://db.phasep.pro/browse/",-;|-,"[32-44],[162-179],[306-335];|[17-104],[106-237];|[94-102],[108-135],[138-167]",In vitro,1.25 µM [PTBP1]-[FUS IDR];|100 nM [Lsm4 IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
33,33,33,PMID: 26412307,RNAPS0000047,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + proteins,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[FUS IDR] with PTB residues 1-531 fused to FUS residues 1-237|Linker is missing|length=768aa|residues=1-531/1-237
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTIMASNDYTQQ
ATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQ
STPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGS
YSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGG
SGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSG;
sp|P32588|PUB1_YEAST Nuclear and cytoplasmic polyadenylated RNA-binding protein PUB1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PUB1 PE=1 SV=4|length=85aa|residues=243-327
NNNNNNYQQRRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIG
AMPLPSQGQPQQSQTIGLPPQVNPQ",PTBP1-FUS;|Pub1,[PTBP1-FUS]:IDR;|[Pub1]:IDR,-;|-,"768aa(1-531,1-237);|85aa(243-327)","P26599,P35637;P32588","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/,https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",-;|[1-237];|[243-262],"[32-44],[162-179],[306-335];|[17-104],[106-237];|[243-297],[307-316]",In vitro,1.25 µM [PTBP1]-[FUS IDR];|100 nM [Pub1 IDR];|0.4 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h,-,Fluorescence microscopy,liquid,"All IDR proteins were recruited into the PTB-Fus IDR+RNA droplets, with partition coefficients ranging from approximately 3 to 12. GFP alone was not selectively recruited into, or excluded from, any of the droplets, with partition coefficients of approximately 1 in all cases. All IDR proteins were recruited into PTB+RNA droplets. But for GFP-Lsm4 IDR, GFP-Tia1 IDR, and GFP-Fus IDR, the recruitment degree into the PTB-Fus IDR+RNA droplets was significantly higher, suggesting that interactions dependent on FusIDR can enhance hetero- and homotypic recruitment of IDRs into the phase-separated droplets.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
34,34,34,PMID: 26412307,RNAPS0000048,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"A fusion protein construct [PTB]-[Pub1 IDR] with PTB residues 1-531 fused to Pub1 residues 243-327|Linker is missing|length=616aa|residues=1-531;243-327
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTINNNNNNYQQ
RRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIGAMPLPSQGQ
PQQSQTIGLPPQVNPQ",PTBP1-PUB1,IDR,-,"616aa(1-531,243-327)","P26599,P32588","PTBP1:DrLLPS,LLPSDB,PhaSepDB,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/,https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",-;|[243-262],"[32-44],[162-179],[306-335];|[243-297],[307-316]",In vitro,2.5 µM [PTBP1]-[PUB1 IDR];|0.8 µM RNA,100 mM NaCl,"20 mM imidazole, pH 7.0, 1 mM DTT, 10% glycerol",RT,> 1 h;24 h,-,Electron microscopy,liquid,"All six PTB-IDR fusions phase separated upon addition of RNA, producing droplets that concentrated both molecules. At 1 hr after RNA addition, droplets formed by the eIF4GII IDR, Pub1 IDR, and Fus IDR fusions were relatively large, round, and separated into discrete structures. By contrast, the Lsm4 IDR, Tia1 IDR, and hnRNPA1 IDR fusions created droplets that were smaller, and often attached to each other in long irregular chains, as though coalescence into larger structures had been aborted.",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
35,35,35,PMID: 26412307,RNAPS0000049,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P32588|PUB1_YEAST Nuclear and cytoplasmic polyadenylated RNA-binding protein PUB1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PUB1 PE=1 SV=4|length=85aa|residues=243-327
NNNNNNYQQRRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMPIG
AMPLPSQGQPQQSQTIGLPPQVNPQ",PUB1,IDR,-,85aa(243-327),P32588,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/",[243-262],"[243-297],[307-316]",In vitro,30 µM [PUB1 IDR];|0.1-10 µM RNA,100 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,-,-,Fluorescence microscopy,liquid,"A range of RNA concentrations (0.1-10 mM) did not promote phase separation of the IDR proteins up to protein concentrations of 10-30 µM, SNAP-eIF4GII IDR, which did phase separate upon addition of RNA (0.1~4 µM).",50,0.5,0.3,0.0,0.2,,1.6666666666666667,14.875,0.4337530580078101,"[0.         0.         0.         0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.         0.74750746 0.        ]",0.1495014924906154,0.08940278502768616,[1 0 1 0 1 0 1 0 1 0],0.5,0.25,0.0,-0.042943477630615234,49.78931427001953,0.10836298095642874,0.0,0.932694889154734,230.70609334798704,0.21598484363398035,0,1,0,1,0.16996998605078645
36,36,36,PMID: 26412307,RNAPS0000050,https://pubmed.ncbi.nlm.nih.gov/26412307,RNA + protein,-,-,"hnRNPA1_ligand RNA (Lin,2015)",46nt,UAGGGACUUAGGGUUCUCUCUAGGGACUUAGGGUUCUCUCUAGGGA,irregular RNA,-,"sp|P09651-2|ROA1_HUMAN Isoform A1-A of Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1|length=320aa|residues=1-320
MSKSESPKEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPNTKRSRGFGFV
TYATVEEVDAAMNARPHKVDGRVVEPKRAVSREDSQRPGAHLTVKKIFVGGIKEDTEEHH
LRDYFEQYGKIEVIEIMTDRGSGKKRGFAFVTFDDHDSVDKIVIQKYHTVNGHNCEVRKA
LSKQEMASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGS
GDGYNGFGNDGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPR
NQGGYGGSSSSSSYGSGRRF",HNRNPA1,-,-,320aa(1-320),P09651,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/P09651,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2438","[1-8],[92-102],[182-196],[197-208],[309-318]",[190-320],In vitro,50 µM [HNRNPA1];|100 µM RNA,300 mM NaCl,"20 mM Tris pH 7.4, 1 mM DTT",RT,> 1 h,crowding agent:100 mg/ml Ficoll400,Electron microscopy,liquid,"If we added PEG as a crowding agent, we observed phase separation of hnRNPA1 without RNA at high protein concentrations, and stimulation of LLPS with RNA addition at lower protein concentrations, demonstrating that RNA can promote LLPS of hnRNPA1. Similar results were observed with Ficoll as a crowding agent.",46,0.17391304347826084,0.32608695652173914,0.32608695652173914,0.17391304347826084,1.875,0.5333333333333333,15.714285714285715,0.4738553863019861,"[1.         1.72475733 1.         1.         1.22974241 1.49501492
 1.72475733 2.72475733 0.         0.         1.97724987 0.74750746
 0.74750746 1.97724987]",1.2391817130735276,0.5399846185905032,[1 0 1 1 1 0 1 1 1],0.7777777777777778,0.1728395061728395,-14.600000381469727,-15.400063514709473,29.57650375366211,11.058931580752272,-9.300000190734863,0.27304255493834617,2.7607597182676007,15.92189808682475,0,0,1,1,0.13766881836099643
37,37,37,PMID: 27212236,RNAPS0000058,https://pubmed.ncbi.nlm.nih.gov/27212236,RNA + protein,-,-,polyU(50),50nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|Q22053|FBRL_CAEEL rRNA 2'-O-methyltransferase fibrillarin OS=Caenorhabditis elegans OX=6239 GN=fib-1 PE=2 SV=1|length=352aa|residues=1-352
MGRPEFNRGGGGGGFRGGRGGDRGGSRGGFGGGGRGGYGGGDRGSFGGGDRGGFRGGRGG
GDRGGFRGGRGGGDRGGFGGRGSPRGGFGGRGSPRGGRGSPRGGRGGAGGMRGGKTVVVE
PHRLGGVFIVKGKEDALATKNMVVGESVYGEKRVSVDDGAGSIEYRVWNPFRSKLAASIM
GGLENTHIKPGTKLLYLGAASGTTVSHCSDVVGPEGIVYAVEFSHRSGRDLLGVAKKRPN
VVPIVEDARHPHKYRMLVGMVDVIFSDVAQPDQARIVALNAQNFLRNGGHAVISIKANCI
DSTAEPEAVFAGEVNKLKEEKFKPLEQVTLEPYERDHAVVVAVYRPVKGKKV",fib1,-,-,352aa(1-352),Q22053,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q22053,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0032,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0019,http://db.phasep.pro/browse/",[1-115],[8-114],In vitro,600 nM [fib1];|5 µM polyU,150 mM NaCl,"20 mM Tris, pH 7.5, 1 mM DTT",RT,> 30 min,-,Microscopy,liquid,"Indeed, in the presence of 5 mg/ml rRNA and 150 mM NaCl, FIB1 condenses into droplets at a protein concentration of 600 nM. FIB1 can phase separate even in the presence of non-specific poly-U50 and heparin, suggesting that electrostatic interactions contribute to droplet assembly.",50,0.0,1.0,0.0,0.0,,,12.25,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,50.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.11598025653561128
38,38,38,PMID: 27374333,RNAPS0000166,https://pubmed.ncbi.nlm.nih.gov/27374333,RNAs + proteins,-;|-,-;|-,(UCUCU)5;|UCUCU,25nt;|5nt,UCUCUUCUCUUCUCUUCUCUUCUCU;|UCUCU,repeat RNA;|-,-;|-,"synthetic protein construct [PTBP1 RRM]4|length=510aa
GGSWGGSKGDSRSAGVPSRVIHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIE
MNTEEAANTMVNYYTSVTPVLRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSG
NLGGSGGSGGSGGSKGDSRSAGVPSRVIHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKG
KNQAFIEMNTEEAANTMVNYYTSVTPVLRGQPIYIQFSNHKELKTDSSPNQARAQAALQA
VNSVQSGNLGGSGGSGGSGGSKGDSRSAGVPSRVIHIRKLPIDVTEGEVISLGLPFGKVT
NLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPVLRGQPIYIQFSNHKELKTDSSPNQAR
AQAALQAVNSVQSGNLGGSGGSGGSGGSKGDSRSAGVPSRVIHIRKLPIDVTEGEVISLG
LPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPVLRGQPIYIQFSNHKELKTD
SSPNQARAQAALQAVNSVQSGNLGGSCGGS;
synthetic protein construct [PTBP1 RRM]|length=115aa
KGDSRSAGVPSRVIHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAA
NTMVNYYTSVTPVLRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNL",PTBP1;|PTBP1,[PTBP1]:(RRM)4;|[PTBP1]:RRM,-;|-,510aa;|115aa,P26599;P26599,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-;|-,"[32-44],[162-179],[306-335];|[32-44]",In vitro,30-70 µM [PTBP1 RRM]4(Module Concentration);|200 nM [RFP-RRM];|20-60 µM UCUCU(5)(Module Concentration);|200 nM UCUCU,"100 mM NaCl, 1 mM MgCl2","20 mM Imidazole, pH 7.0, 50 mM sodiµM Phosphate, pH 6.0",RT,-,crowding agent:100 mg/ml PEG 3350,Confocal microscopy,liquid,"To model client recruitment into the bodies, we engineered a series of fluorescently labeled, monovalent clients (containing a single element that binds the scaffold) and characterized their partitioning into droplets generated by their cognate scaffolds. We mixed (1) GFP-SUMO and RFP-SIM (or GFP-SIM) with polySUMO/polySIM; (2) GFP-PRM and RFP-SH3 with polySH3/polyPRM; and s GFP-RRM and UCUCU-AlexaFluor647 (AF647) with PTB/polyUCUCU. Client recruitment in all three systems was qualitatively similar. Clients partitioned asymmetrically about the diagonal of the phase diagram (the line of equal scaffold stoichiometry) or near to it; each client was enriched only on the side where its cognate scaffold was in stoichiometric excess in the solution.",25,0.0,0.6,0.0,0.4,,,16.0,0.4823076390268878,"[0.74750746 1.22974241 1.22974241 0.74750746 0.97724987 0.74750746
 1.22974241 1.22974241 0.74750746]",0.9873610378065673,0.05169067733382714,[1 1 1 1 1 1],1.0,0.0,0.0,2.189611297113178e-15,32.0,0.0,0.0,1.0000000000000036,0.0,0.0,0,0,1,1,0.15707437238683175
39,39,39,PMID: 27914198,RNAPS0000091,https://pubmed.ncbi.nlm.nih.gov/27914198,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1|length=544aa|residues=1-544
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSS",meg-3,IDR,-,544aa(1-544),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492]",In vitro,0.1-5 µM [MEG3 IDR];|0.1-10 µM polyU,150 mM NaCl,"25 mM HEPES, pH7.4",RT,≤ 10 min,-,Confocal microscopy,liquid,"MEG-3 and MEG-3IDR behaved similarly to each other, except that in the low concentration range (<5 mM), MEG-3 formed more condensates than MEG-3IDR, and in the high concentration range (>5 mM) MEG-3IDR tended to form larger condensates.",30,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,30.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.1482762666082112
40,40,40,PMID: 27914198,RNAPS0000092,https://pubmed.ncbi.nlm.nih.gov/27914198,RNA + proteins,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1|length=862aa|residues=1-862
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ;
sp|Q9XUB2|MEX5_CAEEL Zinc finger protein mex-5 OS=Caenorhabditis elegans OX=6239 GN=mex-5 PE=1 SV=1|length=233aa|residues=236-468
TMSAEKENHFHEHRGEKFGRRGFPIPETDSQQPPNYKTRLCMMHASGIKPCDMGARCKFA
HGLKELRATDAPARYPNNKYKTKLCKNFARGGTGFCPYGLRCEFVHPTDKEFQNIPPYQR
MSHDDQDYDQDVIPEDYVVARHQPRFMRTGGRATTPTKVMLKHRNVAGSMMCLSNAGRDL
QAGGDYNQPESNEDDLPPHLRRNRRENPPMNKRRTSLSTKWTSEENLGLRGHY",meg-3;|mex-5,-;|-,-;|-,862aa(1-862);|233aa(236-468),Q9TXM1;Q9XUB2,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2100,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0146,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534];|[243-269],[414-468]","[14-27],[154-168],[456-492],[559-572],[799-808];|-",In vitro,5 µM [MEG3];|3.5 µM [MEX-5 236-468];|20 µM polyU,150 mM NaCl,"25 mM HEPES, pH7.4",RT,≤ 10 min,-,Confocal microscopy,liquid,"We pre-incubated recombinant MEX-5 with poly-U in buffer for 30 min before adding MEG-3. We found that MEX-5 strongly inhibited MEG-3 phase separation induced by RNA. Addition of excess RNA (3-fold increase) restored robust phase separation in the presence of MEX-5. Additionally, MEX-5 had no effect on the phase separation of MEG-3 in the absence of RNA.",30,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,30.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.1482762666082112
41,41,41,PMID: 28283059,RNAPS0000093,https://pubmed.ncbi.nlm.nih.gov/28283059,RNA + protein,-,-,polyA(19),19nt,AAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|P04147|PABP_YEAST Polyadenylate-binding protein, cytoplasmic and nuclear OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAB1 PE=1 SV=4|length=597aa|residues=2-577
MGSSHHHHHHHHASENLYFQSADITDKTAEQLENLNIQDDQKQAATGSESQSVENSSASL
YVGDLEPSVSEAHLYDIFSPIGSVSSIRVCRDAITKTSLGYAYVNFNDHEAGRKAIEQLN
YTPIKGRLCRIMWSQRDPSLRKKGSGNIFIKNLHPDIDNKALYDTFSVFGDILSSKIATD
ENGKSKGFGFVHFEEEGAAKEAIDALNGMLLNGQEIYVAPHLSRKERDSQLEETKAHYTN
LYVKNINSETTDEQFQELFAKFGPIVSASLEKDADGKLKGFGFVNYEKHEDAVKAVEALN
DSELNGEKLYVGRAQKKNERMHVLKKQYEAYRLEKMAKYQGVNLFVKNLDDSVDDEKLEE
EFAPYGTITSAKVMRTENGKSKGFGFVCFSTPEEATKAITEKNQQIVAGKPLYVAIAQRK
DVRRSQLAQQIQARNQMRYQQATAAAAAAAAGMPGQFMPPMFYGVMPPRGVPFNGPNPQQ
MNPMGGMPKNGMPPQFRNGPVYGVPPQGGFPRNANDNNQFYQQKQRQALGEQLYKKVSAK
TSNEEAAGKITGMILDLPPQEVFPLLESDELFEQHYKEASAAYESFKKEQEQQTEQA",Pab1,-,-,597aa(1-597),P04147,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P04147,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0254,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0048,http://db.phasep.pro/browse/","[1-12],[29-65],[118-118],[130-143],[199-207],[217-231],[307-327],[357-357],[414-450],[471-501],[549-566],[588-596]",-,In vitro,15 µM [Pab1 2-577];|100 µg/ml polyA,"150 mM KCl, 2.5 mM MgCl2",20 mM HEPES pH 6.4,46˚C,> 30 min,-,Gel filtration,solute,"Adding RNA increasingly inhibited Pab1 demixing. Pab1 releases RNA and demixes, forming particles stabilized by protein-protein interactions, consistent with its behavior in vivo.",19,1.0,0.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0.],0.0,0.0,[0 0 0],0.0,0.0,0.0,5.474028242782945e-16,19.0,0.0,0.0,1.0000000000000009,0.0,0.0,1,0,0,1,0.12373393955129636
42,42,42,PMID: 28306503,RNAPS0000094,https://pubmed.ncbi.nlm.nih.gov/28306503,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,PRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPR,poly(proline−arginine)20,-,-,[PR]20:40aa,-,-,-,-,-,In vitro,0-250 µM [PR]20;|0-1 µg/µl polyU,-,100mM K2HPO4/KH2PO4 buffer,RT,-,-,"Turbidity measurement,FRAP,Cryo-EM",liquid,"This raised the idea that biological anions could support PR LLPS as well. Indeed, addition of polyU RNA promoted LLPS in a dose-dependent manner even without molecular crowders being present.",30,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,30.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.1482762666082112
43,43,43,PMID: 28306503,RNAPS0000095,https://pubmed.ncbi.nlm.nih.gov/28306503,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2
MSTLCPPPSPAVAKTEIALSGKSPLLAATFAYWDNILGPRVRHIWAPKTEQVLLSDGEIT
FLANHTLNGEILRNAESGAIDVKFFVLSEKGVIIVSLIFDGNWNGDRSTYGLSIILPQTE
LSFYLPLHRVCVDRLTHIIRKGRIWMHKERQENVQKIILEGTERMEDQGQSIIPMLTGEV
IPVMELLSSMKSHSVPEEIDIADTVLNDDDIGDSCHEGFLLNAISSHLQTCGCSVVVGSS
AEKVNKIVRTLCLFLTPAERKCSRLCEAESSFKYESGLFVQGLLKDSTGSFVLPFRQVMY
APYPTTHIDVDVNTVKQMPPCHEHIYNQRRYMRSELTAFWRATSEEDMAQDTIIYTDESF
TPDLNIFQDVLHRDTLVKAFLDQVFQLKPGLSLRSTFLAQFLLVLHRKALTLIKYIEDDT
QKGKKPFKSLRNLKIDLDLTAEGDLNIIMALAEKIKPGLHSFIFGRPFYTSVQERDVLMT
F",C9orf72,-,-,481aa(1-481),Q96LT7,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0616,http://db.phasep.pro/browse/",-,-,In vitro,0.05-0.25 µg/µL [polyU];|20 µM [C9orf72],200 µM NaCl,"50mM MES,pH 5",RT,≤ 200 min,-,FRAP,liquid,"Similar to the PEG-induced LLPS, PR20-RNA droplets were highly circular (Figure 4A). They also continuously increased in size over time, as measured by dynamic light scattering (DLS).",30,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,30.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.1482762666082112
44,44,44,PMID: 28472520,RNAPS0000097,https://pubmed.ncbi.nlm.nih.gov/28472520,RNA + protein,-,-,(GA-rich U5)30,30nt,GGAGUGAGAGGAAGGAAGGGAAGAAAGAAG,nucleotide rich RNA,-,"sp|O94752|EDC3_SCHPO Enhancer of mRNA-decapping protein 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=edc3 PE=1 SV=1|length=331aa|residues=1-71,195-454
MSVADFYGSNVEVLLNNDSKARGVITNFDSSNSILQLRLANDSTKSIVTKDIKDLRILPK
NEIMPKNGTKSKPFVDENIPAELHTTTGDILKPITPEQLSQGIALAIAKTSTDIVVENAA
QLLSQFVFSVLGGHKRLSSRNHNSQPLVCILVGSHDHASAAVAAGRRLCAIGIKVVLRLL
TPFNVDNRQLLMFQAAGGYIPTENFDQFLNKLTSPIELVVDVLTGFHPSIDKNSHALIQW
ANDLNVLILSVDIPSGYTVQKKNTAILPKWTLALGAVTTTLAQAALVKQAAGVSVFVGNL
GTGSQTWAELGILESQVTGQYLAQISCTSTN",edc3,-,-,"331aa(1-71,195-454)",O94752,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/O94752,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0071,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0103,http://db.phasep.pro/browse/",-,[394-415],In vitro,0-60 µM [edc3△IDR];|0.00-15.0 µM RNA,125 mM NaCl,"25 mM HEPES, pH 7.3, 1 mM DTT",30˚C,immediately,-,Turbidity measurement,solute,"This effect is even more prominent in RNA:Edc3 phase diagrams, where the removal of the IDR results in the almost complete loss of LLPS (Figure4B). These data indicate that the IDR in Edc3 is an important RNA interaction site.",30,0.4666666666666667,0.03333333333333333,0.5,0.0,,14.0,14.0,0.4675589168157056,"[2.72475733 1.49501492 1.72475733 2.72475733 1.72475733 1.
 1.72475733 0.74750746 0.97724987]",1.6492843231039491,0.4489526553851035,[1 1 1 1 0 1],0.8333333333333334,0.1388888888888889,0.0,-0.00604035798460245,29.98062515258789,0.009752801968035695,0.0,0.9902471980319668,1538.0195403497094,0.019480435690404484,0,0,1,1,0.1309212463939291
45,45,45,PMID: 28472520,RNAPS0000098,https://pubmed.ncbi.nlm.nih.gov/28472520,RNA + proteins,-,-,(GA-rich)100,100nt,GGGAAGGAAGGGAAUAAAGAAGGGAAGAGGAAGGAGAGGAGGGAAGAAAGAAGAGGAGAGGAAGGAAGGGAAGAAAGAAGAGGGAAGAGGAAGGAGAGGA,nucleotide rich RNA,-,"sp|Q9P805|DCP1_SCHPO mRNA-decapping enzyme subunit 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp1 PE=1 SV=1|length=127aa|residues=1-127
MEDENILRNAVNLQVLKFHYPEIESIIDIASHVAVYQFDVGSQKWLKTSIEGTFFLVKDQ
RARVGYVILNRNSPENLYLFINHPSNVHLVDRYLIHRTENQHVVGLWMFDPNDMSRIFNI
VKESLLR;
sp|O13828|DCP2_SCHPO mRNA decapping complex subunit 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp2 PE=1 SV=1|length=476aa|residues=1-289,555-741
MSFTNATFSQVLDDLSARFILNLPAEEQSSVERLCFQIEQAHWFYEDFIRAQNDQLPSLG
LRVFSAKLFAHCPLLWKWSKVHEEAFDDFLRYKTRIPVRGAIMLDMSMQQCVLVKGWKAS
SGWGFPKGKIDKDESDVDCAIREVYEETGFDCSSRINPNEFIDMTIRGQNVRLYIIPGIS
LDTRFESRTRKEISKIEWHNLMDLPTFKKNKPQTMKNKFYMVIPFLAPLKKWIKKRNIAN
NTTKEKNISVDVDADASSQLLSLLKSSTAPSDLATPQPSTFPQPPVESHHSAQLLQALLH
PSATETKEETPKKTSDSLSLLTLLKSGLPTPANDLQNKSQNNERKASSQVKELEVKNYSK
STDLLKKTLRIPRNDEPLEAANQFDLLKVSPQQKSEVPPKRNELSQSKLKNRKKKENSET
NKNHVDMSPGFVKILKRSPLADQKKEDTQESDFKGSDDHFLSYLQSVVSSNSNGLH;
sp|O94752|EDC3_SCHPO Enhancer of mRNA-decapping protein 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=edc3 PE=1 SV=1|length=454aa|residues=1-454
MSVADFYGSNVEVLLNNDSKARGVITNFDSSNSILQLRLANDSTKSIVTKDIKDLRILPK
NEIMPKNGTKSPSTNSTKLKSAETYSSKNKWSMDCDEEFDFAANLEKFDKKQVFAEFREK
DKKDPAKLLVSHNKSPNRNYHHKQNVLGPSVKDEFVDLPSAGSQINGIDAVLSSSSNGHV
TPGSKKGSRETLKKKPFVDENIPAELHTTTGDILKPITPEQLSQGIALAIAKTSTDIVVE
NAAQLLSQFVFSVLGGHKRLSSRNHNSQPLVCILVGSHDHASAAVAAGRRLCAIGIKVVL
RLLTPFNVDNRQLLMFQAAGGYIPTENFDQFLNKLTSPIELVVDVLTGFHPSIDKNSHAL
IQWANDLNVLILSVDIPSGYTVQKKNTAILPKWTLALGAVTTTLAQAALVKQAAGVSVFV
GNLGTGSQTWAELGILESQVTGQYLAQISCTSTN",dcp1;|dcp2;|edc3,-;|-;|-,-;|-;|-,"127aa(1-127);|476aa(1-289,555-741);|454aa(1-454)",Q9P805;O13828;O94752,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0003,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0143,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O13828,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0124,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0102,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O94752,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0071,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0103,http://db.phasep.pro/browse/",-;|[555-741];|[173-192],-;|-;|[394-415],In vitro,0-30 µM [dcp1];|0-30 µM [dcp2 1-289 555-741];|0-60 µM [edc3];|1.5 µM RNA,125 mM NaCl,"25 mM HEPES, pH 7.3, 1 mM DTT",30˚C,immediately,-,Turbidity measurement,"solute, liquid","Keeping the number of nucleotides constant, RNA substrates of 15 nt or less have no or only a weak effect on the phase diagrams, whereas substrates of 30 or more nucleotides have a similarly strong effect. This shows that three 30 mer RNAs have the same effect as one 100mer RNA, which provides strong evidence that the individual protein:RNA interactions are independent. In addition, our data indicate that the RNA length that is required to efficiently link into the interaction network is around 30 nt.",100,0.49,0.01,0.5,0.0,,49.0,14.625,0.4888880264448384,"[1.97724987 0.25249254 1.97724987 0.         0.         0.
 1.97724987 1.97724987 1.72475733 1.72475733 1.22974241 2.72475733
 3.44951466 1.         0.97724987 0.74750746 0.97724987 1.72475733
 2.72475733 1.22974241 1.72475733 2.72475733 1.         0.97724987
 0.74750746 0.97724987 2.47226479 1.97724987 1.72475733 1.72475733
 1.22974241 2.72475733]",1.512541757835389,0.7323087622759286,[1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1],0.9,0.09000000000000001,0.0,-0.005486239679157735,99.98381042480469,0.008862096160217534,0.0,0.9911379038397912,5642.00603289015,0.01770902382327401,0,0,1,1,0.05186202992653799
46,46,46,PMID: 28472520,RNAPS0000099,https://pubmed.ncbi.nlm.nih.gov/28472520,RNA + proteins,-,-,(GA-rich)15,15nt,GGAGAAGAGAAGGAG,nucleotide rich RNA,-,"sp|Q9P805|DCP1_SCHPO mRNA-decapping enzyme subunit 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp1 PE=1 SV=1|length=127aa|residues=1-127
MEDENILRNAVNLQVLKFHYPEIESIIDIASHVAVYQFDVGSQKWLKTSIEGTFFLVKDQ
RARVGYVILNRNSPENLYLFINHPSNVHLVDRYLIHRTENQHVVGLWMFDPNDMSRIFNI
VKESLLR;
sp|O13828|DCP2_SCHPO mRNA decapping complex subunit 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp2 PE=1 SV=1|length=476aa|residues=1-289,555-741
MSFTNATFSQVLDDLSARFILNLPAEEQSSVERLCFQIEQAHWFYEDFIRAQNDQLPSLG
LRVFSAKLFAHCPLLWKWSKVHEEAFDDFLRYKTRIPVRGAIMLDMSMQQCVLVKGWKAS
SGWGFPKGKIDKDESDVDCAIREVYEETGFDCSSRINPNEFIDMTIRGQNVRLYIIPGIS
LDTRFESRTRKEISKIEWHNLMDLPTFKKNKPQTMKNKFYMVIPFLAPLKKWIKKRNIAN
NTTKEKNISVDVDADASSQLLSLLKSSTAPSDLATPQPSTFPQPPVESHHSAQLLQALLH
PSATETKEETPKKTSDSLSLLTLLKSGLPTPANDLQNKSQNNERKASSQVKELEVKNYSK
STDLLKKTLRIPRNDEPLEAANQFDLLKVSPQQKSEVPPKRNELSQSKLKNRKKKENSET
NKNHVDMSPGFVKILKRSPLADQKKEDTQESDFKGSDDHFLSYLQSVVSSNSNGLH;
sp|O94752|EDC3_SCHPO Enhancer of mRNA-decapping protein 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=edc3 PE=1 SV=1|length=454aa|residues=1-454
MSVADFYGSNVEVLLNNDSKARGVITNFDSSNSILQLRLANDSTKSIVTKDIKDLRILPK
NEIMPKNGTKSPSTNSTKLKSAETYSSKNKWSMDCDEEFDFAANLEKFDKKQVFAEFREK
DKKDPAKLLVSHNKSPNRNYHHKQNVLGPSVKDEFVDLPSAGSQINGIDAVLSSSSNGHV
TPGSKKGSRETLKKKPFVDENIPAELHTTTGDILKPITPEQLSQGIALAIAKTSTDIVVE
NAAQLLSQFVFSVLGGHKRLSSRNHNSQPLVCILVGSHDHASAAVAAGRRLCAIGIKVVL
RLLTPFNVDNRQLLMFQAAGGYIPTENFDQFLNKLTSPIELVVDVLTGFHPSIDKNSHAL
IQWANDLNVLILSVDIPSGYTVQKKNTAILPKWTLALGAVTTTLAQAALVKQAAGVSVFV
GNLGTGSQTWAELGILESQVTGQYLAQISCTSTN",dcp1;|dcp2;|edc3,-;|-;|-,-;|-;|-,"127aa(1-127);|476aa(1-289,555-741);|454aa(1-454)",Q9P805;O13828;O94752,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0003,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0143,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O13828,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0124,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0102,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O94752,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0071,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0103,http://db.phasep.pro/browse/",-;|[555-741];|[173-192],-;|-;|[394-415],In vitro,0-30 µM [dcp1];|0-30 µM [dcp2 1-289 555-741];|0-60 µM [edc3];|10 µM RNA,125 mM NaCl,"25 mM HEPES, pH 7.3, 1 mM DTT",30˚C,immediately,-,Turbidity measurement,"solute, liquid","Keeping the number of nucleotides constant, RNA substrates of 15 nt or less have no or only a weak effect on the phase diagrams, whereas substrates of 30 or more nucleotides have a similarly strong effect. This shows that three 30 mer RNAs have the same effect as one 100mer RNA, which provides strong evidence that the individual protein:RNA interactions are independent. In addition, our data indicate that the RNA length that is required to efficiently link into the interaction network is around 30 nt.",15,0.4666666666666667,0.0,0.5333333333333333,0.0,,,19.5,0.4584962500721156,[1.72475733 1.22974241 1.22974241 1.22974241],1.3534961368252825,0.045944957977471015,[1 1 1],1.0,0.0,0.0,1.094805648556589e-15,15.0,0.0,0.0,1.0000000000000018,0.0,0.0,0,0,1,1,0.16045098910794653
47,47,47,PMID: 28472520,RNAPS0000100,https://pubmed.ncbi.nlm.nih.gov/28472520,RNA + proteins,-,-,(GA-rich U5)30,30nt,GGAGUGAGAGGAAGGAAGGGAAGAAAGAAG,nucleotide rich RNA,-,"sp|Q9P805|DCP1_SCHPO mRNA-decapping enzyme subunit 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp1 PE=1 SV=1|length=127aa|residues=1-127
MEDENILRNAVNLQVLKFHYPEIESIIDIASHVAVYQFDVGSQKWLKTSIEGTFFLVKDQ
RARVGYVILNRNSPENLYLFINHPSNVHLVDRYLIHRTENQHVVGLWMFDPNDMSRIFNI
VKESLLR;
sp|O13828|DCP2_SCHPO mRNA decapping complex subunit 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp2 PE=1 SV=1|length=476aa|residues=1-289,555-741
MSFTNATFSQVLDDLSARFILNLPAEEQSSVERLCFQIEQAHWFYEDFIRAQNDQLPSLG
LRVFSAKLFAHCPLLWKWSKVHEEAFDDFLRYKTRIPVRGAIMLDMSMQQCVLVKGWKAS
SGWGFPKGKIDKDESDVDCAIREVYEETGFDCSSRINPNEFIDMTIRGQNVRLYIIPGIS
LDTRFESRTRKEISKIEWHNLMDLPTFKKNKPQTMKNKFYMVIPFLAPLKKWIKKRNIAN
NTTKEKNISVDVDADASSQLLSLLKSSTAPSDLATPQPSTFPQPPVESHHSAQLLQALLH
PSATETKEETPKKTSDSLSLLTLLKSGLPTPANDLQNKSQNNERKASSQVKELEVKNYSK
STDLLKKTLRIPRNDEPLEAANQFDLLKVSPQQKSEVPPKRNELSQSKLKNRKKKENSET
NKNHVDMSPGFVKILKRSPLADQKKEDTQESDFKGSDDHFLSYLQSVVSSNSNGLH;
sp|O94752|EDC3_SCHPO Enhancer of mRNA-decapping protein 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=edc3 PE=1 SV=1|length=331aa|residues=1-71,195-454
MSVADFYGSNVEVLLNNDSKARGVITNFDSSNSILQLRLANDSTKSIVTKDIKDLRILPK
NEIMPKNGTKSKPFVDENIPAELHTTTGDILKPITPEQLSQGIALAIAKTSTDIVVENAA
QLLSQFVFSVLGGHKRLSSRNHNSQPLVCILVGSHDHASAAVAAGRRLCAIGIKVVLRLL
TPFNVDNRQLLMFQAAGGYIPTENFDQFLNKLTSPIELVVDVLTGFHPSIDKNSHALIQW
ANDLNVLILSVDIPSGYTVQKKNTAILPKWTLALGAVTTTLAQAALVKQAAGVSVFVGNL
GTGSQTWAELGILESQVTGQYLAQISCTSTN",dcp1;|dcp2;|edc3,-;|-;|-,-;|-;|-,"127aa(1-127);|476aa(1-289,555-741);|331aa(1-71,195-454)",Q9P805;O13828;O94752,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0003,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0143,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O13828,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0124,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0102,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O94752,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0071,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0103,http://db.phasep.pro/browse/",-;|[555-741];|-,-;|-;|[394-415],In vitro,0-30 µM [dcp1];|0-30 µM [dcp2 1-289 555-741];|0-60 µM [edc3△IDR];|5 µM RNA,125 mM NaCl,"25 mM HEPES, pH 7.3, 1 mM DTT",30˚C,immediately,-,Turbidity measurement,"solute, liquid","In the absence of RNA, we observe that deletion of the IDR moves the phase separation boundary slightly toward higher concentrations. More importantly, the addition of RNA to Edc3 lacking the IDR does not result in the strong shift of the phase separation boundary toward lower protein concentrations as observed for full-length Edc3.",30,0.4666666666666667,0.03333333333333333,0.5,0.0,,14.0,14.0,0.4675589168157056,"[2.72475733 1.49501492 1.72475733 2.72475733 1.72475733 1.
 1.72475733 0.74750746 0.97724987]",1.6492843231039491,0.4489526553851035,[1 1 1 1 0 1],0.8333333333333334,0.1388888888888889,0.0,-0.00604035798460245,29.98062515258789,0.009752801968035695,0.0,0.9902471980319668,1538.0195403497094,0.019480435690404484,0,0,1,1,0.1309212463939291
48,48,48,PMID: 28472520,RNAPS0000101,https://pubmed.ncbi.nlm.nih.gov/28472520,RNA + proteins,-,-,(GA-rich)63,63nt,GGAAGGAGAGGAAGGAAGGGAAGAAAGAAGAGGAGAGGAAGGAAGGGAAGAAAGAAGGGAAGA,nucleotide rich RNA,-,"sp|Q9P805|DCP1_SCHPO mRNA-decapping enzyme subunit 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp1 PE=1 SV=1|length=127aa|residues=1-127
MEDENILRNAVNLQVLKFHYPEIESIIDIASHVAVYQFDVGSQKWLKTSIEGTFFLVKDQ
RARVGYVILNRNSPENLYLFINHPSNVHLVDRYLIHRTENQHVVGLWMFDPNDMSRIFNI
VKESLLR;
sp|O13828|DCP2_SCHPO mRNA decapping complex subunit 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dcp2 PE=1 SV=1|length=476aa|residues=1-289,555-741
MSFTNATFSQVLDDLSARFILNLPAEEQSSVERLCFQIEQAHWFYEDFIRAQNDQLPSLG
LRVFSAKLFAHCPLLWKWSKVHEEAFDDFLRYKTRIPVRGAIMLDMSMQQCVLVKGWKAS
SGWGFPKGKIDKDESDVDCAIREVYEETGFDCSSRINPNEFIDMTIRGQNVRLYIIPGIS
LDTRFESRTRKEISKIEWHNLMDLPTFKKNKPQTMKNKFYMVIPFLAPLKKWIKKRNIAN
NTTKEKNISVDVDADASSQLLSLLKSSTAPSDLATPQPSTFPQPPVESHHSAQLLQALLH
PSATETKEETPKKTSDSLSLLTLLKSGLPTPANDLQNKSQNNERKASSQVKELEVKNYSK
STDLLKKTLRIPRNDEPLEAANQFDLLKVSPQQKSEVPPKRNELSQSKLKNRKKKENSET
NKNHVDMSPGFVKILKRSPLADQKKEDTQESDFKGSDDHFLSYLQSVVSSNSNGLH;
sp|O94752|EDC3_SCHPO Enhancer of mRNA-decapping protein 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=edc3 PE=1 SV=1|length=454aa|residues=1-454
MSVADFYGSNVEVLLNNDSKARGVITNFDSSNSILQLRLANDSTKSIVTKDIKDLRILPK
NEIMPKNGTKSPSTNSTKLKSAETYSSKNKWSMDCDEEFDFAANLEKFDKKQVFAEFREK
DKKDPAKLLVSHNKSPNRNYHHKQNVLGPSVKDEFVDLPSAGSQINGIDAVLSSSSNGHV
TPGSKKGSRETLKKKPFVDENIPAELHTTTGDILKPITPEQLSQGIALAIAKTSTDIVVE
NAAQLLSQFVFSVLGGHKRLSSRNHNSQPLVCILVGSHDHASAAVAAGRRLCAIGIKVVL
RLLTPFNVDNRQLLMFQAAGGYIPTENFDQFLNKLTSPIELVVDVLTGFHPSIDKNSHAL
IQWANDLNVLILSVDIPSGYTVQKKNTAILPKWTLALGAVTTTLAQAALVKQAAGVSVFV
GNLGTGSQTWAELGILESQVTGQYLAQISCTSTN",dcp1;|dcp2;|edc3,-;|-;|-,-;|-;|-,"127aa(1-127);|476aa(1-289,555-741);|454aa(1-454)",Q9P805;O13828;O94752,"DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0003,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0143,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O13828,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0124,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0102,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/O94752,http://llps.biocuckoo.cn/view.php?id=LLPS-Scp-0071,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0103,http://db.phasep.pro/browse/",-;|[555-741];|[173-192],-;|-;|[394-415],In vitro,0-30 µM [dcp1];|0-30 µM [dcp2 1-289 555-741];|0-60 µM [edc3];|2.5 µM RNA,125 mM NaCl,"25 mM HEPES, pH 7.3, 1 mM DTT",30˚C,immediately,-,Turbidity measurement,"solute, liquid","Keeping the number of nucleotides constant, RNA substrates of 15 nt or less have no or only a weak effect on the phase diagrams, whereas substrates of 30 or more nucleotides have a similarly strong effect. This shows that three 30 mer RNAs have the same effect as one 100mer RNA, which provides strong evidence that the individual protein:RNA interactions are independent. In addition, our data indicate that the RNA length that is required to efficiently link into the interaction network is around 30 nt.",63,0.5079365079365079,0.0,0.492063492063492,0.0,,,15.1,0.4902515087574607,"[2.72475733 1.72475733 1.72475733 2.72475733 1.72475733 1.
 1.72475733 0.74750746 0.97724987 1.72475733 1.72475733 1.72475733
 2.72475733 1.72475733 1.         1.72475733 0.74750746 0.97724987
 1.         1.72475733]",1.5935679978786734,0.3629588083262077,[1 1 1 1 0 1 1 1 1 1 0 1],0.8333333333333334,0.1388888888888889,0.0,2.189611297113178e-15,63.0,0.0,0.0,1.0000000000000036,0.0,0.0,0,0,1,1,0.1510723054618467
49,49,49,PMID: 28488892,RNAPS0000102,https://pubmed.ncbi.nlm.nih.gov/28488892,Undefined,NCBI ID:406933,https://www.ncbi.nlm.nih.gov/gene/406933,hsa-miR-141-3p,22nt(1-22),CCAUCUUUACCAGACAGUGUUA,miRNA,Homo sapiens,"sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRS
ASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAK
LMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISS
PGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSE
EMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASIT
QSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPV
PELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVAS
FSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSS
AIPVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSI
ILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL",DCP1A,-,-,582aa(1-582),Q9NPI6,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0531,-,-,In vivo,-,-,-,RT,-,organelle:P-body;cell:HeLa cells,"Immunofluorescence,Confocal microscopy",-,"To further confirm that Cy3-miRNA-141 can also be recruited into endo-P-bodies, we analyzed the P-bodies using a specific antibody for Dcp1a and found that miRNA was localized in the endo-P-bodies soon after being transfected into the cells (Fig. 3C).",22,0.2727272727272727,0.3181818181818182,0.13636363636363635,0.2727272727272727,0.5,0.8571428571428571,18.0,0.4365620099311843,[1.72475733 0.         0.         2.72475733 1.49501492 0.74750746],1.1153395080615045,0.9548390136547464,[1 1 1 1],1.0,0.0,0.0,-0.4780838787555695,19.019960403442386,1.4900949599061946,0.0,0.460378525107617,7.382079864690287,2.717438498510768,0,0,1,1,0.16454444370719007
50,50,50,PMID: 28562589,RNAPS0000353,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)10,30nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",30,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.0,0.50718800023077,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481]",2.4594848111974885,0.0,[1 1 1 1 1 1],1.0,0.0,-8.300000190734862,-8.38075065612793,28.75729179382324,0.9428581159585021,-8.300000190734862,0.8772004628937433,24.136938255704642,1.7970497863916937,0,1,0,1,0.12832910933636704
51,51,51,PMID: 28562589,RNAPS0000354,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)20,60nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",60,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,15.222222222222221,0.5181608175434552,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,1.9721522630525289e-31,[1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-18.299999237060547,-19.09359169006348,32.81582260131836,15.843402506624091,0.0,0.27592402188100873,2.3568502965376115,24.028486054215183,0,1,0,1,0.1146572902711106
52,52,52,PMID: 28562589,RNAPS0000356,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)20,60nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",60,0.0,0.3333333333333333,0.3333333333333333,0.3333333333333333,1.0,,15.222222222222221,0.5181608175434552,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,1.9721522630525289e-31,[1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-22.100000381469727,-22.89026069641113,33.92575454711914,15.955686116326664,0.0,0.2774204645416558,2.4701232607840184,23.0425026346035,0,1,0,1,0.11405564302075044
53,53,53,PMID: 28562589,RNAPS0000357,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)31,93nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",93,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.733333333333333,0.5223171877376531,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,7.888609052210118e-31,[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-33.299999237060554,-34.23328399658203,49.73334503173828,27.729324059370718,0.0,0.21996590809841726,2.1494091896282894,45.121585278228274,0,1,0,1,0.09870197762332406
54,54,54,PMID: 28562589,RNAPS0000358,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)31,93nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",93,0.0,0.3333333333333333,0.3333333333333333,0.3333333333333333,1.0,,14.733333333333333,0.5223171877376531,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,7.888609052210118e-31,[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-40.099998474121094,-40.99913024902344,52.484840393066406,27.850356425739218,0.0,0.2324995723152072,2.295284453388096,42.625863631843465,0,1,0,1,0.09875084740637935
55,55,55,PMID: 28562589,RNAPS0000359,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)47,141nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",141,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.478260869565215,0.5244361215621458,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,1.9721522630525289e-31,[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-53.29999923706055,-54.41332626342773,70.08137512207031,43.55422737869593,0.0,0.16424342482462365,1.9881517765184824,75.17695241120127,0,1,0,1,0.0742022892755852
56,56,56,PMID: 28562589,RNAPS0000360,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)47,141nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",141,0.0,0.3333333333333333,0.3333333333333333,0.3333333333333333,1.0,,14.478260869565215,0.5244361215621458,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,1.9721522630525289e-31,[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-64.09999847412111,-65.13725280761719,75.58805084228516,43.71040760678417,0.0,0.18582059900761147,2.1554357573030263,70.6788607988104,0,1,0,1,0.0692334408973298
57,57,57,PMID: 28562589,RNAPS0000113,https://pubmed.ncbi.nlm.nih.gov/28562589,Undefined,-,-,(CAG)47,141nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,"sp|Q07955|SRSF1_HUMAN Serine/arginine-rich splicing factor 1 OS=Homo sapiens OX=9606 GN=SRSF1 PE=1 SV=2
MSGGGVIRGPAGNNDCRIYVGNLPPDIRTKDIEDVFYKYGAIRDIDLKNRRGGPPFAFVE
FEDPRDAEDAVYGRDGYDYDGYRLRVEFPRSGRGTGRGGGGGGGGGAPRGRYGPPSRRSE
NRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKF
RSHEGETAYIRVKVDGPRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPR
HSRSRSRT",SRSF1,-,-,248aa(1-248),Q07955,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1134,"[97-104],[106-106],[107-120],[196-248]","[72-85],[89-119],[196-247]",In vivo,-,-,-,-,-,cell:U2OS cell,Confocal microscopy,-,Upon induction of 47×CAG or 120×CAG RNA transcription numerous nuclear foci appeared as early as 1 h after induction. The number of foci per nucleus increased with higher levels of RNA induction.,141,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.478260869565215,0.5244361215621458,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974867,1.9721522630525289e-31,[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-53.29999923706055,-54.41332626342773,70.08137512207031,43.55422737869593,0.0,0.16424342482462365,1.9881517765184824,75.17695241120127,0,1,0,1,0.0742022892755852
58,58,58,PMID: 28562589,RNAPS0000114,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)66,198nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with this valency dependence, we found that the formation of CAG/CUG RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c). The intermolecular interactions between the transcripts potentially could be competed out by shorter complementary antisense oligonucleotides (ASO).",198,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.0,0.5255834199282572,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974885,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1]",1.0,0.0,-78.30000305175781,-78.66997528076172,164.1678924560547,32.363675818384905,-78.30000305175781,0.5486508905426969,5.852058161512443,55.79903392844693,0,1,0,1,0.040761562857868916
59,59,59,PMID: 28562589,RNAPS0000115,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)66,198nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with this valency dependence, we found that the formation of CAG/CUG RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c). The intermolecular interactions between the transcripts potentially could be competed out by shorter complementary antisense oligonucleotides (ASO).",198,0.0,0.3333333333333333,0.3333333333333333,0.3333333333333333,1.0,,14.0,0.5255834199282572,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974885,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1]",1.0,0.0,-94.0999984741211,-94.4303970336914,186.9110565185547,10.269738662156477,-94.0999984741211,0.585036015956937,17.848332461126102,19.58450681664776,0,1,0,1,0.033626139628496476
60,60,60,PMID: 28562589,RNAPS0000116,https://pubmed.ncbi.nlm.nih.gov/28562589,Undefined,-,-,(CAG)120,360nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,"sp|Q07955|SRSF1_HUMAN Serine/arginine-rich splicing factor 1 OS=Homo sapiens OX=9606 GN=SRSF1 PE=1 SV=2
MSGGGVIRGPAGNNDCRIYVGNLPPDIRTKDIEDVFYKYGAIRDIDLKNRRGGPPFAFVE
FEDPRDAEDAVYGRDGYDYDGYRLRVEFPRSGRGTGRGGGGGGGGGAPRGRYGPPSRRSE
NRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKF
RSHEGETAYIRVKVDGPRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPR
HSRSRSRT",SRSF1,-,-,248aa(1-248),Q07955,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1134,"[97-104],[106-106],[107-120],[196-248]","[72-85],[89-119],[196-247]",In vivo,-,-,-,-,-,cell:U2OS cell,Confocal microscopy,-,Upon induction of 47×CAG or 120×CAG RNA transcription numerous nuclear foci appeared as early as 2 h after induction. The number of foci per nucleus increased with higher levels of RNA induction.,360,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.0,0.5268326058735131,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481]",2.4594848111974894,1.7749370367472766e-30,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]",1.0,0.0,-145.8000030517578,-146.63722229003906,233.12301635742188,113.2295961360602,-26.29999923706055,0.25706799312187345,2.837322204924885,178.2267910600917,0,1,0,-1,-0.05126124446391833
61,61,61,PMID: 29064502,RNAPS0000124,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,-,-,polyA(30),30nt,AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-9 mg/ml [laf-1];|7.5 µM polyA,0-500 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,"solute, liquid","In the presence of polyadenylate RNA (poly-rA) of various lengths, the low-concentration arm of the LAF-1 binodal and the concentrations corresponding to the critical region remain essentially invariant. However, upon addition of RNA we observe a marked shift of the high-concentration arm of the LAF-1 binodal, toward lower values of dense phase concentration.",30,1.0,0.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,30.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.1482762666082112
62,62,62,PMID: 29064502,RNAPS0000125,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,-,-,polyA(15),15nt,AAAAAAAAAAAAAAA,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-9 mg/ml [laf-1];|15 µM polyA,0-500 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,"solute, liquid","In the presence of polyadenylate RNA (poly-rA) of various lengths, the low-concentration arm of the LAF-1 binodal and the concentrations corresponding to the critical region remain essentially invariant. However, upon addition of RNA we observe a marked shift of the high-concentration arm of the LAF-1 binodal, toward lower values of dense phase concentration.",15,1.0,0.0,0.0,0.0,,,16.5,0.5268326058735131,[0. 0. 0. 0.],0.0,0.0,[0 0 0],0.0,0.0,0.0,1.094805648556589e-15,15.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.11246343406425546
63,63,63,PMID: 29233785,RNAPS0000130,https://pubmed.ncbi.nlm.nih.gov/29233785,Undefined,NCBI ID:387140,https://www.ncbi.nlm.nih.gov/gene/387140,mmu-miR-21a-5p,92nt(1-92),UGUACCACCUUGUCGGAUAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACAGCAGUCGAUGGGCUGUCUGACAUUUUGGUAUC,miRNA,Mus musculus,"sp|P14780|MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens OX=9606 GN=MMP9 PE=1 SV=3
MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEM
RGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHN
ITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYP
FDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVVVPTRFGNADGAACHFPFIFEGRS
YSACTTDGRSDGLPWCSTTANYDTDDRFGFCPSERLYTQDGNADGKPCQFPFIFQGQSYS
ACTTDGRSDGYRWCATTANYDRDKLFGFCPTRADSTVMGGNSAGELCVFPFTFLGKEYST
CTSEGRGDGRLWCATTSNFDSDKKWGFCPDQGYSLFLVAAHEFGHALGLDHSSVPEALMY
PMYRFTEGPPLHKDDVNGIRHLYGPRPEPEPRPPTTTTPQPTAPPTVCPTGPPTVHPSER
PTAGPTGPPSAGPTGPPTAGPSTATTVPLSPVDDACNVNIFDAIAEIGNQLYLFKDGKYW
RFSEGRGSRPQGPFLIADKWPALPRKLDSVFEERLSKKLFFFSGRQVWVYTGASVLGPRR
LDKLGLGADVAQVTGALRSGRGKMLLFSGRRLWRFDVKAQMVDPRSASEVDRMFPGVPLD
THDVFQYREKAYFCQDRFYWRVSSRSELNQVDQVGYVTYDILQCPED",MMP9,-,-,707aa(1-707),P14780,-,-,[446-508],"[7-14],[65-81],[445-477],[481-506]",In vivo,-,-,-,RT,-,organelle:P-body;cell:Cardiac fibroblasts,"ISH,RT-PCR,Laser confocal telescope",-,"ISH showed that miR-21, concentrated in cytoplasmic foci in the proximity of the nucleus, was mainly localized in cardiac fibroblasts and at relatively low levels in cardiomyocytes within cardiac tissue with DN.",92,0.21739130434782608,0.32608695652173914,0.25,0.2065217391304348,1.2105263157894737,0.6666666666666666,14.666666666666664,0.4527698756308951,"[1.72475733 3.44951466 1.72475733 2.47226479 0.         0.
 0.         0.         1.49501492 0.74750746 0.97724987 1.22974241
 1.49501492 0.97724987 0.74750746 0.74750746 1.72475733 1.
 1.22974241 2.45948481 2.72475733 1.72475733 1.97724987 2.47226479
 1.49501492 1.49501492 0.         0.         0.        ]",1.2445218004477419,0.8634593638279758,[1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1],0.8888888888888888,0.09876543209876544,-46.20000076293945,-47.40008163452149,87.70199584960938,2.455753903987286,-43.5,0.14267767246989332,21.03786345863843,3.3694317571223285,0,0,1,1,0.16239238419609137
64,64,64,PMID: 29262335,RNAPS0000131,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,(AAAACC)4,24nt,AAAACCAAAACCAAAACCAAAACC,repeat RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0-1.5µM [(A4C2)4];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,-,Fluorescence microscopy,solute,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24,0.6666666666666666,0.0,0.0,0.3333333333333333,,,14.0,0.4568263160931184,[0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[1 1 0 0],0.5,0.25,0.0,1.094805648556589e-15,24.0,0.0,0.0,1.0000000000000018,0.0,0.0,0,1,0,1,0.1012325337860095
65,65,65,PMID: 29262335,RNAPS0000132,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,r(GGGGCC)4,24nt,GGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0.1-10µM [(G4C2)4];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,crowding agent:with or without 0-5% Ficoll,Fluorescence microscopy,liquid,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4568263160931184,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-11.300000190734865,-11.621955871582033,18.40277862548828,4.296563344327007,-11.300000190734865,0.5931053474955872,4.28771025655211,6.030620573984631,0,1,0,1,0.11406159519390374
66,66,66,PMID: 29262335,RNAPS0000133,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,r(CCCCGG)4,24nt,CCCCGGCCCCGGCCCCGGCCCCGG,repeat RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0-1.0µM [(C4G2)4];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,-,Fluorescence microscopy,solute,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24,0.0,0.0,0.3333333333333333,0.6666666666666666,0.5,,14.0,0.4568263160931184,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-9.899999618530273,-9.983051300048828,22.97175407409668,0.6418025956175697,-9.899999618530273,0.8739315047624201,23.338094744698,1.2246523901489266,0,1,0,1,0.08794237329916305
67,67,67,PMID: 29262335,RNAPS0000134,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)11,66nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ;

sp|P55884|EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3
MQDAENVAVPEAAEERAEPGQQQPAAEPPPAEGLLRPAGPGAPEAAGTEASSEEVGIAEA
GPESEVRTEPAAEAEAASGPSESPSPPAAEELPGSHAEPPVPAQGEAPGEQARDERSDSR
AQAVSEDAGGNEGRAAEAEPRALENGDADEPSFSDPEDFVDDVSEEELLGDVLKDRPQEA
DGIDSVIVVDNVPQVGPDRLEKLKNVIHKIFSKFGKITNDFYPEEDGKTKGYIFLEYASP
AHAVDAVKNADGYKLDKQHTFRVNLFTDFDKYMTISDEWDIPEKQPFKDLGNLRYWLEEA
ECRDQYSVIFESGDRTSIFWNDVKDPVSIEERARWTETYVRWSPKGTYLATFHQRGIALW
GGEKFKQIQRFSHQGVQLIDFSPCERYLVTFSPLMDTQDDPQAIIIWDILTGHKKRGFHC
ESSAHWPIFKWSHDGKFFARMTLDTLSIYETPSMGLLDKKSLKISGIKDFSWSPGGNIIA
FWVPEDKDIPARVTLMQLPTRQEIRVRNLFNVVDCKLHWQKNGDYLCVKVDRTPKGTQGV
VTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKNNGKI
ELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWD
PTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQI
KKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRKYRKMAQELYMEQKNERLELRG
GVDTDELDSNVDDWEEETIEFFVTEEIIPLGNQE",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",66,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4743005467633472,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453]",6.426764529061616,0.0,[1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-46.5,-47.08744812011719,61.056373596191406,3.7171837488143176,-46.5,0.3855244026147244,13.347425396011346,6.417094769014971,0,1,0,1,0.08149180351162938
68,68,68,PMID: 29262335,RNAPS0000072,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)38,228nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",228,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4800431991232614,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453]",6.426764529061616,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1]",1.0,0.0,-185.6000061035156,-186.1923065185547,221.9561462402344,4.628013152587815,-185.6000061035156,0.3825000465431454,37.714417632306706,7.697382536494857,0,1,0,1,5.263710204783667e-05
69,69,69,PMID: 29262335,RNAPS0000135,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)28,168nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",168,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4792472395823508,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061619,7.099748146989106e-30,[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],1.0,0.0,-134.10000610351562,-134.67379760742188,162.30752563476562,4.32778273235692,-134.10000610351562,0.3941645620844778,29.505278933404185,7.100332403826747,0,1,0,1,0.020192202341714816
70,70,70,PMID: 29262335,RNAPS0000136,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)75,450nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",450,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4811219478853398,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453]",6.426764529061616,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]",1.0,0.0,-376.1000061035156,-376.8034057617188,442.9564514160156,5.526554321232238,-376.1000061035156,0.3194029386486674,63.86043838428518,10.057793198168003,0,1,0,-1,-0.12226563083700259
71,71,71,PMID: 29262335,RNAPS0000137,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)4,24nt,GGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,RT,-,organelle:stress granule;cell:Mouse embryonic fibroblasts,FRAP,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly. FRAP analysis of rG4C2-induced SGs in U2OS cells stably expressing mCherry-G3BP1 and transiently transfected with 3' FAM-labeled r(G4C2)4. Graphs represent relative fluorescence of mCherry-G3BP1 and 3' FAM-labeled r(G4C2)4 before (first 3 data points) and after photobleaching (last 10 data points).",24,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4568263160931184,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-11.300000190734865,-11.621955871582033,18.40277862548828,4.296563344327007,-11.300000190734865,0.5931053474955872,4.28771025655211,6.030620573984631,0,1,0,1,0.11406159519390374
72,72,72,PMID: 29262335,RNAPS0000138,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-;|-,-;|-,r(GGGGCC)4;|polyA,24nt;|-,GGGGCCGGGGCCGGGGCCGGGGCC;|-,repeat RNA;|poly RNA,-;|-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ;
>sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4
MNKAPQSTGPPPAPSPGLPQPAFPPGQTAPVVFSTPQATQMNTPSQPRQHFYPSRAQPPS
SAASRVQSAAPARPGPAAHVYPAGSQVMMIPSQISYPASQGAYYIPGQGRSTYVVPTQQY
PVQPGAPGFYPGASPTEFGTYAGAYYPAQGVQQFPTGVAPTPVLMNQPPQIAPKRERKTI
RIRDPNQGGKDITEEIMSGARTASTPTPPQTGGGLEPQANGETPQVAVIVRPDDRSQGAI
IADRPGLPGPEHSPSESQPSSPSPTPSPSPVLEPGSEPNLAVLSIPGDTMTTIQMSVEES
TPISRETGEPYRLSPEPTPLAEPILEVEVTLSKPVPESEFSSSPLQAPTPLASHTVEIHE
PNGMVPSEDLEPEVESSPELAPPPACPSESPVPIAPTAQPEELLNGAPSPPAVDLSPVSE
PEEQAKEVTASMAPPTIPSATPATAPSATSPAQEEEMEEEEEEEEGEAGEAGEAESEKGG
EELLPPESTPIPANLSQNLEAAAATQVAVSVPKRRRKIKELNKKEAVGDLLDAFKEANPA
VPEVENQPPAGSNPGPESEGSGVPPRPEEADETWDSKEDKIHNAENIQPGEQKYEYKSDQ
WKPLNLEEKKRYDREFLLGFQFIFASMQKPEGLPHISDVVLDKANKTPLRPLDPTRLQGI
NCGPDFTPSFANLGRTTLSTRGPPRGGPGGELPRGPAGLGPRRSQQGPRKEPRKIIATVL
MTEDIKLNKAEKAWKPSSKRTAADKDRGEEDADGSKTQDLFRRVRSILNKLTPQMFQQLM
KQVTQLAIDTEERLKGVIDLIFEKAISEPNFSVAYANMCRCLMALKVPTTEKPTVTVNFR
KLLLNRCQKEFEKDKDDDEVFEKKQKEMDEAATAEERGRLKEELEEARDIARRRSLGNIK
FIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFN
QMEKIIKEKKTSSRIRFMLQDVLDLRGSNWVPRRGDQGPKTIDQIHKEAEMEEHREHIKV
QQLMAKGSDKRRGGPPGPPISRGLPLVDDGGWNTVPISKGSRPIDTSRLTKITKPGSIDS
NNQLFAPGGRLSWGKGSSGGSGAKPSDAASEAARPATSTLNRFSALQQAVPTESTDNRRV
VQRSSLSRERGEKAGDRGDRLERSERGGDRGDRLDRARTPATKRSFSKEVEERSRERPSQ
PEGLRKAASLTEDRDRGRDAVKREAALPPVSPLKAALSEEELEKKSKAIIEEYLHLNDMK
EAVQCVQELASPSLLFIFVRHGVESTLERSAIAREHMGQLLHQLLCAGHLSTAQYYQGLY
EILELAEDMEIDIPHVWLYLAELVTPILQEGGVPMGELFREITKPLRPLGKAASLLLEIL
GLLCKSMGPKKVGTLWREAGLSWKEFLPEGQDIGAFVAEQKVEYTLGEESEAPGQRALPS
EELNRQLEKLLKEGSSNQRVFDWIEANLSEQQIVSNTLVRALMTAVCYSAIIFETPLRVD
VAVLKARAKLLQKYLCDEQKELQALYALQALVVTLEQPPNLLRMFFDALYDEDVVKEDAF
YSWESSKDPAEQQGKGVALKSVTAFFKWLREAEEESDHN;

sp|P55884|EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3
MQDAENVAVPEAAEERAEPGQQQPAAEPPPAEGLLRPAGPGAPEAAGTEASSEEVGIAEA
GPESEVRTEPAAEAEAASGPSESPSPPAAEELPGSHAEPPVPAQGEAPGEQARDERSDSR
AQAVSEDAGGNEGRAAEAEPRALENGDADEPSFSDPEDFVDDVSEEELLGDVLKDRPQEA
DGIDSVIVVDNVPQVGPDRLEKLKNVIHKIFSKFGKITNDFYPEEDGKTKGYIFLEYASP
AHAVDAVKNADGYKLDKQHTFRVNLFTDFDKYMTISDEWDIPEKQPFKDLGNLRYWLEEA
ECRDQYSVIFESGDRTSIFWNDVKDPVSIEERARWTETYVRWSPKGTYLATFHQRGIALW
GGEKFKQIQRFSHQGVQLIDFSPCERYLVTFSPLMDTQDDPQAIIIWDILTGHKKRGFHC
ESSAHWPIFKWSHDGKFFARMTLDTLSIYETPSMGLLDKKSLKISGIKDFSWSPGGNIIA
FWVPEDKDIPARVTLMQLPTRQEIRVRNLFNVVDCKLHWQKNGDYLCVKVDRTPKGTQGV
VTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKNNGKI
ELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWD
PTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQI
KKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRKYRKMAQELYMEQKNERLELRG
GVDTDELDSNVDDWEEETIEFFVTEEIIPLGNQE",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,FISH;Fluorescence microscopy,-,"Interestingly, transfection of r(G4C2)4, but not r(C4G2)4, also promotes formation of cytoplasmic foci positive for G3BP1, a standard SG marker. These r(G4C2)4-induced cytoplasmic foci also contain the SG markers eIF3b, eIF4G, and poly(A) mRNA.",24,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,16.75,0.4577125002840918,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-12.300000190734865,-12.5885648727417,21.509428024291992,4.231556664253694,-12.300000190734865,0.6261248392925042,4.917379815419003,5.943685550691347,0,0,1,1,0.11396844053032501
73,73,73,PMID: 29262335,RNAPS0000139,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-;|-,-;|-,r(CCCCGG)4;|polyA,24nt;|-,CCCCGGCCCCGGCCCCGGCCCCGG;|-,repeat RNA;|poly RNA,-;|-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ;
>sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4
MNKAPQSTGPPPAPSPGLPQPAFPPGQTAPVVFSTPQATQMNTPSQPRQHFYPSRAQPPS
SAASRVQSAAPARPGPAAHVYPAGSQVMMIPSQISYPASQGAYYIPGQGRSTYVVPTQQY
PVQPGAPGFYPGASPTEFGTYAGAYYPAQGVQQFPTGVAPTPVLMNQPPQIAPKRERKTI
RIRDPNQGGKDITEEIMSGARTASTPTPPQTGGGLEPQANGETPQVAVIVRPDDRSQGAI
IADRPGLPGPEHSPSESQPSSPSPTPSPSPVLEPGSEPNLAVLSIPGDTMTTIQMSVEES
TPISRETGEPYRLSPEPTPLAEPILEVEVTLSKPVPESEFSSSPLQAPTPLASHTVEIHE
PNGMVPSEDLEPEVESSPELAPPPACPSESPVPIAPTAQPEELLNGAPSPPAVDLSPVSE
PEEQAKEVTASMAPPTIPSATPATAPSATSPAQEEEMEEEEEEEEGEAGEAGEAESEKGG
EELLPPESTPIPANLSQNLEAAAATQVAVSVPKRRRKIKELNKKEAVGDLLDAFKEANPA
VPEVENQPPAGSNPGPESEGSGVPPRPEEADETWDSKEDKIHNAENIQPGEQKYEYKSDQ
WKPLNLEEKKRYDREFLLGFQFIFASMQKPEGLPHISDVVLDKANKTPLRPLDPTRLQGI
NCGPDFTPSFANLGRTTLSTRGPPRGGPGGELPRGPAGLGPRRSQQGPRKEPRKIIATVL
MTEDIKLNKAEKAWKPSSKRTAADKDRGEEDADGSKTQDLFRRVRSILNKLTPQMFQQLM
KQVTQLAIDTEERLKGVIDLIFEKAISEPNFSVAYANMCRCLMALKVPTTEKPTVTVNFR
KLLLNRCQKEFEKDKDDDEVFEKKQKEMDEAATAEERGRLKEELEEARDIARRRSLGNIK
FIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFN
QMEKIIKEKKTSSRIRFMLQDVLDLRGSNWVPRRGDQGPKTIDQIHKEAEMEEHREHIKV
QQLMAKGSDKRRGGPPGPPISRGLPLVDDGGWNTVPISKGSRPIDTSRLTKITKPGSIDS
NNQLFAPGGRLSWGKGSSGGSGAKPSDAASEAARPATSTLNRFSALQQAVPTESTDNRRV
VQRSSLSRERGEKAGDRGDRLERSERGGDRGDRLDRARTPATKRSFSKEVEERSRERPSQ
PEGLRKAASLTEDRDRGRDAVKREAALPPVSPLKAALSEEELEKKSKAIIEEYLHLNDMK
EAVQCVQELASPSLLFIFVRHGVESTLERSAIAREHMGQLLHQLLCAGHLSTAQYYQGLY
EILELAEDMEIDIPHVWLYLAELVTPILQEGGVPMGELFREITKPLRPLGKAASLLLEIL
GLLCKSMGPKKVGTLWREAGLSWKEFLPEGQDIGAFVAEQKVEYTLGEESEAPGQRALPS
EELNRQLEKLLKEGSSNQRVFDWIEANLSEQQIVSNTLVRALMTAVCYSAIIFETPLRVD
VAVLKARAKLLQKYLCDEQKELQALYALQALVVTLEQPPNLLRMFFDALYDEDVVKEDAF
YSWESSKDPAEQQGKGVALKSVTAFFKWLREAEEESDHN;

sp|P55884|EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3
MQDAENVAVPEAAEERAEPGQQQPAAEPPPAEGLLRPAGPGAPEAAGTEASSEEVGIAEA
GPESEVRTEPAAEAEAASGPSESPSPPAAEELPGSHAEPPVPAQGEAPGEQARDERSDSR
AQAVSEDAGGNEGRAAEAEPRALENGDADEPSFSDPEDFVDDVSEEELLGDVLKDRPQEA
DGIDSVIVVDNVPQVGPDRLEKLKNVIHKIFSKFGKITNDFYPEEDGKTKGYIFLEYASP
AHAVDAVKNADGYKLDKQHTFRVNLFTDFDKYMTISDEWDIPEKQPFKDLGNLRYWLEEA
ECRDQYSVIFESGDRTSIFWNDVKDPVSIEERARWTETYVRWSPKGTYLATFHQRGIALW
GGEKFKQIQRFSHQGVQLIDFSPCERYLVTFSPLMDTQDDPQAIIIWDILTGHKKRGFHC
ESSAHWPIFKWSHDGKFFARMTLDTLSIYETPSMGLLDKKSLKISGIKDFSWSPGGNIIA
FWVPEDKDIPARVTLMQLPTRQEIRVRNLFNVVDCKLHWQKNGDYLCVKVDRTPKGTQGV
VTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKNNGKI
ELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWD
PTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQI
KKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRKYRKMAQELYMEQKNERLELRG
GVDTDELDSNVDDWEEETIEFFVTEEIIPLGNQE",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,FISH;Fluorescence microscopy,-,"Interestingly, transfection of r(G4C2)4, but not r(C4G2)4, also promotes formation of cytoplasmic foci positive for G3BP1, a standard SG marker. These r(G4C2)4-induced cytoplasmic foci also contain the SG markers eIF3b, eIF4G, and poly(A) mRNA.",24,0.0,0.0,0.3333333333333333,0.6666666666666666,0.5,,16.75,0.4577125002840918,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-10.300000190734863,-10.37170124053955,26.04716682434082,0.5989978490690451,-10.300000190734863,0.8901748516005986,28.33009397924055,1.1469310132752435,0,0,1,1,0.11573557343357938
74,74,74,PMID: 29262335,RNAPS0000140,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)38,228nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,RT,-,other_molecular:cycloheximide  for 30 min;organelle:stress granule;cell:U2OS cell,Microscopy,-,"rG4C2-38X (38 repeats of the G4C2) induced granules decrease when treated with cycloheximide and increase when treated with puromycin, consistent with these granules being in dynamic equilibrium with polysomes (Kedersha et al., 2000).",228,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4800431991232614,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453]",6.426764529061616,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1]",1.0,0.0,-185.6000061035156,-186.1923065185547,221.9561462402344,4.628013152587815,-185.6000061035156,0.3825000465431454,37.714417632306706,7.697382536494857,0,1,0,1,5.263710204783667e-05
75,75,75,PMID: 29262335,RNAPS0000141,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,rScramble RNA,24nt,GGCCCGGCGGGGGGCGGCGGCCGG,nucleotide rich RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0-1.5µM [rScram];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,-,Fluorescence microscopy,liquid,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,13.5,0.4087665310904671,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-12.699999809265135,-12.979220390319824,19.72255516052246,2.8845910392006404,-12.699999809265135,0.6356900205697371,5.6104983833797215,4.319817778364532,0,0,1,1,0.10047937310105232
76,76,76,PMID: 29314832,RNAPS0000142,https://pubmed.ncbi.nlm.nih.gov/29314832,RNA + protein,-,-,luciferase_antisense_siRNA,21nt,UCGAAGUACUCAGCGUAAGUU,siRNA,Photinus pyralis,KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK,50 aa pLys,-,-,50aa,-,-,-,[1-50],-,In vitro,5 mM([RNA phosphate] + [pLys amine]),18.2 MΩ water and concentrated NaCl solutions,pH 7,RT,4 h,-,-,liquid,"Single- and double-stranded RNA oligonucleotides displayed the same phase behavior as DNA: single-stranded RNA formed coacervates and double-stranded RNA formed precipitates. When mixed with 50 aa pLys, ssRNA forms coacervates while dsRNA forms solid precipitates, just as for DNA.",21,0.2857142857142857,0.2857142857142857,0.2380952380952381,0.19047619047619047,1.25,1.0,17.666666666666668,0.4465539064152648,[1.72475733 0.97724987 0.74750746 2.47226479 0.         0.        ],0.9869632423279618,0.7926811860701868,[1 1 1 0],0.75,0.1875,0.0,-0.7483680844306946,17.02967643737793,1.985224176488868,0.0,0.2969323632148064,5.289075221001312,3.2315688508334337,0,0,1,1,0.18908290216272072
77,77,77,PMID: 29314832,RNAPS0000143,https://pubmed.ncbi.nlm.nih.gov/29314832,RNA + protein,-,-,luciferase_dsRNA_siRNA,42nt,UCGAAGUACUCAGCGUAAGUUUUAGCUUCAUGAGUCGCAUUC,siRNA,Photinus pyralis,KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK,50 aa pLys,-,-,50aa,-,-,-,[1-50],-,In vitro,5 mM([RNA phosphate] + [pLys amine]),18.2 MΩ water and concentrated NaCl solutions,pH 7,RT,4 h,-,-,solid,"Single- and double-stranded RNA oligonucleotides displayed the same phase behavior as DNA: single-stranded RNA formed coacervates and double-stranded RNA formed precipitates. When mixed with 50 aa pLys, ssRNA forms coacervates while dsRNA forms solid precipitates, just as for DNA.",42,0.2380952380952381,0.3333333333333333,0.21428571428571427,0.21428571428571427,1.0,0.7142857142857143,13.714285714285715,0.4515681307930531,"[1.72475733 0.97724987 0.74750746 2.47226479 0.         0.
 0.         0.         1.72475733 0.97724987 1.49501492 2.72475733
 1.        ]",1.0648891467642725,0.8036913401982964,[1 1 1 0 1 0 1 1],0.75,0.1875,-7.199999809265138,-8.155482292175293,35.66520690917969,3.5880186668250658,-7.199999809265138,0.21218417122344144,6.629459475532112,5.1665463107859235,0,0,1,1,0.17827869162935295
78,78,78,PMID: 29898402,RNAPS0000030,https://pubmed.ncbi.nlm.nih.gov/29898402,RNA + protein,NCBI ID: 850499,https://www.ncbi.nlm.nih.gov/gene/850499,SEC53,350nt(416-765),CUAUAAGUUGAAUAGUUCAGUCAAAAUUUUGACGGUGUCAUCAGGGGAUUGUACUGAAUGUCCGAUGGUUCUUUCAUCGACAAAAAUUUCGUAAUCGUUACCACCGACCAUAGUCUUGUCACCAAAGAAAUGAAUUUCCUUGAAACCAUCUUUUUCAACGUGUUGCAAACAGUAGGUCUUAUCCCAACCAGCGGGGAAAACGUCGAAAGAGAUUUGGCCACCAAUGGAGAAAGUCAAACCGUAGUCUGGGAAUUCCUUUUUCAAAGCUUCAACGAACUUGGCUCUGAUUUGGUGUUCCUUAUCGUAUCUUUCGAAUUCGUUUCUUUCCUCAGUAGAAGCAUUUCUACCAA,mRNA,yeast,"sp|P32588|PUB1_YEAST Nuclear and cytoplasmic polyadenylated RNA-binding protein PUB1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PUB1 PE=1 SV=4|length=453aa|residues=1-453
MSENNEEQHQQQQQQQPVAVETPSAVEAPASADPSSEQSVAVEGNSEQAEDNQGENDPSV
VPANAITGGRETSDRVLYVGNLDKAITEDILKQYFQVGGPIANIKIMIDKNNKNVNYAFV
EYHQSHDANIALQTLNGKQIENNIVKINWAFQSQQSSSDDTFNLFVGDLNVNVDDETLRN
AFKDFPSYLSGHVMWDMQTGSSRGYGFVSFTSQDDAQNAMDSMQGQDLNGRPLRINWAAK
RDNNNNNNYQQRRNYGNNNRGGFRQYNSNNNNNMNMGMNMNMNMNMNNSRGMPPSSMGMP
IGAMPLPSQGQPQQSQTIGLPPQVNPQAVDHIIRSAPPRVTTAYIGNIPHFATEADLIPL
FQNFGFILDFKHYPEKGCCFIKYDTHEQAAVCIVALANFPFQGRNLRTGWGKERSNFMPQ
QQQQGGQPLIMNDQQQPVMSEQQQQQQQQQQQQ",PUB1,-,-,453aa(1-453),P32588,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P32588,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0524,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0004,http://db.phasep.pro/browse/","[1-67],[241-262],[418-453]","[8-16],[103-116],[152-158],[243-297],[307-316],[420-427],[434-452]",In vitro,20 µM [PUB1];|0-183 nM mRNA,183 mM NaCl,"200 mM phosphate buffer (with pH 6.5), 1 mM TCEP",46˚C,> 10 min,crowding agent:20% Ficoll,Fluorescence microscopy,liquid,"When we mixed Pub1 with this RNA and induced phase separation by lowering the pH, we observed that the RNA reduced the number and size of Pub1 condensates (Figures S2J and S2L). Similar findings were made for heat-induced Pub1 assemblies (Figures S2K and S2L).",350,0.2828571428571429,0.3142857142857143,0.19142857142857145,0.21142857142857144,0.9054054054054054,0.9,14.06896551724138,0.4599613484956832,"[0.         0.97724987 0.         0.         0.97724987 1.49501492
 0.         0.         0.         1.72475733 2.72475733 1.49501492
 0.97724987 2.47226479 1.97724987 0.74750746 0.97724987 0.74750746
 0.74750746 2.47226479 1.97724987 0.25249254 0.97724987 0.74750746
 1.72475733 1.72475733 0.         0.         0.         0.
 0.         0.         0.         4.44951466 4.44951466 0.
 0.         1.22974241 0.74750746 1.72475733 1.         0.
 0.         0.         0.         1.72475733 0.         0.
 1.72475733 0.         0.         1.72475733 1.72475733 1.72475733
 0.         0.         1.22974241 1.22974241 0.         0.
 1.         1.72475733 4.44951466 6.42676453 0.         0.
 3.44951466 0.         0.         0.         0.         2.72475733
 3.44951466 1.         1.22974241 0.         0.         0.
 0.         1.97724987 0.74750746 2.47226479 0.         0.
 0.         0.         0.         0.         1.72475733 1.72475733
 1.72475733 0.97724987 1.         2.72475733 0.         0.
 1.72475733 1.72475733 0.         0.         0.         0.
 1.         0.         0.         0.         0.         1.
 1.72475733 0.74750746 0.97724987 1.72475733 0.         0.
 1.72475733]",0.9171963398350552,1.3983988486600876,"[0 1 0 1 0 0 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 1 0 1 0 1 1 1 1 1 1
 1 1 0 1 0 0 1 1 1 1 1 1 1 0 0 0 1 1 1 1 0 1 1 1 0 1 1 0 1 1 1 0 1]",0.7,0.21,-77.9000015258789,-85.8435287475586,239.4633026123047,67.99060789724282,-54.5,2.526625270847683e-06,2.56638529353365,100.32005255689613,0,0,1,1,0.06870077635032606
79,79,79,PMID: 30110628,RNAPS0000236,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,(UC-rich A4)50,50nt,UUUAUUUCCUUCCUUCCUUCCUUCCUUCCUUCCUUCCUUCCCUCCUUCCU,nucleotide rich RNA,-,RRRR,poly(R)4,-,-,4aa,-,-,-,-,-,In vitro,25 µM [polyR];|1 µM (UC-rich A4)50,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,liquid,"In vitro, R4 peptide formed droplets in the presence of low-, but not high-, complexity rIGSRNA (Figure 3E). Increasing [NaCl] to 250 mM was sufficient to rapidly dissolve R4-GFP nucleolar foci and R4 peptide droplets in vivo and in vitro (Figures 3F and S3H).",50,0.02,0.52,0.0,0.46,,0.038461538461538464,15.25,0.4935115742076217,"[0.         0.         2.72475733 1.72475733 0.25249254 1.72475733
 2.72475733 1.72475733 0.25249254 1.72475733 2.72475733 1.72475733
 1.         3.44951466 2.72475733]",1.631821047376515,1.1770137790568749,[0 1 1 1 1 1 1 1 1 1],0.9,0.09000000000000001,0.0,-0.0011622468009591105,49.99659729003906,0.0018840054074126208,0.0,0.9981159945925898,13269.600979719846,0.003765447912977539,0,0,1,1,0.04978341061578895
80,80,80,PMID: 30110628,RNAPS0000237,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,(CU-rich)100,100nt,UCUGUCUCUGUCUUUGUCUCUCUCUCUCCCUCUCUGCCUGUCUCACUGUGUCUGUCUUCUGUCUUACUCUCUUUCUCUCCCCGUCUGUCUCUCUCUCUCU,nucleotide rich RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=16aa|residues=104-119
GTGRRIHSYRGHLWLF",APP,ACM,-,16aa(104-119),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",-,-,In vitro,25 µM [APP ACM];|1 µM (CU-rich)100,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,liquid,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.02,0.48,0.11,0.39,0.28205128205128205,0.04166666666666667,14.25,0.464229013308452,"[1.49501492 1.49501492 1.49501492 0.         0.         1.49501492
 1.49501492 1.49501492 2.47226479 2.47226479 1.49501492 2.72475733
 2.72475733 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492
 0.97724987 1.49501492 0.         0.         1.49501492 0.74750746
 0.74750746 2.47226479 4.44951466 2.72475733 1.49501492 1.49501492
 1.49501492 1.49501492]",1.5444723272708492,0.8243293943062058,[1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],0.95,0.04750000000000002,0.0,-1.1395797729492188,93.0806121826172,3.4660817224674734,0.0,0.1573938071034609,14.42551099585888,5.5241762654414615,0,0,1,1,0.1525808611493964
81,81,81,PMID: 30110628,RNAPS0000238,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,(AG-rich U89)100,100nt,AGAGAGAGAGACAGAGAGAGACAGAGAGAGAGAGAGAGGAGGGAGAGAGAAAAAAGAAAGAAAAAAAGAAAAGAAAAGAAAGAGAAAAUGAAAGAAAAGG,nucleotide rich RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=16aa|residues=104-119
GTGRRIHSYRGHLWLF",APP,ACM,-,16aa(104-119),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",-,-,In vitro,25 µM [APP ACM];|1 µM (AG-rich U89)100,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,liquid,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.62,0.01,0.35,0.02,17.5,62.0,13.5,0.4382566563793388,"[1.49501492 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492
 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492 2.72475733
 3.44951466 2.72475733 1.49501492 0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.25249254 0.         0.         0.         0.         0.
 0.         0.25249254]",0.90122526315292,0.9007190157108116,[1 1 1 1 1 1 1 1 1 1 0 1 0 0 0 0 1 0 0 1],0.65,0.2275,0.0,-0.05954261124134064,99.80162048339844,0.10020591770731092,0.0,0.9079102254609448,498.97252721185447,0.1997445735605337,0,0,1,1,0.011486532302336538
82,82,82,PMID: 30110628,RNAPS0000239,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,(CU-rich)100,100nt,UCUGUCUCUGUCUUUGUCUCUCUCUCUCCCUCUCUGCCUGUCUCACUGUGUCUGUCUUCUGUCUUACUCUCUUUCUCUCCCCGUCUGUCUCUCUCUCUCU,nucleotide rich RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=17aa|residues=672-688
DAEFRHDSGYEVHHQKL",β-amyloid,ACM,-,17aa(672-688),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",[672-688],-,In vitro,25 µM [β-amyloid 672-688];|1 µM (CU-rich)100,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,liquid,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.02,0.48,0.11,0.39,0.28205128205128205,0.04166666666666667,14.25,0.464229013308452,"[1.49501492 1.49501492 1.49501492 0.         0.         1.49501492
 1.49501492 1.49501492 2.47226479 2.47226479 1.49501492 2.72475733
 2.72475733 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492
 0.97724987 1.49501492 0.         0.         1.49501492 0.74750746
 0.74750746 2.47226479 4.44951466 2.72475733 1.49501492 1.49501492
 1.49501492 1.49501492]",1.5444723272708492,0.8243293943062058,[1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],0.95,0.04750000000000002,0.0,-1.1395797729492188,93.0806121826172,3.4660817224674734,0.0,0.1573938071034609,14.42551099585888,5.5241762654414615,0,0,1,1,0.1525808611493964
83,83,83,PMID: 30110628,RNAPS0000240,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,(AG-rich U89)100,100nt,AGAGAGAGAGACAGAGAGAGACAGAGAGAGAGAGAGAGGAGGGAGAGAGAAAAAAGAAAGAAAAAAAGAAAAGAAAAGAAAGAGAAAAUGAAAGAAAAGG,nucleotide rich RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=17aa|residues=672-688
DAEFRHDSGYEVHHQKL",β-amyloid,ACM,-,17aa(672-688),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",[672-688],-,In vitro,25 µM [β-amyloid 672-688];|1 µM (AG-rich U89)100,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,liquid,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.62,0.01,0.35,0.02,17.5,62.0,13.5,0.4382566563793388,"[1.49501492 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492
 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492 2.72475733
 3.44951466 2.72475733 1.49501492 0.74750746 0.         0.
 0.74750746 0.         0.         0.         0.         0.
 0.25249254 0.         0.         0.         0.         0.
 0.         0.25249254]",0.90122526315292,0.9007190157108116,[1 1 1 1 1 1 1 1 1 1 0 1 0 0 0 0 1 0 0 1],0.65,0.2275,0.0,-0.05954261124134064,99.80162048339844,0.10020591770731092,0.0,0.9079102254609448,498.97252721185447,0.1997445735605337,0,0,1,1,0.011486532302336538
84,84,84,PMID: 30110628,RNAPS0000241,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,"rIGS16RNA-Low complexity (Wang,2018)",50nt,CGAUUGAUUGCGAUCUCAAUUGCCUUUUAGCUUCAUUCAUACCCUGUUAU,irregular RNA,-,RRRR,poly(R)4,-,-,4aa,-,-,-,-,-,In vitro,25 µM [polyR];|1 µM irregular RNA 12,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,solute,"In vitro, R4 peptide formed droplets in the presence of low-, but not high-, complexity rIGSRNA (Figure 3E). Increasing [NaCl] to 250 mM was sufficient to rapidly dissolve R4-GFP nucleolar foci and R4 peptide droplets in vivo and in vitro (Figures 3F and S3H).",50,0.2,0.42,0.14,0.24,0.5833333333333334,0.4761904761904762,15.25,0.4574547686761044,"[0.74750746 0.74750746 1.         1.72475733 0.74750746 0.25249254
 1.         0.         0.         1.72475733 0.         0.
 1.         2.72475733 0.        ]",0.7779524610947232,0.6023854955557926,[1 1 1 0 1 0 1 0 1 0],0.6,0.24,-4.400000095367432,-5.317068576812744,37.77247619628906,7.373028213135212,-4.400000095367432,0.2258299773551856,4.088122201276589,10.572649071883845,0,0,1,1,0.1380739691618964
85,85,85,PMID: 30110628,RNAPS0000242,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,"High complexity-rIGSRNA2 (Wang,2018)",100nt,CCGGGAUUUCAGCCUUUAAAAGCGCGGGCCCUGCCACCUUUCGCUGUGGCCCUUACGCUCAGAAUGACGUGUCCUCUCUGCCGUAGGUUGACUCCUUGAG,irregular RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=16aa|residues=104-119
GTGRRIHSYRGHLWLF",APP,ACM,-,16aa(104-119),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",-,-,In vitro,25 µM [APP ACM];|1 µM irregular RNA 18,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,solute,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.15,0.27,0.26,0.32,0.8125,0.5555555555555555,14.625,0.4595277852281551,"[4.44951466 0.         0.         2.72475733 0.         0.
 0.         6.42676453 6.42676453 3.95449974 2.72475733 3.44951466
 1.         1.         2.72475733 3.95449974 1.97724987 1.
 2.72475733 1.49501492 0.74750746 1.72475733 1.72475733 1.72475733
 2.72475733 2.72475733 2.72475733 2.72475733 1.72475733 0.74750746
 1.72475733 1.72475733]",2.149232506165088,2.664716563190593,[1 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1],0.85,0.1275,-29.399999618530273,-31.19841766357422,86.34000396728516,8.051870797022056,-28.60000038146973,0.0540422602178064,7.1301621021180175,12.972627844172434,0,0,1,1,0.15824627422411414
86,86,86,PMID: 30110628,RNAPS0000243,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,"High complexity-rIGSRNA2 (Wang,2018)",100nt,CCGGGAUUUCAGCCUUUAAAAGCGCGGGCCCUGCCACCUUUCGCUGUGGCCCUUACGCUCAGAAUGACGUGUCCUCUCUGCCGUAGGUUGACUCCUUGAG,irregular RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=17aa|residues=672-688
DAEFRHDSGYEVHHQKL",β-amyloid,ACM,-,17aa(672-688),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",[672-688],-,In vitro,25 µM [β-amyloid 672-688];|1 µM irregular RNA 18,150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,solute,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.15,0.27,0.26,0.32,0.8125,0.5555555555555555,14.625,0.4595277852281551,"[4.44951466 0.         0.         2.72475733 0.         0.
 0.         6.42676453 6.42676453 3.95449974 2.72475733 3.44951466
 1.         1.         2.72475733 3.95449974 1.97724987 1.
 2.72475733 1.49501492 0.74750746 1.72475733 1.72475733 1.72475733
 2.72475733 2.72475733 2.72475733 2.72475733 1.72475733 0.74750746
 1.72475733 1.72475733]",2.149232506165088,2.664716563190593,[1 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1],0.85,0.1275,-29.399999618530273,-31.19841766357422,86.34000396728516,8.051870797022056,-28.60000038146973,0.0540422602178064,7.1301621021180175,12.972627844172434,0,0,1,1,0.15824627422411414
87,87,87,PMID: 30110628,RNAPS0000244,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,"UC RNA(Loughlin,2021)",100nt,CCGGCCCGCCUGGUCUUCUGUCUCUGCGCUCUGGUGACCUCAGCCUCCCAAAUAGCUGGGACUACAGGGAUCUCUUAAGCCCGGGAGGGAGAGGUUAACG,nucleotide rich RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=16aa|residues=104-119
GTGRRIHSYRGHLWLF",APP,ACM,-,16aa(104-119),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",-,-,In vitro,"25 µM [APP ACM];|1 µM UC RNA(Loughlin,2021)",150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,solute,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.17,0.22,0.3,0.31,0.9677419354838708,0.7727272727272728,14.75,0.4637989913824229,"[6.42676453 6.42676453 3.95449974 2.45948481 1.22974241 0.74750746
 1.49501492 2.72475733 2.72475733 2.72475733 2.45948481 2.72475733
 1.72475733 2.47226479 4.44951466 1.         0.         0.
 4.44951466 2.47226479 0.97724987 2.47226479 1.97724987 0.74750746
 0.         0.         6.42676453 3.95449974 2.72475733 2.72475733
 1.22974241 0.25249254]",2.379809207214852,3.2440969602211918,[1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1],0.95,0.04750000000000002,-36.0,-37.4102897644043,86.49964141845703,8.200302187698616,-32.59999847412109,0.1014449209605364,6.0004295326434365,11.418524684287643,0,0,1,1,0.13518358998595675
88,88,88,PMID: 30110628,RNAPS0000245,https://pubmed.ncbi.nlm.nih.gov/30110628,RNA + protein,-,-,"UC RNA(Loughlin,2021)",100nt,CCGGCCCGCCUGGUCUUCUGUCUCUGCGCUCUGGUGACCUCAGCCUCCCAAAUAGCUGGGACUACAGGGAUCUCUUAAGCCCGGGAGGGAGAGGUUAACG,nucleotide rich RNA,-,"sp|P05067|A4_HUMAN Amyloid-beta A4 protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3|length=17aa|residues=672-688
DAEFRHDSGYEVHHQKL",β-amyloid,ACM,-,17aa(672-688),P05067,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P05067,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2530,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0179,http://db.phasep.pro/browse/",[672-688],-,In vitro,"25 µM [β-amyloid 672-688];|1 µM UC RNA(Loughlin,2021)",150 mM NaCl,50mM nuclease-free-water,RT,> 10 min,-,Microscopy,solute,"Mixing of 5’FAM labeled low-complexity RNA derived from rIGSRNA CU or AG repeats with unlabeled peptides containing the short cationic domain of VHL ACM or β-amyloid resulted in numerous liquid droplets observable by differential interference contrast and fluorescence microscopy. In contrast, two independent RNA derived from high-complexity regions of rIGSRNA failed to form droplets under identical conditions. Interactions between the short cationic domain of VHL ACM or β-amyloid and low-complexity rIGSRNA were disrupted by salts. Increasing salt concentration from 150 to 250 mM rapidly dissolved the liquid droplets in vitro.",100,0.17,0.22,0.3,0.31,0.9677419354838708,0.7727272727272728,14.75,0.4637989913824229,"[6.42676453 6.42676453 3.95449974 2.45948481 1.22974241 0.74750746
 1.49501492 2.72475733 2.72475733 2.72475733 2.45948481 2.72475733
 1.72475733 2.47226479 4.44951466 1.         0.         0.
 4.44951466 2.47226479 0.97724987 2.47226479 1.97724987 0.74750746
 0.         0.         6.42676453 3.95449974 2.72475733 2.72475733
 1.22974241 0.25249254]",2.379809207214852,3.2440969602211918,[1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1],0.95,0.04750000000000002,-36.0,-37.4102897644043,86.49964141845703,8.200302187698616,-32.59999847412109,0.1014449209605364,6.0004295326434365,11.418524684287643,0,0,1,1,0.13518358998595675
89,89,89,PMID: 30442662,RNAPS0000254,https://pubmed.ncbi.nlm.nih.gov/30442662,RNA + protein,-,-,polyU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526|mutation=R244C
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGCGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,protein_mutation:R244C,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[3-251],[284-292],[332-338],[375-415],[451-499],[501-501],[503-505],[507-526]",-,In vitro,1 µM [FUS];|1 µM polyU,100 mM NaCl,"50 mM Tris·HCl (pH 7.4), 1 mM EDTA, 1 mM DTT",RT,≤ 20 h,-,Microscopy,"liquid, solid","Within a period of 20 h, FUS_M(R244C)-RNA droplets formed and increased in both size and number. When UBQLN2 was present, the FUS_M(R244C)-RNA droplets formed were smaller in size but more numerous compared with those formed in the absence of UBQLN2. Notably, the FUS_M(R244C)-RNA droplets in the absence of UBQLN2 displayed nonspherical, irregular patterns, whereas those in the presence of UBQLN2 remained highly spherical over the entire time course. These nonspherical irregular droplets may represent the transition from the reversible liquid-like, phase-separated state of FUS to a more stable, solid state of FUS.",40,0.0,1.0,0.0,0.0,,,13.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,40.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.14134523778500913
90,90,90,PMID: 30442662,RNAPS0000255,https://pubmed.ncbi.nlm.nih.gov/30442662,RNA + proteins,-,-,polyU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526|mutation=R244C
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGCGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY;
sp|Q9UHD9|UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens OX=9606 GN=UBQLN2 PE=1 SV=2|length=624aa|residues=1-624
MAENGESSGPPRPSRGPAAAQGSAAAPAEPKIIKVTVKTPKEKEEFAVPENSSVQQFKEA
ISKRFKSQTDQLVLIFAGKILKDQDTLIQHGIHDGLTVHLVIKSQNRPQGQSTQPSNAAG
TNTTSASTPRSNSTPISTNSNPFGLGSLGGLAGLSSLGLSSTNFSELQSQMQQQLMASPE
MMIQIMENPFVQSMLSNPDLMRQLIMANPQMQQLIQRNPEISHLLNNPDIMRQTLEIARN
PAMMQEMMRNQDLALSNLESIPGGYNALRRMYTDIQEPMLNAAQEQFGGNPFASVGSSSS
SGEGTQPSRTENRDPLPNPWAPPPATQSSATTSTTTSTGSGSGNSSSNATGNTVAAANYV
ASIFSTPGMQSLLQQITENPQLIQNMLSAPYMRSMMQSLSQNPDLAAQMMLNSPLFTANP
QLQEQMRPQLPAFLQQMQNPDTLSAMSNPRAMQALMQIQQGLQTLATEAPGLIPSFTPGV
GVGVLGTAIGPVGPVTPIGPIGPIVPFTPIGPIGPIGPTGPAAPPGSTGSGGPTGPTVSS
AAPSETTSPTSESGPNQQFIQQMVQALAGANAPQLPNPEVRFQQQLEQLNAMGFLNREAN
LQALIATGGDINAAIERLLGSQPS",FUS;|UBQLN2,-;|-,protein_mutation:R244C;|protein_mutation:-,526aa(1-526);|624aa(1-624),P35637;Q9UHD9,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/Q9UHD9,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0803,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0038,http://db.phasep.pro/browse/","[3-251],[284-292],[332-338],[375-415],[451-499],[501-501],[503-505],[507-526];|[450-624]",-;|-,In vitro,1 µM [FUS];|4 µM [UBQLN2];|1 µM polyU,100 mM NaCl,"50 mM Tris·HCl (pH 7.4), 1 mM EDTA, 1 mM DTT",RT,≤ 20 h,-,Microscopy,liquid,"Within a period of 20 h, FUS_M(R244C)-RNA droplets formed and increased in both size and number. When UBQLN2 was present, the FUS_M(R244C)-RNA droplets formed were smaller in size but more numerous compared with those formed in the absence of UBQLN2. Notably, the FUS_M(R244C)-RNA droplets in the absence of UBQLN2 displayed nonspherical, irregular patterns, whereas those in the presence of UBQLN2 remained highly spherical over the entire time course. These nonspherical irregular droplets may represent the transition from the reversible liquid-like, phase-separated state of FUS to a more stable, solid state of FUS.",40,0.0,1.0,0.0,0.0,,,13.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,40.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.14134523778500913
91,91,91,PMID: 30765518,RNAPS0000261,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,-,-,"sc1 G quadruplex RNA (Tsang,2019)",36nt,GCUGCGGUGUGGAAGGAGUGGUCGGGUUGCGCAGCG,irregular RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,"150 µM [FMR1 LCR];|5 µM sc1 G quadruplex RNA (Tsang,2019)",30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",RT,-,-,"Differential interference contrast microscopy,FRAP",liquid,"This suggests that binding between FMRPLCR and sc1 RNA may be more dynamic than the stable interaction depicted by the crystal structure of a small RGG peptide in complex with sc1 (Protein Data Bank ID codes 5DE5, 5DE8, and 5DEA)",36,0.1111111111111111,0.19444444444444445,0.5277777777777778,0.16666666666666666,3.166666666666667,0.5714285714285714,14.0,0.4573045700320517,"[4.44951466 3.95449974 2.72475733 1.72475733 1.22974241 2.72475733
 3.44951466 2.72475733 2.72475733 2.72475733 4.44951466]",2.9892118279782878,0.9502624456934868,[1 1 1 1 1 1 1],1.0,0.0,-12.300000190734865,-12.511248588562012,34.394405364990234,0.9737709701163628,-12.300000190734865,0.7098103961656947,22.412270507488863,1.7187968952018613,0,0,1,1,0.13357012607799706
92,92,92,PMID: 30765518,RNAPS0000262,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + proteins,-,-,"sc1 G quadruplex RNA (Tsang,2019)",36nt,GCUGCGGUGUGGAAGGAGUGGUCGGGUUGCGCAGCG,irregular RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP;
sp|Q13542|4EBP2_HUMAN Eukaryotic translation initiation factor 4E-binding protein 2 OS=Homo sapiens OX=9606 GN=EIF4EBP2 PE=1 SV=1|length=120aa|residues=1-120
MSSSAGSGHQPSQSRAIPTRTVAISDAAQLPHDYCTTPGGTLFSTTPGGTRIIYDRKFLL
DRRNSPMAQTPPCHLPNIPGVTSPGTLIEDSKVEVNNLNNLNNHDRKHAVGDDAQFEMDI",FMR1;|EIF4EBP2,[FMR1]:LCR;|[EIF4EBP2]:-,-;|-,188aa(445-632);|120aa(1-120),Q06787;Q13542,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-5015,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0271,http://db.phasep.pro/browse/","FMR1:[445-515],[516-632];|EIF4EBP2:[1-120]","[492-504],[527-549];|[96-103]",In vitro,"250 µM [FMR1 LCR];|500 nM [EIF4EBP2];|5 µM sc1 G quadruplex RNA (Tsang,2019)",-,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 30 min,-,Sedimentation assay,liquid,"Cy3-labeled sc1 G quadruplex RNA (Tsang,2019) and miRNA125b are nearly completely sequestered into droplets (>90%), whereas 4EBP2 strongly partitions into the droplet (∼60%). In contrast, the free Cy3 dye and Cy3- BSA exhibit negligible partitioning.",36,0.1111111111111111,0.19444444444444445,0.5277777777777778,0.16666666666666666,3.166666666666667,0.5714285714285714,14.0,0.4573045700320517,"[4.44951466 3.95449974 2.72475733 1.72475733 1.22974241 2.72475733
 3.44951466 2.72475733 2.72475733 2.72475733 4.44951466]",2.9892118279782878,0.9502624456934868,[1 1 1 1 1 1 1],1.0,0.0,-12.300000190734865,-12.511248588562012,34.394405364990234,0.9737709701163628,-12.300000190734865,0.7098103961656947,22.412270507488863,1.7187968952018613,0,0,1,1,0.13357012607799706
93,93,93,PMID: 30765518,RNAPS0000263,https://pubmed.ncbi.nlm.nih.gov/30765518,RNAs + protein,-;|-,-;|-,"sc1 G quadruplex RNA (Tsang,2019);|miR-125b",36nt;|22nt(1-22),GCUGCGGUGUGGAAGGAGUGGUCGGGUUGCGCAGCG;|UCACAAGUUAGGGUCUCAGGGA,irregular RNA;|miRNA,-;|Mus musculus,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,"250 µM [FMR1 LCR];|5 µM sc1 G quadruplex RNA (Tsang,2019);|500 nM miRNA125b",-,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 30 min,-,Sedimentation assay,liquid,"Cy3-labeled sc1 G quadruplex RNA (Tsang,2019) and miRNA125b are nearly completely sequestered into droplets (>90%), whereas 4EBP2 strongly partitions into the droplet (∼60%). In contrast, the free Cy3 dye and Cy3- BSA exhibit negligible partitioning.",36,0.1724137931034483,0.206896551724138,0.4482758620689655,0.1724137931034483,2.6,0.8333333333333334,14.0,0.4614171971051869,"[4.44951466 3.95449974 2.72475733 1.72475733 1.22974241 2.72475733
 3.44951466 2.72475733 2.72475733 2.72475733 4.44951466 2.47226479
 0.74750746 0.97724987 1.         2.72475733 1.49501492 2.47226479]",2.4872438488662807,1.2102564274028669,[1 1 1 1 1 1 1 1 0 1 1],0.9090909090909092,0.08264462809917354,-12.300000190734865,-12.80708122253418,56.59382247924805,1.9108028553756304,-12.300000190734865,0.4392199832262674,17.59937771071418,3.5139021402692814,0,0,1,1,0.15321217127652126
94,94,94,PMID: 33290746,RNAPS0000420,https://pubmed.ncbi.nlm.nih.gov/33290746,RNA + protein,-,-,"H20 RNA(Chen,2020)",20nt,AGAUUCAACUGGCAGUAACC,irregular RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,4 µM[SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,RT,20 min,-,Fluorescence microscopy,"liquid, solute","Pure N-protein demixed into droplets (consistent with results from the Morgan [Carlson et al., 2020] and Fawzi [Myrto Perdikari et al., 2020] labs) and LLPS was enhanced by RNA extracted from the culture medium supernatant of infected cells containing full-length SARS-CoV-2 genome",20,0.35,0.2,0.2,0.25,0.8,1.7499999999999998,17.333333333333332,0.4281036112553423,[0.74750746 0.97724987 2.47226479 2.47226479 0.74750746],1.4833588757747849,0.658994151750657,[0 1 1 1],0.75,0.1875,0.0,-0.2881852686405182,18.299144744873047,0.8505031800152119,0.0,0.6265104987619228,11.757745573415892,1.519019847018545,0,0,1,1,0.17229907959998608
95,95,95,PMID: 31188823,RNAPS0000300,https://pubmed.ncbi.nlm.nih.gov/31188823,RNA + protein,-,-,"12-mer RNA (Kang,2019)",12nt,UAGUUUGGUGAU,irregular RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=267aa|residues=1-267
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGG",FUS,NTD,-,267aa(1-267),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[1-267],"[17-104],[106-261]",In vitro,20µM [FUS NTD];|40 µM RNA,"150 mM NaCl, 1 mM MgCl2, 4 mM ZnCl2",5 mM sodium phosphate buffer at pH 6.0,25˚C,-,-,Differential interference contrast microscopy,liquid,"Like ATP, RNA and two ssDNA molecules also induced the same monotonic dissolution of LLPS of NTD. Briefly, a ratio of 1:2 was required for RNA, but only a ratio of 1:1 was sufficient for two ssDNA molecules to significantly disrupt LLPS to reduce the sizes of droplets, with the maximal diameter reduced from approximately 7.6 to < 3.0 μm. Furthermore, a ratio of 1:5 was required for RNA (0.1 mM), but only a ratio of 1:2 was sufficient for two ssDNA molecules (0.04 mM) to completely dissolve LLPS of the NTD.",12,0.16666666666666666,0.5,0.3333333333333333,0.0,,0.3333333333333333,14.0,0.41285357149725294,[0.         0.         1.72475733],0.5749191101682993,0.6610639664734183,[0 1],0.5,0.25,0.0,-0.03119535930454732,11.764424324035645,0.1177877401665253,0.0,0.9506441617010764,50.93908747648398,0.2294055858885524,0,0,1,1,0.13301439979781504
96,96,96,PMID: 31292544,RNAPS0000315,https://pubmed.ncbi.nlm.nih.gov/31292544,RNA + protein,-,-,"m6A RNA(Ries,2019)",65nt,CCAGAGCCAGAACCAGAGACCAGAAACCAGAACCAGAACCAGAAGCCAGAGCCAGAAACCAGA,irregular RNA,-,"sp|Q9Y5A9|YTHD2_HUMAN YTH domain-containing family protein 2 OS=Homo sapiens OX=9606 GN=YTHDF2 PE=1 SV=2
MSASSLLEQRPKGQGNKVQNGSVHQKDGLNDDDFEPYLSPQARPNNAYTAMSDSYLPSYY
SPSIGFSYSLGEAAWSTGGDTAMPYLTSYGQLSNGEPHFLPDAMFGQPGALGSTPFLGQH
GFNFFPSGIDFSAWGNNSSQGQSTQSSGYSSNYAYAPSSLGGAMIDGQSAFANETLNKAP
GMNTIDQGMAALKLGSTEVASNVPKVVGSAVGSGSITSNIVASNSLPPATIAPPKPASWA
DIASKPAKQQPKLKTKNGIAGSSLPPPPIKHNMDIGTWDNKGPVAKAPSQALVQNIGQPT
QGSPQPVGQQANNSPPVAQASVGQQTQPLPPPPPQPAQLSVQQQAAQPTRWVAPRNRGSG
FGHNGVDGNGVGQSQAGSGSTPSEPHPVLEKLRSINNYNPKDFDWNLKHGRVFIIKSYSE
DDIHRSIKYNIWCSTEHGNKRLDAAYRSMNGKGPVYLLFSVNGSGHFCGVAEMKSAVDYN
TCAGVWSQDKWKGRFDVRWIFVKDVPNSQLRHIRLENNENKPVTNSRDTQEVPLEKAKQV
LKIIASYKHTTSIFDDFSHYEKRQEEEESVKKERQGRGK",YTHDF2,-,-,579aa(1-579),Q9Y5A9,"PhaSePro,DrLLPS","https://phasepro.elte.hu/entry/Q9Y5A9,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1477","[1-45],[247-382]","[52-63],[135-153],[324-349]",In vitro,570 nM [RNA];|25  µM [DF2],-,-,-,-,-,Differential interference contrast microscopy,solute,"We next asked whether the binding of m6 A-RNA to the YTH domain  regulates LLPS of DF proteins. We chose a buffer and protein concen tration in which LLPS does not occur. Addition of a 65-nucleotide-long  RNA containing either zero m6 A nucleotides or one m6 A nucleotide  did not induce LLPS of DF2 (Fig. 1f, Extended Data Fig. 1f). However,  an RNA that contained ten m6 A nucleotides triggered LLPS within  minutes",65,0.4603174603174603,0.0,0.2222222222222222,0.31746031746031744,0.7,,15.1,0.4771886855292613,"[2.72475733 2.72475733 1.72475733 1.72475733 2.72475733 2.72475733
 1.72475733 0.74750746 1.22974241 1.22974241 1.22974241 1.22974241
 1.22974241 1.22974241 1.         2.72475733 2.72475733 1.72475733
 1.         1.72475733]",1.7549146265799709,0.4728806542998177,[1 1 1 1 0 1 1 1 1 1 1 1],0.9166666666666666,0.07638888888888888,0.0,-0.6319799423217773,60.12013244628906,1.4399792158864757,0.0,0.35865029824530964,21.87531573544836,2.289979555275988,0,0,1,1,0.17055390117332914
97,97,97,PMID: 31586050,RNAPS0000339,https://pubmed.ncbi.nlm.nih.gov/31586050,RNA + protein,-,-,(GA-rich)30,30nt,GGAGGAGAGGAAGGUAAGGGAAGAAAGAAG,nucleotide rich RNA,-,"sp|Q96F86|EDC3_HUMAN Enhancer of mRNA-decapping protein 3 OS=Homo sapiens OX=9606 GN=EDC3 PE=1 SV=1
MATDWLGSIVSINCGDSLGVYQGRVSAVDQVSQTISLTRPFHNGVKCLVPEVTFRAGDIT
ELKILEIPGPGDNQHFGDLHQTELGPSGAGCQVGINQNGTGKFVKKPASSSSAPQNIPKR
TDVKSQDVAVSPQQQQCSKSYVDRHMESLSQSKSFRRRHNSWSSSSRHPNQATPKKSGLK
NGQMKNKDDECFGDDIEEIPDTDFDFEGNLALFDKAAVFEEIDTYERRSGTRSRGIPNER
PTRYRHDENILESEPIVYRRIIVPHNVSKEFCTDSGLVVPSISYELHKKLLSVAEKHGLT
LERRLEMTGVCASQMALTLLGGPNRLNPKNVHQRPTVALLCGPHVKGAQGISCGRHLANH
DVQVILFLPNFVKMLESITNELSLFSKTQGQQVSSLKDLPTSPVDLVINCLDCPENVFLR
DQPWYKAAVAWANQNRAPVLSIDPPVHEVEQGIDAKWSLALGLPLPLGEHAGRIYLCDIG
IPQQVFQEVGINYHSPFGCKFVIPLHSA",EDC3,-,-,508aa(1-508),Q96F86,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1241,"[95-189],[192-192],[203-258],[",[154-167],In vitro,150 µM Edc3 protein,25 mM NaCl,"25 mM HEPES, pH 7.3",RT,≤ 180 min,-,ssNMR,liquid,"In conclusion, our ssNMR data suggest that RNA is recruited to the dynamic and unstructured IDR in Edc3, which results in decreased internal mobility.",30,0.4666666666666667,0.03333333333333333,0.5,0.0,,14.0,14.0,0.4675589168157056,"[3.44951466 2.72475733 1.22974241 1.72475733 1.         1.
 1.72475733 0.74750746 0.97724987]",1.6198095987364591,0.7427813860724086,[1 1 1 1 0 1],0.8333333333333334,0.1388888888888889,0.0,-0.006421700585633515,29.979307174682607,0.010365318894483954,0.0,0.9896346811055184,1447.133479702439,0.020703574168478886,0,0,1,1,0.1197794042950876
98,98,98,PMID: 31630970,RNAPS0000340,https://pubmed.ncbi.nlm.nih.gov/31630970,RNA + protein,-,-,polyrU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,1µM poly(rU)40;|1µM FUS,100mM NaCl,"100mM Tris-HCl,pH 7.5,1mM EDTA,1mM DTT",RT,≤ 6 h,-,FRAP,"solute, liquid","The size of condensates was determined over the course of six hours; whereas WT-FUS, NLS, and G mutant FUS form small droplets (area of ~1.5μm2, R) R mutants grow much larger (area ~ 3-6 μm2) (Fig. 6B). Even after three hours, a stark difference in droplet size is observed (Fig 6C).",40,0.0,1.0,0.0,0.0,,,13.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,40.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.14134523778500913
99,99,99,PMID: 31677973,RNAPS0000342,https://pubmed.ncbi.nlm.nih.gov/31677973,RNA + protein,-,-,"MajSAT RNA (Huo,2020)",231nt,GGACCUGGAAUAUGGCGAGAAAACUGAAAAUCACGGAAAAUGAGAAAUACACACUUUAGGACGUGAAAUAUGGCGAGGAAAACUGAAAAAGGUGGAAAAUUUAGAAAUGUCCACUGUAGGUCGUGGAAUAUGGCAAGAAAACUGAAAAUCAUGGAAAAUGAGAAACAUCCACUUGACGACUUGAAAAAUGACGAAAUCACUAAAAAACGUGAAAAAUGAGAAAUGCACACUGAA,irregular RNA,-,"sp|Q15424|SAFB1_HUMAN Scaffold attachment factor B1 OS=Homo sapiens OX=9606 GN=SAFB PE=1 SV=4
MAETLSGLGDSGAAGAAALSSASSETGTRRLSDLRVIDLRAELRKRNVDSSGNKSVLMER
LKKAIEDEGGNPDEIEITSEGNKKTSKRSSKGRKPEEEGVEDNGLEENSGDGQEDVETSL
ENLQDIDIMDISVLDEAEIDNGSVADCVEDDDADNLQESLSDSRELVEGEMKELPEQLQE
HAIEDKETINNLDTSSSDFTILQEIEEPSLEPENEKILDILGETCKSEPVKEESSELEQP
FAQDTSSVGPDRKLAEEEDLFDSAHPEEGDLDLASESTAHAQSSKADSLLAVVKREPAEQ
PGDGERTDCEPVGLEPAVEQSSAASELAEASSEELAEAPTEAPSPEARDSKEDGRKFDFD
ACNEVPPAPKESSTSEGADQKMSSPEDDSDTKRLSKEEKGRSSCGRNFWVSGLSSTTRAT
DLKNLFSKYGKVVGAKVVTNARSPGARCYGFVTMSTAEEATKCINHLHKTELHGKMISVE
KAKNEPVGKKTSDKRDSDGKKEKSSNSDRSTNLKRDDKCDRKDDAKKGDDGSGEKSKDQD
DQKPGPSERSRATKSGSRGTERTVVMDKSKGVPVISVKTSGSKERASKSQDRKSASREKR
SVVSFDKVKEPRKSRDSESHSRVRERSEREQRMQAQWEREERERLEIARERLAFQRQRLE
RERMERERLERERMHVEHERRREQERIHREREELRRQQELRYEQERRPAVRRPYDLDRRD
DAYWPEAKRAALDERYHSDFNRQDRFHDFDHRDRGRYPDHSVDRREGSRSMMGEREGQHY
PERHGGPERHGRDSRDGWGGYGSDKRMSEGRGLPPPPRRDWGDHGRREDDRSWQGTADGG
MMDRDHKRWQGGERSMSGHSGPGHMMNRGGMSGRGSFAPGGASRGHPIPHGGMQGGFGGQ
SRGSRPSDARFTRRY",SAFB,-,-,915aa(1-915),Q15424,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2609,http://db.phasep.pro/browse/",-,"[5-24],[83-94],[96-108],[201-215],[319-347],[514-541],[614-707],[739-756],[863-876],[891-905]",In vitro,0-3.75µM MajSAT RNA;|5µM SAFB-GEP,50mM NaCl,"50mM Tris pH 7.5, 5mM DTT",25˚C,10 min,"other_molecular:10% 1,6-hexanediol, 0.1% Triton",FRAP,"solute, liquid","When no RNAs were added, SAFB-GFP formed condensed droplets under 50 mM NaCl concentration. Surprisingly, by adding MajSAT RNAs, SAFB-GFP formed larger “droplet clusters,” whose sizes enlarged with the increase in concentrations of MajSAT RNAs (Figures 6E and 6F).",231,0.45299145299145294,0.1794871794871795,0.2307692307692308,0.13675213675213674,1.6875,2.523809523809524,13.692307692307693,0.4495303499475792,"[3.44951466 3.44951466 0.         0.         2.72475733 1.72475733
 0.25249254 0.74750746 0.         0.         2.47226479 0.
 0.         0.74750746 0.         0.         1.49501492 0.
 0.         3.44951466 1.72475733 0.         0.         1.97724987
 4.44951466 0.         0.         0.74750746 0.         0.
 3.44951466 0.         0.         0.         0.         0.
 2.45948481 1.49501492 1.72475733 3.44951466 3.44951466 0.
 0.         1.         1.72475733 0.         0.         0.
 0.         0.97724987 0.25249254 0.         0.         0.
 0.         1.72475733 1.72475733 1.22974241 2.45948481 1.22974241
 0.         0.         0.         1.22974241 0.25249254 0.74750746
 0.         0.         0.         1.72475733 0.         0.
 0.74750746 0.25249254 1.22974241 1.49501492 0.74750746]",0.8596029187608303,1.3374146916001544,"[1 0 1 0 1 0 1 0 0 1 0 1 1 0 1 0 1 1 1 0 0 1 1 1 1 0 1 0 0 0 1 1 0 1 1 1 0
 1 0 1 0 1 0 1 1 1]",0.5869565217391305,0.2424385633270321,-28.899999618530273,-33.98397827148437,191.6097412109375,25.380935685590547,-24.899999618530273,0.0002615422662781345,5.038213378619683,41.1080976136584,0,0,1,1,0.10801901689386723
100,100,100,PMID: 31677973,RNAPS0000343,https://pubmed.ncbi.nlm.nih.gov/31677973,RNA + protein,-,-,"U1 RNA (Huo,2020)",156nt,AUACUUACCUGGCAGGGGAGAUACCAUGAUCACGAAGGUGGUUUUCCCAGGGCGAGGCUUAUCCAUUGCACUCCGGAUGUGCUGACCCCUGCGAUUUCCCCAAAUGCGGGAAACUCGACUGCAUAAUUUGUGGUAGUGGGGGACUGCGUUCGCGCU,irregular RNA,-,"sp|Q15424|SAFB1_HUMAN Scaffold attachment factor B1 OS=Homo sapiens OX=9606 GN=SAFB PE=1 SV=4
MAETLSGLGDSGAAGAAALSSASSETGTRRLSDLRVIDLRAELRKRNVDSSGNKSVLMER
LKKAIEDEGGNPDEIEITSEGNKKTSKRSSKGRKPEEEGVEDNGLEENSGDGQEDVETSL
ENLQDIDIMDISVLDEAEIDNGSVADCVEDDDADNLQESLSDSRELVEGEMKELPEQLQE
HAIEDKETINNLDTSSSDFTILQEIEEPSLEPENEKILDILGETCKSEPVKEESSELEQP
FAQDTSSVGPDRKLAEEEDLFDSAHPEEGDLDLASESTAHAQSSKADSLLAVVKREPAEQ
PGDGERTDCEPVGLEPAVEQSSAASELAEASSEELAEAPTEAPSPEARDSKEDGRKFDFD
ACNEVPPAPKESSTSEGADQKMSSPEDDSDTKRLSKEEKGRSSCGRNFWVSGLSSTTRAT
DLKNLFSKYGKVVGAKVVTNARSPGARCYGFVTMSTAEEATKCINHLHKTELHGKMISVE
KAKNEPVGKKTSDKRDSDGKKEKSSNSDRSTNLKRDDKCDRKDDAKKGDDGSGEKSKDQD
DQKPGPSERSRATKSGSRGTERTVVMDKSKGVPVISVKTSGSKERASKSQDRKSASREKR
SVVSFDKVKEPRKSRDSESHSRVRERSEREQRMQAQWEREERERLEIARERLAFQRQRLE
RERMERERLERERMHVEHERRREQERIHREREELRRQQELRYEQERRPAVRRPYDLDRRD
DAYWPEAKRAALDERYHSDFNRQDRFHDFDHRDRGRYPDHSVDRREGSRSMMGEREGQHY
PERHGGPERHGRDSRDGWGGYGSDKRMSEGRGLPPPPRRDWGDHGRREDDRSWQGTADGG
MMDRDHKRWQGGERSMSGHSGPGHMMNRGGMSGRGSFAPGGASRGHPIPHGGMQGGFGGQ
SRGSRPSDARFTRRY",SAFB,-,-,915aa(1-915),Q15424,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2609,http://db.phasep.pro/browse/",-,"[5-24],[83-94],[96-108],[201-215],[319-347],[514-541],[614-707],[739-756],[863-876],[891-905]",In vitro,"0-3.75µM U1 RNA (Huo,2020);|5µM SAFB-GEP",50mM NaCl,"50mM Tris pH 7.5, 5mM DTT",25˚C,10 min,"other_molecular:10% 1,6-hexanediol, 0.1% Triton",FRAP,"liquid, solute","When no RNAs were added, SAFB-GFP formed condensed droplets under 50 mM NaCl concentration. Surprisingly, by adding MajSAT RNAs, SAFB-GFP formed larger “droplet clusters,” whose sizes enlarged with the increase in concentrations of MajSAT RNAs (Figures 6E and 7F).",156,0.20512820512820512,0.25,0.2948717948717949,0.25,1.1794871794871795,0.8205128205128205,13.769230769230768,0.4557098064740266,"[0.         1.         3.44951466 2.72475733 3.95449974 2.47226479
 0.74750746 0.25249254 0.97724987 1.22974241 1.22974241 1.72475733
 3.44951466 0.         0.         4.44951466 4.44951466 4.44951466
 1.         0.25249254 0.25249254 1.         1.72475733 2.47226479
 1.97724987 1.22974241 2.45948481 2.72475733 2.72475733 4.44951466
 0.         0.         2.72475733 0.         0.         4.44951466
 1.         1.72475733 1.72475733 1.72475733 0.         0.
 0.         1.22974241 1.22974241 3.95449974 3.95449974 2.72475733
 1.         1.97724987 4.44951466]",1.817581390309701,2.2229803110964417,[0 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 0 1 1 1 1 1],0.8064516129032258,0.1560874089490115,-52.0,-54.90591812133789,100.2794189453125,35.39579590151457,-23.5,0.008960365454887938,2.563196351334489,48.2682242448872,0,0,1,1,0.11693592060783786
101,101,101,PMID: 31975687,RNAPS0000039,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:174158,https://www.ncbi.nlm.nih.gov/gene/174158,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [nos-2];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as efficient as longer RNAs at stimulating MEG-3 condensation.",30,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,30.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.1482762666082112
102,102,102,PMID: 31975687,RNAPS0000377,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(100),100nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U100];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",100,0.0,1.0,0.0,0.0,,,11.75,0.5268326058735131,"[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0. 0. 0. 0. 0. 0.]",0.0,0.0,[0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0],0.0,0.0,0.0,4.379222594226356e-15,100.0,0.0,0.0,1.000000000000007,0.0,0.0,1,0,0,1,0.062167640815542546
103,103,103,PMID: 31975687,RNAPS0000378,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(200),200nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U200];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",200,0.0,1.0,0.0,0.0,,,11.303030303030305,0.5268326058735131,"[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.]",0.0,0.0,"[0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
 0 0 0]",0.0,0.0,0.0,8.758445188452712e-15,200.0,0.0,0.0,1.0000000000000142,0.0,0.0,1,0,0,1,0.009798310726351511
104,104,104,PMID: 31975687,RNAPS0000379,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(300),300nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U300];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",300,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,"[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 0. 0. 0.]",0.0,0.0,"[0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]",0.0,0.0,0.0,8.758445188452712e-15,300.0,0.0,0.0,1.0000000000000142,0.0,0.0,1,0,0,-1,-0.029774622860313738
105,105,105,PMID: 32301603,RNAPS0000381,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(CAG)8,24nt,CAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(CAG)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",24,0.3333333333333333,0.0,0.3333333333333333,0.3333333333333333,1.0,,14.0,0.5005144739119439,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481]",2.4594848111974885,0.0,[1 1 1 1],1.0,0.0,-5.800000190734862,-5.8727664947509775,23.089902877807607,0.6418702165359418,-5.800000190734862,0.8886377229916039,26.36618825002853,1.223686115964732,0,1,0,1,0.1326559722274852
106,106,106,PMID: 32301603,RNAPS0000382,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(CUG)8,24nt,CUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(CUG)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",24,0.0,0.3333333333333333,0.3333333333333333,0.3333333333333333,1.0,,14.0,0.5005144739119439,"[2.45948481 2.45948481 2.45948481 2.45948481 2.45948481 2.45948481
 2.45948481]",2.4594848111974885,0.0,[1 1 1 1],1.0,0.0,-7.099999904632568,-7.182991981506348,23.4258975982666,0.3743761549381126,-7.099999904632568,0.8740156089982191,41.771310870628966,0.7249486244826671,0,1,0,1,0.1306260929137253
107,107,107,PMID: 32301603,RNAPS0000383,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(GGGGCC)8,48nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(GGGGCC)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",48,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4709914731812773,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1 1 1 1 1 1],1.0,0.0,-31.10000038146973,-31.66337776184082,41.620216369628906,4.825697635882105,-30.399999618530273,0.4008785241678085,7.522544160127796,7.543464805338832,0,1,0,1,0.10114322897593364
108,108,108,PMID: 32301603,RNAPS0000384,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(GGGUUA)8,48nt,GGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUA,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(GGGUUA)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",48,0.16666666666666666,0.3333333333333333,0.5,0.0,,0.5,14.0,0.4592003392451181,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[1 1 1 1 1 1 1 1 1],1.0,0.0,0.0,-0.8427376747131348,39.05889129638672,4.4710330340381965,0.0,0.2547765096317814,5.367886977637341,8.289263246549401,0,1,0,1,0.10313361556958783
109,109,109,PMID: 32301603,RNAPS0000385,https://pubmed.ncbi.nlm.nih.gov/32301603,Undefined,-,-,(GGGGCC)8,48nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,other molecular:10 μM channel inhibitor;cell:SH-SY5Y cells,"FISH,Confocal microscopy",gel,"Without r(GGGGCC)8 expression, punctate staining (BG4 foci) was not observed (Figure 6a). In contrast, with r(GGGGCC)8 expression, BG4 foci were observed in the cells (Figure 6b, yellow arrows). To confirm the localization of the BG4 foci, the nuclei were counterstained with DAPI . As a result, BG4 foci were found to be located in the nuclei and cytoplasm. Moreover, we added a potassium ion channel inhibitor of imipramine and monitored the BG4 foci after 24 h",48,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4709914731812773,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1 1 1 1 1 1],1.0,0.0,-31.10000038146973,-31.66337776184082,41.620216369628906,4.825697635882105,-30.399999618530273,0.4008785241678085,7.522544160127796,7.543464805338832,0,1,0,1,0.10114322897593364
110,110,110,PMID: 32513655,RNAPS0000391,https://pubmed.ncbi.nlm.nih.gov/32513655,RNA + protein,-,-,polyA(15),15nt,AAAAAAAAAAAAAAA,poly RNA,-,"sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|residues=296-754
TEDPYNEDFYFQVYKIIQRGGITSESNKGLIARAYLEHSGHRLGGRYKRTDIALQRMQSQVEKA
VTVAKERPSKLKDQQAAAGNSSQDNKQANTVLGKISSTLNSKNPRRQLQIPRQQPSDPDA
LKDVTDSLTNVDLASSGSSSTGSSAAAVASKQRRRSSYAFNNGNGATNLNKSGGKKFILE
LIETVYEEILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIF
NFLDKQQKLKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLS
NNSNFIEIMGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEIS
TWNEIYDKLFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQ
RIIIDEVRDEIFATINEAETLQKKEKELSVLPQR;|-",PAT1;|Dcp1-Dcp2,M+C-term,-;|-,458aa(296-754),"P25644;Q12517,P53550 ","DrLLPS,LLPSDB,PhaSepDB;Dcp-1:DrLLPS,PhaSepDB,
Dcp-2:PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0754,http://db.phasep.pro/browse/;http://db.phasep.pro/browse/","[1-4],[5-24],[55-79],[164-200],[365-421],[422-469];|-","[59-74],[111-137],[149-157],[165-183],[187-224],[404-415],[434-450],[545-555],[571-583];|-",In vitro,13.4 ng/µl [polyA];|2.5µM [Pat1];|2.5µM Dcp1/Dcp2Ext,60 mM NaCl,"20 mM HEPES pH 7.0, 1 mM DTT",RT,20 min,-,"Bright-field microscopy,Fluorescence microscopy",liquid,"PatMC and Dcp2 both weakly interact with RNA, which can trigger or potentiate liquid-liquid phase separation with oligomeric RNA binding proteins (RBPs)The PatMC/Dcp1/Dcp2Ext droplets were able to incorporate A15 RNA,though A15 RNA did not change the critical concentration required for phase separation However, neither short A15 RNAs nor polyA RNA promoted droplet formation with either PatMC",15,1.0,0.0,0.0,0.0,,,16.5,0.5268326058735131,[0. 0. 0. 0.],0.0,0.0,[0 0 0],0.0,0.0,0.0,1.094805648556589e-15,15.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.11246343406425546
111,111,111,PMID: 32637943,RNAPS0000405,https://pubmed.ncbi.nlm.nih.gov/32637943,RNA + protein,-,-,SARS-CoV-2 virus RNA,318nt(PS-318),UAGCUUGUGCUGGUCCCUUUGAAGGUGUUAGACCUUUGACUGAACCUUCUGUUAUUAAAACACCAUUACGGGCGUUUCUAAAAAGGUCUACCUGUCCUUCCACUCUACCAUCAAACAAGACAGUAAGUGAAGAACAAGCACUCUCAGUAGGUUUCUUGGCAAUGUCAGUCAUUGUGCAGACACCUAUUGUAGAUACAUGUGCUGGGGCUUCUCUUUUGUAGUCCCAGAUGUACAGUAUUAGCAGCGAUAUCAACACCCAAAUUAUUGAGUAUCUUAAUCUCUGGCACUGGUUUAAUGUUACGCUUAGCCCAAAGCUCA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|mutation:R10D
MSDNGPQNQDNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_mutation:R10D,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,1 µM [SARS-CoV-2];|10 µM [SARS-CoV-2 N protein],70 mM KCl,25 mM Hepes pH 7.5,RT,15 min,-,Negative-stain electron microscopy,solid,"We used negative-stain electron microscopy to further analyze mixtures of 10 µM N protein and  1 µM RNA.These images represent the saturated protein-RNA solution surrounding  condensates. Unmodified wild-type protein and viral RNA formed uniform particles of ~20 nm diameter, reminiscent of structures seen in previous studies of partially disrupted MHV  nucleocapsids.Thus, the gel filamentous condensates of the unmodified protein – and possibly the nucleocapsid – are likely to be assembled on a foundation of discrete structural  building blocks. In contrast, the mixture of 10D mutant and RNA formed nonuniform, diffuse chains",318,0.2672955974842767,0.3113207547169811,0.1949685534591195,0.22641509433962265,0.8611111111111112,0.8585858585858586,13.867924528301884,0.4615897682692743,"[0.25249254 1.22974241 2.45948481 2.45948481 2.72475733 1.
 0.97724987 1.22974241 0.         0.         1.22974241 0.74750746
 1.49501492 1.22974241 0.25249254 1.22974241 0.         0.
 0.         0.         1.22974241 0.25249254 1.97724987 4.44951466
 1.         0.         0.         0.         1.72475733 1.72475733
 2.72475733 1.22974241 1.72475733 2.72475733 1.22974241 0.25249254
 0.97724987 0.74750746 0.97724987 1.49501492 0.         0.
 1.22974241 0.97724987 0.97724987 1.22974241 1.49501492 1.49501492
 1.22974241 0.25249254 0.74750746 1.72475733 1.         0.74750746
 1.49501492 1.49501492 0.74750746 1.72475733 1.72475733 1.49501492
 1.22974241 0.25249254 0.97724987 0.         0.         1.22974241
 2.45948481 3.95449974 1.97724987 1.22974241 0.         0.
 0.97724987 2.47226479 2.47226479 0.97724987 0.97724987 0.74750746
 0.         0.         4.44951466 0.         0.         0.97724987
 2.47226479 0.         0.         0.         0.74750746 0.74750746
 0.         0.         0.74750746 2.47226479 2.47226479 1.72475733
 0.         0.         0.         0.         0.         0.
 1.97724987 1.         1.72475733]",1.0494657801601701,0.9702469575887036,"[1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1
 0 1 1 1 1 0 1 1 1 1 0 1 0 1 1 0 1 0 1 1 1 0 1 1 1 1]",0.8095238095238095,0.15419501133786856,-85.69999694824219,-91.47622680664062,231.13645935058602,52.2730970502486,-58.4000015258789,8.506275411795632e-05,3.2623722907122272,78.6926612321501,0,0,1,1,0.1013122270673919
112,112,112,PMID: 32637943,RNAPS0000406,https://pubmed.ncbi.nlm.nih.gov/32637943,RNA + protein,-,-,SARS-CoV-2 virus RNA,10nt(TRS),UCUAAACGAA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|mutation:R10D
MSDNGPQNQDNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_mutation:R10D,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10 µM [SARS-CoV-2];|5-25 µM [SARS-CoV-2 N protein],70 mM KCl,25 mM Hepes pH 7.5,RT,30 min,-,Microscopy,"solute, solid","We explored the role of phosphorylation in depth with studies of a phosphomimetic mutant in  which the ten serines and threonines in the SR region were replaced with aspartate (the 10D  mutant). When combined with the 5’-400 viral RNA, the 10D protein rapidly formed condensates with a spherical droplet morphology that was clearly distinct from the filamentous structures of  the wild-type protein",10,0.5,0.2,0.1,0.2,0.5,2.5,11.0,0.3723308333814104,[0. 0.],0.0,0.0,[0 1],0.5,0.25,0.0,-0.05148908868432045,9.702425003051758,0.14878757738791568,0.0,0.9198518249085696,33.60495605734685,0.27583095484108555,0,0,1,1,0.1043743850378801
113,113,113,PMID: 32637943,RNAPS0000408,https://pubmed.ncbi.nlm.nih.gov/32637943,RNA + protein,-,-,SARS-CoV-2 virus RNA,400nt(1-400),AUGUUGACGUGCCUCUGAUAAGACCUCCUCCACGGAGUCUCCAAAGCCACGUACGAGCACGUCGCGAACCUGUAAAACAGGCAAACUGAGUUGGACGUGUGUUUUCUCGUUGAAACCAGGGACAAGGCUCUCCAUCUUACCUUUCGGUCACACCCGGACGAAACCUAGAUGUGCUGAUGAUCGGCUGCAACACGGACGAAACCGUAAGCAGCCUGCAGAAGAUAGACGAGUUACUCGUGUCCUGUCAACGACAGUAAUUAGUUAUUAAUUAUACUGCGUGAGUGCACUAAGCAUGCAGCCGAGUGACAGCCACACAGAUUUUAAAGUUCGUUUAGAGAACAGAUCUACAAGAGAUCGAAAGUUGGUUGGUUUGUUACCUGGGAAGGUAUAAACCUUUAAU,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residue=1-364|mutation:R10D
MSDNGPQNQDNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFP",SARS-CoV-2 Nucleoprotein,△CTE,protein_mutation:R10D,364aa(1-364),P0DTC9,-,-,"[1-43],[73-102],[145-149],[152-160],[172-215],[235-271]",-,In vitro,1 µM [SARS-CoV-2];|5-25 µM [SARS-CoV-2 N protein],70 mM KCl,25 mM Hepes pH 7.5,RT,30 min,-,Microscopy,liquid,"All three large viral RNAs were effective in driving droplet  formation, although N-1260 appeared to reduce the saturating concentration (Extended Data  Fig. 4a). NTE deletion in the 10D protein reduced droplet formation, showing once again the  positive role of this region",400,0.2875,0.2425,0.24,0.23,1.0434782608695652,1.1855670103092784,14.06060606060606,0.4668697258905387,"[0.97724987 1.72475733 3.44951466 2.72475733 1.49501492 0.
 0.         2.45948481 2.45948481 2.45948481 2.72475733 2.72475733
 2.72475733 0.         0.         4.44951466 1.72475733 1.22974241
 2.45948481 2.45948481 3.95449974 1.97724987 1.22974241 0.
 0.         1.72475733 1.         0.74750746 1.49501492 1.22974241
 1.22974241 2.45948481 1.49501492 0.         0.         1.22974241
 0.97724987 1.         3.44951466 2.72475733 1.22974241 1.
 2.72475733 1.22974241 0.97724987 1.         0.         0.
 2.47226479 1.49501492 3.95449974 3.95449974 1.22974241 1.
 1.72475733 0.97724987 1.72475733 1.72475733 0.97724987 1.72475733
 2.72475733 3.44951466 1.72475733 2.47226479 4.44951466 0.
 0.         0.         0.         4.44951466 4.44951466 1.72475733
 0.97724987 0.74750746 1.72475733 1.72475733 0.74750746 1.72475733
 1.72475733 1.72475733 2.72475733 1.22974241 1.22974241 1.49501492
 0.         0.         0.         0.         0.         0.
 0.         2.72475733 2.72475733 2.72475733 1.72475733 0.74750746
 0.25249254 1.72475733 4.44951466 3.95449974 1.49501492 1.49501492
 2.72475733 2.72475733 1.49501492 0.         0.         0.
 1.72475733 0.         0.         0.74750746 1.22974241 1.22974241
 0.97724987 0.97724987 0.74750746 1.72475733 0.         0.
 1.72475733 2.72475733 0.         0.         1.         3.44951466
 1.         1.72475733 0.         0.         0.25249254 0.        ]",1.4599176175188109,1.4985789749143732,"[0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1
 1 1 1 1 1 1 1 1 1 0 1 1 1 1 0 0 0 0 1 1 0 1 1 1 1 1 0 0 1 0 1 1 0 1 1 1 1
 0 1 1 0 1 0]",0.7625,0.18109375,-116.0999984741211,-124.50528717041016,275.50289916992193,82.55215487404959,-77.30000305175781,1.1944197599555503e-06,2.080125017964793,120.47538703302533,0,0,1,1,0.021508733032121308
114,114,114,PMID: 32766587,RNAPS0000412,https://pubmed.ncbi.nlm.nih.gov/32766587,RNA + protein,-,-,"17-mer RNA(Lu,2020)",17nt,AAGCAGCUAAGAGCGAA,irregular RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,2µM 17-mer RNA;|10µM N protein,80mM KCl,"5 mM HEPES, pH 7.5",20˚C,10–20 min,-,"Turbidity measurement,Differential interference contrast microscopy,Electron microscopy",liquid,"With 10 μM N protein, maximal phase separation occurred in the presence of 5 μM 17-mer RNA (85 μM nucleotide), above which phase separation was inhibited. The central intrinsic disordered region is required for RNA-dependent phase separation of N protein. (Fig.3K) Summary of phase separation behaviors of N protein variants shown in (A-J). Domain schematic of the SARS-CoV-2 N protein, with known domains marked. Gray shading indicates the region implicated in N+RNA phase separation.",17,0.4705882352941176,0.05882352941176471,0.29411764705882354,0.17647058823529413,1.6666666666666663,8.0,20.5,0.4192982640291136,[3.44951466 0.         0.         2.72475733],1.5435679978786734,2.4482613125902497,[1 1 1],1.0,0.0,-1.0,-1.5070477724075315,13.659400939941404,1.9909266099544496,-0.10000000149011612,0.4392435888768118,4.965099850668888,2.437317306452872,0,0,1,1,0.12842928489118266
115,115,115,PMID: 32870271,RNAPS0000414,https://pubmed.ncbi.nlm.nih.gov/32870271,RNA + protein,-,-,"rA2RE11 cis-acting element RNA (H. Ryan,2020)",11nt,GCCAAGGAGCC,irregular RNA,Homo sapiens,"sp|P22626|ROA2_HUMAN Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens OX=9606 GN=HNRNPA2B1 PE=1 SV=2
MEKTLETVPLERKKREKEQFRKLFIGGLSFETTEESLRNYYEQWGKLTDCVVMRDPASKR
SRGFGFVTFSSMAEVDAAMAARPHSIDGRVVEPKRAVAREESGKPGAHVTVKKLFVGGIK
EDTEEHHLRDYFEEYGKIDTIEIITDRQSGKKRGFGFVTFDDHDPVDKIVLQKYHTINGH
NAEVRKALSRQEMQEVQSSRSGRGGNFGFGDSRGGGGNFGPGPGSNFRGGSDGYGSGRGF
GDGYNGYGGGPGGGNFGGSPGYGGGRGGYGGGGPGYGNQGGGYGGGYDNYGGGNYGSGNY
NDFGNYNQQPSNYGPMKSGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGRSRY",HNRNPA2B1,C,-,-,P22626,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2608,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0117,http://db.phasep.pro/browse/","[190-341],[342-353]","[11-22],[198-307],[322-352]",In vitro,15 µM [A2RE];|15 µM [HNRNPA2B1],50mM NaCl or 150mM NaCl,20 mM Tris pH 7.5,RT,≤ 120 min,-,Differential interference contrast microscopy,solute,"rA2RE11 and rA2RE21 prevent phase separation and aggregation of full-length hnRNPA2 WT and mutants.After cleavage of a C-terminal maltose binding protein solubility tag by TEV protease, hnRNPA2 FL D290V (B) and P298L (C) undergo LLPS followed by aggregation. In the presence of either rA2RE11 or rA2RE21, neither phase separation nor aggregation occur.",11,0.2727272727272727,0.0,0.3636363636363637,0.3636363636363637,1.0,,11.0,0.4192982640291137,[2.72475733 3.44951466],3.0871359957573468,0.13131829703014647,[1 1],1.0,0.0,0.0,-0.3778599500656128,9.1588134765625,0.9205931564480032,0.0,0.5416746301926054,5.974408957395557,1.102133414637929,0,0,1,1,0.1557602427569576
116,116,116,PMID: 32870271,RNAPS0000415,https://pubmed.ncbi.nlm.nih.gov/32870271,RNA + protein,-,-,"rA2RE21 two overlapping tandem A2REs RNA (H. Ryan,2020)",21nt,GCCAAGGAGCCAGAGAGCAUG,irregular RNA,Homo sapiens,"sp|P22626|ROA2_HUMAN Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens OX=9606 GN=HNRNPA2B1 PE=1 SV=2
MEKTLETVPLERKKREKEQFRKLFIGGLSFETTEESLRNYYEQWGKLTDCVVMRDPASKR
SRGFGFVTFSSMAEVDAAMAARPHSIDGRVVEPKRAVAREESGKPGAHVTVKKLFVGGIK
EDTEEHHLRDYFEEYGKIDTIEIITDRQSGKKRGFGFVTFDDHDPVDKIVLQKYHTINGH
NAEVRKALSRQEMQEVQSSRSGRGGNFGFGDSRGGGGNFGPGPGSNFRGGSDGYGSGRGF
GDGYNGYGGGPGGGNFGGSPGYGGGRGGYGGGGPGYGNQGGGYGGGYDNYGGGNYGSGNY
NDFGNYNQQPSNYGPMKSGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGRSRY",HNRNPA2B1,C,-,-,P22626,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2608,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0117,http://db.phasep.pro/browse/","[190-341],[342-353]","[11-22],[198-307],[322-352]",In vitro,15 µM [A2RE];|15 µM [HNRNPA2B1],50mM NaCl or 150mM NaCl,20 mM Tris pH 7.5,RT,≤ 120 min,-,Differential interference contrast microscopy,solute,"rA2RE11 and rA2RE21 prevent phase separation and aggregation of full-length hnRNPA2 WT and mutants.After cleavage of a C-terminal maltose binding protein solubility tag by TEV protease, hnRNPA2 FL D290V (B) and P298L (C) undergo LLPS followed by aggregation. In the presence of either rA2RE11 or rA2RE21, neither phase separation nor aggregation occur.",21,0.3333333333333333,0.047619047619047616,0.3809523809523809,0.2380952380952381,1.6,7.0,17.666666666666668,0.4673872397485982,[1.97724987 1.22974241 2.72475733 2.72475733 2.72475733 1.72475733],2.1843369326116933,0.3402519655601484,[1 1 1 1],1.0,0.0,-0.5,-1.0697702169418335,17.803264617919922,1.8591014559150103,0.0,0.3967415580920259,6.568877058105353,2.5718014309456985,0,0,1,1,0.16155702559797785
117,117,117,PMID: 32901111,RNAPS0000421,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,"A20 RNA(Chen,2020)A20 RNA(Chen,2020)",20nt,UAGCUUAUCAGACUGAUGUU,irregular RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.2-10µM [A20];|1-40µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,Fluorescence microscopy,"liquid, solute","We observed formation of liquid-like droplets when N protein or RNA concentration was higher than certain thresholds.Phase diagram of N protei-20 RNA LLPS in the presence of 2.5% PEG8000, N protein is labeled with Alexa-488.",20,0.25,0.4,0.2,0.15,1.3333333333333337,0.625,17.333333333333332,0.4086048612313037,[0.         0.         1.49501492 1.49501492 0.97724987],0.7934559435728258,0.4554589768072784,[1 0 1 0],0.5,0.25,-0.8000000119209291,-1.5175760984420776,14.8234224319458,2.752029254041956,0.4000000059604645,0.3121442092437498,3.8633600597692253,3.9374889924147385,0,0,1,1,0.13859372755144972
118,118,118,PMID: 32901111,RNAPS0000422,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,"A85 RNA(Chen,2020)",85nt,GGCGCAUAAAGAUGAGACGCGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGUUCG,irregular RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.1-5µM [A85];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"Representative fluorescence and DIC images of LLPS formed by N protein (green) with 85-nt RNA A85 at the indicated concentrations. Representative fluorescence and DIC images of LLPS formed by N protein (red) with the positive strand RNA of N protein (N1541, 1541 nt) at the indicated concentrations.",85,0.3647058823529412,0.2470588235294117,0.2470588235294117,0.1411764705882353,1.75,1.4761904761904758,13.785714285714285,0.44614848355035264,"[4.44951466 0.         0.         0.97724987 1.49501492 3.95449974
 0.         0.         1.72475733 1.72475733 0.         0.
 0.25249254 0.97724987 0.         0.         0.         1.
 1.22974241 2.72475733 0.         0.         0.97724987 0.97724987
 0.         0.         1.22974241]",0.8775658568328141,1.4133430255760908,[1 0 1 1 0 1 0 1 0 0 1 1 1 1 0 0 1],0.5882352941176471,0.2422145328719723,-12.699999809265135,-14.51580047607422,53.502906799316406,19.132538509347807,-0.699999988079071,0.05253926332304968,2.6982431048798903,27.906268750021358,0,0,1,1,0.11366986853716787
119,119,119,PMID: 32901111,RNAPS0000423,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(10),10nt,UUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10µM[U10];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated",10,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0.],0.0,0.0,[0 0],0.0,0.0,0.0,5.474028242782945e-16,10.0,0.0,0.0,1.0000000000000009,0.0,0.0,1,0,0,1,0.09015902344519094
120,120,120,PMID: 32901111,RNAPS0000424,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(20),20nt,UUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5µM[U20];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"When inducing N protein/RNA LLPS by using these poly-U oligos with the same mass and the same concentrations of N protein, we found that the longest ssRNA, U60, could phase separate with N protein to form much larger droplets compared with other shorter oligoes (Supplementary information, Fig. S5a), confirming that the LLPS is indeed dependent on ssRNA length.Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated.",20,0.0,1.0,0.0,0.0,,,14.333333333333336,0.5268326058735131,[0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,20.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.13011870644341134
121,121,121,PMID: 32901111,RNAPS0000425,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,2.5µM[U40];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"When inducing N protein/RNA LLPS by using these poly-U oligos with the same mass and the same concentrations of N protein, we found that the longest ssRNA, U60, could phase separate with N protein to form much larger droplets compared with other shorter oligoes (Supplementary information, Fig. S5a), confirming that the LLPS is indeed dependent on ssRNA length.Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated.",40,0.0,1.0,0.0,0.0,,,13.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,40.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.14134523778500913
122,122,122,PMID: 32901111,RNAPS0000426,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(60),60nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,1.67µM[U60];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"When inducing N protein/RNA LLPS by using these poly-U oligos with the same mass and the same concentrations of N protein, we found that the longest ssRNA, U60, could phase separate with N protein to form much larger droplets compared with other shorter oligoes (Supplementary information, Fig. S5a), confirming that the LLPS is indeed dependent on ssRNA length.Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated.",60,0.0,1.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,60.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.09223080522050109
123,123,123,PMID: 32909564,RNAPS0000427,https://pubmed.ncbi.nlm.nih.gov/32909564,RNA + protein,-,-,polyU(20),20nt,UUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,5 or 10 µM[polyU];|5 µM[laf-1],-,"20 mM Tris–HCl, 5 mM TCEP, pH 7.4",25˚C,-,-,Microscopy,liquid,"Light microscopy snapshots of (A) LAF-1 (5 μM) + polyU20 RNA (5 μM), (B) LAF-1 (5 μM) + polyU20 RNA (10 μM), (C) LAF-1 (5 μM) + polyU20 RNA (5 μM) + LL-III (50 μM), (D) LAF-1 (5 μM) + polyU20 RNA (5 μM) + LL-III (500 μM), at 25˚C in buffer (20 mM Tris–HCl, 5 mM TCEP, pH 7.4). (Scale bar, 30 µm).",20,0.0,1.0,0.0,0.0,,,14.333333333333336,0.5268326058735131,[0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,20.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.13011870644341134
124,124,124,PMID: 33337476,RNAPS0000453,https://pubmed.ncbi.nlm.nih.gov/33337476,Undefined,-,-,U2,188nt(1-188),AUCGCUUCUCGGCCUUUUGGCUAAGAUCAAGUGUAGUAUCUGUUCUUAUCAGUUUAAUAUCUGAUACGUCCUCUAUCCGAGGACAAUAUAUUAAAUGGAUUUUUGGAGCAGGGAGAUGGAAUAGGAGCUUGCUCCGUCCACUCCACGCAUCGACCUGGUAUUGCAGUACCUCCAGGAACGGUGCACCC,snRNA,Homo sapiens,"sp|Q01130|SRSF2_HUMAN Serine/arginine-rich splicing factor 2 OS=Homo sapiens OX=9606 GN=SRSF2 PE=1 SV=4
MSYGRPPPDVEGMTSLKVDNLTYRTSPDTLRRVFEKYGRVGDVYIPRDRYTKESRGFAFV
RFHDKRDAEDAMDAMDGAVLDGRELRVQMARYGRPPDSHHSRRGPPPRRYGGGGYGRRSR
SPRRRRRSRSRSRSRSRSRSRSRYSRSKSRSRTRSRSRSTSKSRSARRSKSKSSSVSRSR
SRSRSRSRSRSPPPVSKRESKSRSRSKSPPKSPEEEGAVSS",SRSF2,-,-,221aa(1-221),Q01130,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0150,http://db.phasep.pro/browse/","[1-22],[37-45],[54-60],[92-221]",-,In vivo,-,-,-,RT,-,organelle:speckles;cell:Eukaryotic cells,"FISH,Structured illumination microscopy",-,"Importantly, another family of splicing factors, the heterogeneous nuclear ribonucleopro tein splicing factors (hnRNPs) (48,49) are excluded from nuclear speckles (39–41). Finally, spliceosomes, the multi component ribonucleoprotein assemblies that carry out the catalytic splicing reaction, localize to nuclear speckle pe ripheries",188,0.2393617021276596,0.2978723404255319,0.22872340425531915,0.2340425531914893,0.9772727272727272,0.8035714285714286,14.193548387096774,0.4547606759399396,"[1.         1.22974241 3.95449974 1.97724987 0.25249254 1.
 1.         0.97724987 0.97724987 0.74750746 0.97724987 0.74750746
 0.74750746 0.97724987 0.         0.         0.         0.
 0.         0.74750746 0.74750746 1.22974241 2.45948481 0.
 0.         4.44951466 1.72475733 0.         0.         0.
 0.         0.25249254 0.         0.         3.44951466 3.44951466
 2.72475733 1.22974241 0.25249254 0.25249254 1.22974241 1.22974241
 1.72475733 4.44951466 4.44951466 1.72475733 1.72475733 4.44951466
 1.97724987 1.22974241 2.45948481 1.22974241 0.25249254 1.22974241
 1.22974241 1.22974241 2.45948481 1.22974241 1.97724987 4.44951466
 3.44951466]",1.3921438302991456,1.7683818912842255,[1 1 1 1 0 1 1 0 1 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1],0.7567567567567568,0.1840759678597516,-63.5,-65.51557922363281,168.73004150390625,11.227341168566792,-62.9000015258789,0.03799349177564041,9.753870593661151,17.079728554439047,0,0,1,1,0.13944341951465444
125,125,125,PMID: 33477032,RNAPS0000456,https://pubmed.ncbi.nlm.nih.gov/33477032,RNA + protein,-,-,polyA(24),24nt,AAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,Molar Ratio of N protein and A24 from 1:0.5 to 1:1000,70 mM KCl,25 mM HEPES pH 7.5,RT,-,-,Turbidity measurement,liquid,"Indeed, here we found that A24 also biphasically modulated LLPS of the N protein as ATP but the ratios required to induce and dissolve droplets were much lower than those of ATP. Addition of A24 even at 1:0.5 resulted a turbidity value of 0.97 (Fig. 1C)",24,1.0,0.0,0.0,0.0,,,11.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0],0.0,0.0,0.0,1.094805648556589e-15,24.0,0.0,0.0,1.0000000000000018,0.0,0.0,1,0,0,1,0.12608403063781864
126,126,126,PMID: 33523882,RNAPS0000460,https://pubmed.ncbi.nlm.nih.gov/33523882,RNA + protein,-,-,(CGG)99,297nt,CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,632aa(1-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[281-422],[443-515],[516-632]","[492-504],[527-549]",In vitro,20 ng/µl [(CGG)99];|9 µM [FMRpolyG],"25 mM NaCl, 10 mM MgCl2","10 mM tris-HCl buffer pH 7.5,12% (w/v) glycerol",23˚C,1 h,-,FRAP,liquid,We next investigated whether PpIX affects the LLPS of FMRpolyG  in vitro. The phase-separated liquid droplets and hydrogels of com plexes of fluorescein-FMRpolyG and CX rhodamine–CGG99 formed  substantially smaller droplets after PpIX treatment compared to un treated controls,297,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.224489795918364,0.4805541669860831,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453]",6.426764529061616,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]",1.0,0.0,-227.6000061035156,-229.1133575439453,163.44667053222656,97.00650387329388,0.0,0.08582377893266148,2.204255862871785,140.99926585181117,0,1,0,-1,-0.05040687125501264
127,127,127,PMID: 33523882,RNAPS0000461,https://pubmed.ncbi.nlm.nih.gov/33523882,Undefined,-,-,(CGG)99,297nt,CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,cell:Neuro-2a cells,FRAP,solid,"To test this hypothesis, we examined whether recombi nant FMRpolyG mutants could form liquid-like droplets. As we  expected, fluorescein-labeled FL and PolyG formed phase-separated  droplets, but the Cterm construct did not.We found that CX rhodamine–labeled CGG99  RNA could form fibril-like assemblies on its own in the same phase  separation condition, but CGG17 RNA did not",297,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.224489795918364,0.4805541669860831,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453]",6.426764529061616,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]",1.0,0.0,-227.6000061035156,-229.1133575439453,163.44667053222656,97.00650387329388,0.0,0.08582377893266148,2.204255862871785,140.99926585181117,0,1,0,-1,-0.05040687125501264
128,128,128,PMID: 33523882,RNAPS0000462,https://pubmed.ncbi.nlm.nih.gov/33523882,Undefined,-,-,(CGG)8,24nt,CGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,153(1-153),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/",-,-,In vivo,-,-,-,RT,-,cell:Neuro-2a cells,"FISH,Confocal Laser scanning microscopy",-,"In green fluorescent protein (GFP)–tagged FL- and PolyG-expressing cells, we observed strongly aggregated GFP-positive inclusions that colocalized with RNA foci labeled with a CCG8 antisense probe and with transfected CX rhodamine–labeled CGG99 RNA.",24,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.0,0.4568263160931184,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453]",6.426764529061615,7.888609052210118e-31,[1 1 1 1],1.0,0.0,-11.399999618530273,-11.930096626281738,19.742328643798828,2.628468824128475,-11.399999618530273,0.4231201847034645,5.6363429904271785,4.390806194230566,0,1,0,1,0.10977071965289487
129,129,129,PMID: 33523882,RNAPS0000463,https://pubmed.ncbi.nlm.nih.gov/33523882,Undefined,-,-,(CGG)99,297nt,CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,153(1-153),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/",-,-,In vivo,-,-,-,RT,-,cell:Neuro-2a cells,FRAP,-,"To test this hypothesis, we examined whether recombi nant FMRpolyG mutants could form liquid-like droplets. As we  expected, fluorescein-labeled FL and PolyG formed phase-separated  droplets, but the Cterm construct did not.We found that CX rhodamine–labeled CGG99  RNA could form fibril-like assemblies on its own in the same phase  separation condition, but CGG17 RNA did not",297,0.0,0.0,0.6666666666666666,0.3333333333333333,2.0,,14.224489795918364,0.4805541669860831,"[6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453 6.42676453
 6.42676453 6.42676453]",6.426764529061616,0.0,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]",1.0,0.0,-227.6000061035156,-229.1133575439453,163.44667053222656,97.00650387329388,0.0,0.08582377893266148,2.204255862871785,140.99926585181117,0,1,0,-1,-0.05040687125501264
130,130,130,PMID: 33558506,RNAPS0000465,https://pubmed.ncbi.nlm.nih.gov/33558506,RNA + protein,-,-,polyrU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|residues=471-510
DRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGK",FUS,RGG3,-,40aa(471-510),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,0.2 mg/ml µM[GLS1];|0.2 µM [GIRGL];|1 mg/ml µM [FUS],150 mM NaCl,"25 mM Tris-HCl (pH = 7.5), 20 mM DTT",RT,-,-,Confocal fluorescence microscopy,liquid,"MD simulations similar to those in Fig. 1d but now including π-rich FUSPLP as a client (Table S2) revealed enhanced surface recruitment of PLP chains into RRP-RNA droplets only at low-RNA conditions(Fig. 1f, Fig. S9), thereby lending support to this idea. To test this experimentally, we utilized PLPs from two different RNPs, EWS and FUS, and quantified their partitioning in FUSRGG3-poly(rU) condensates.",40,0.0,1.0,0.0,0.0,,,13.0,0.5268326058735131,[0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.],0.0,0.0,[0 0 0 0 0 0 0 0],0.0,0.0,0.0,2.189611297113178e-15,40.0,0.0,0.0,1.0000000000000036,0.0,0.0,1,0,0,1,0.14134523778500913
131,131,131,PMID: 33621982,RNAPS0000467,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,p53,14nt(site1),UUUUUUACCUUGUA,mRNA,Mus musculus,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,1 µM [p53];|5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,≤ 20 min,-,"Turbidity measurement,Differential interference contrast microscopy",liquid,"We therefore tested whether these individual sites were sufficient for inducing TIA-1 condensation in vitro using oligonucleotides repre senting either the short 14-nt TIA-1 binding site (p53 site 1) or the longer 27-nt TIA-1 binding site (p53 site 2). P53 site 1 did not induce self-association of TIA-1 either through phase separation or fibril formation as shown by DIC, tur bidity and ThT fluorescence assay respectively.In con trast, the presence of UC5 resulted in a dramatic increase in ThT fluorescence, after a lag time of ∼6 h",14,0.14285714285714285,0.6428571428571429,0.07142857142857142,0.14285714285714285,0.5,0.22222222222222213,17.5,0.3675856482816957,[0.         0.         1.72475733],0.5749191101682993,0.6610639664734183,[0 1],0.5,0.25,0.0,-0.026401609182357788,13.788439750671387,0.10581517723793142,0.0,0.9580671123769696,66.15308108646931,0.20475907724886208,0,0,1,1,0.11226138774175165
132,132,132,PMID: 33621982,RNAPS0000468,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,p53,27nt(site2),UUUUUUUUUUUUUUACCCCUUUUUAUA,mRNA,Mus musculus,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,1 µM [p53];|5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,≤ 20 min,-,"Turbidity measurement,Differential interference contrast microscopy",liquid,"We therefore tested whether these individual sites were sufficient for inducing TIA-1 condensation in vitro using oligonucleotides repre senting either the short 14-nt TIA-1 binding site (p53 site 1) or the longer 27-nt TIA-1 binding site (p53 site 2). P53 site 1 did not induce self-association of TIA-1 either through phase separation or fibril formation as shown by DIC, tur bidity and ThT fluorescence assay respectively.In con trast, the presence of UC5 resulted in a dramatic increase in ThT fluorescence, after a lag time of ∼6 h",27,0.1111111111111111,0.7407407407407407,0.0,0.14814814814814814,,0.15,14.5,0.2368146556168835,"[0.         0.         0.         0.         0.         1.97724987
 0.         0.        ]",0.2471562335064776,0.4276034263277594,[0 0 0 1 0],0.2,0.16000000000000006,0.0,-0.006904189474880695,26.97240829467773,0.014123249860547828,0.0,0.9888602457657388,955.8706482784233,0.0282090015293011,0,0,1,1,0.036539709616311034
133,133,133,PMID: 33621982,RNAPS0000469,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,p53,326nt(3'UTR),GGGUCCCUUCUGCUGCCUUUUUUACCUUGUAGCUAG GGCUCAGCCCCCUCUCUGAGUAGUGGUUCCUGGCCCAAGUUGGGGAAUAGGUUGAUAGUU GUCAGGUCUCUGCUGGCCCAGCGAAAUUCUAUCCAGCCAGUUGUUGGACCCUGGCACCUA CAAUGAAAUCUCACCCUACCCCACACCCUGUAAGAUUCUAUCUUGGGCCCUCAUAGGGUC CAUAUCCUCCAGGGCCUACUUUCCUUCCAUUCUGCAAAGCCUGUCUGCAUUUAUCCACCC CCCACCCUGUCUCCCUCUUUUUUUUUUUUUUACCCCUUUUUAUAUAUCAA,mRNA,Mus musculus,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,0.25 µM [p53];|2.5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,10 min,-,Turbidity measurement,liquid,Next we tested whether these TIA-1 binding sites also drove TIA-1 condensation in the context of the p53 3  UTR. Wild type p53 3  UTR RNA induced phase separation of TIA-1 in turbidity assay and fibril formation in the ThT assay,326,0.17484662576687116,0.3282208588957055,0.18098159509202447,0.3159509202453988,0.5728155339805825,0.5327102803738317,13.745454545454544,0.4445249493368983,"[4.44951466 1.97724987 1.72475733 3.44951466 1.         0.
 0.         0.25249254 0.97724987 1.72475733 2.72475733 2.72475733
 2.72475733 3.95449974 4.44951466 2.72475733 1.49501492 0.74750746
 1.22974241 1.22974241 1.72475733 4.44951466 4.44951466 1.72475733
 1.72475733 2.72475733 0.         0.         1.72475733 0.74750746
 0.97724987 0.74750746 1.72475733 2.72475733 2.72475733 3.44951466
 4.44951466 4.44951466 1.         0.         0.         1.
 3.44951466 2.72475733 1.22974241 0.97724987 1.22974241 2.72475733
 4.44951466 4.44951466 1.72475733 0.         0.         0.25249254
 0.74750746 2.47226479 1.97724987 1.97724987 2.47226479 2.47226479
 2.47226479 0.74750746 0.         0.         0.74750746 1.72475733
 4.44951466 3.95449974 0.         0.         4.44951466 0.
 0.         3.44951466 3.44951466 4.44951466 1.97724987 0.
 0.         2.72475733 0.         0.         1.22974241 1.
 2.72475733 1.49501492 1.72475733 0.         0.         1.22974241
 3.95449974 4.44951466 4.44951466 2.47226479 1.49501492 2.72475733
 1.72475733 0.         0.         0.         0.         0.
 2.72475733 0.         0.         0.         0.        ]",1.7327527209147724,2.281188685517672,"[1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 0 1 1 1 1
 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 0 1 1 0 0]",0.8,0.16000000000000006,-72.9000015258789,-80.42982482910156,253.6182098388672,47.1254797389021,-53.0,4.9438228616321625e-06,3.652525601806564,71.61742537369206,0,0,1,1,0.08989571450745115
134,134,134,PMID: 33621982,RNAPS0000470,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,p53_mut,326nt(3'UTR),GGGUCCCUUCUGCUGCCUAUGUAACCUAGUAGCUAG GGCUCAGCCCCCUCUCUGAGUAGUGGUUCCUGGCCCAAGUUGGGGAAUAGGUUGAUAGUU GUCAGGUCUCUGCUGGCCCAGCGAAAUUCUAUCCAGCCAGUUGUUGGACCCUGGCACCUA CAAUGAAAUCUCACCCUACCCCACACCCUGUAAGAUUCUAUCUUGGGCCCUCAUAGGGUC CAUAUCCUCCAGGGCCUACUUUCCUUCCAUUCUGCAAAGCCUGUCUGCAUUUAUCCACCC CCCACCCUGUCUCCCUCUAUGUAUGUAUGUAACCCCUGAUUAUAUAUCAA,mRNA,Mus musculus,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,0.25 µM [p53];|2.5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,10 min,-,Turbidity measurement,liquid,Next we tested whether these TIA-1 binding sites also drove TIA-1 condensation in the context of the p53 3  UTR. Wild type p53 3  UTR RNA induced phase separation of TIA-1 in turbidity assay and fibril formation in the ThT assay,326,0.19938650306748465,0.2883435582822086,0.19631901840490806,0.3159509202453988,0.6213592233009708,0.6914893617021276,13.89090909090909,0.4592536668290538,"[4.44951466 1.97724987 1.72475733 3.44951466 1.         0.74750746
 0.74750746 0.25249254 0.97724987 1.72475733 2.72475733 2.72475733
 2.72475733 3.95449974 4.44951466 2.72475733 1.49501492 0.74750746
 1.22974241 1.22974241 1.72475733 4.44951466 4.44951466 1.72475733
 1.72475733 2.72475733 0.         0.         1.72475733 0.74750746
 0.97724987 0.74750746 1.72475733 2.72475733 2.72475733 3.44951466
 4.44951466 4.44951466 1.         0.         0.         1.
 3.44951466 2.72475733 1.22974241 0.97724987 1.22974241 2.72475733
 4.44951466 4.44951466 1.72475733 0.         0.         0.25249254
 0.74750746 2.47226479 1.97724987 1.97724987 2.47226479 2.47226479
 2.47226479 0.74750746 0.         0.         0.74750746 1.72475733
 4.44951466 3.95449974 0.         0.         4.44951466 0.
 0.         3.44951466 3.44951466 4.44951466 1.97724987 0.
 0.         2.72475733 0.         0.         1.22974241 1.
 2.72475733 1.49501492 1.72475733 0.         0.         1.22974241
 3.95449974 4.44951466 4.44951466 2.47226479 1.49501492 2.72475733
 1.72475733 0.74750746 0.74750746 0.         0.         1.
 2.72475733 1.72475733 0.         0.         0.        ]",1.7861619468990455,2.1512822279715973,"[1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 0 1 1 1 1
 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 0 0]",0.8307692307692308,0.14059171597633136,-76.4000015258789,-84.76589965820312,242.11297607421875,54.65480596619946,-54.79999923706055,1.2732513658541754e-06,2.7827072368523043,82.06666027725879,0,0,1,1,0.09873784245376432
135,135,135,PMID: 33621982,RNAPS0000471,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,(UUUUUACUCCAA)4+UUUUUACUCC,58nt,UUUUUACUCCAAUUUUUACUCCAAUUUUUACUCCAAUUUUUACUCCAAUUUUUACUCC,repeat RNA,-,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,0.25 µM [RNA];|2.5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,10 min,-,Turbidity measurement,liquid,"To directly test the ability of the oligonucleotide con centration with specific binding sites to modulate TIA-1 condensation, we varied the concentration of TC5 between 0.125 and 5  M and monitored spontaneous phase sepa ration and fibril formation over time of TIA-1 at 2.5  M",58,0.2241379310344828,0.5172413793103449,0.0,0.25862068965517243,,0.4333333333333333,14.222222222222221,0.4453556624730682,"[0.         0.         1.22974241 0.         0.         0.
 1.22974241 0.         0.         0.         1.22974241 0.
 0.         0.         1.22974241 0.         0.         0.        ]",0.2732760901330542,0.26137937503443204,[0 1 0 1 0 0 1 0 1 0 0],0.3636363636363637,0.231404958677686,0.0,-0.09854459762573242,57.11223602294922,0.4464302101314232,0.0,0.8522360509607791,64.95976155256788,0.8772300835490354,0,1,0,1,0.07962436323805006
136,136,136,PMID: 33621982,RNAPS0000472,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,"UC RNA(Loughlin,2021)",10nt,UUUUUACUCC,irregular RNA,-,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,0.25 µM [RNA];|2.5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,10 min,-,Turbidity measurement,liquid,"To directly test the ability of the oligonucleotide con centration with specific binding sites to modulate TIA-1 condensation, we varied the concentration of TC5 between 0.125 and 5  M and monitored spontaneous phase sepa ration and fibril formation over time of TIA-1 at 2.5  M",10,0.1,0.6,0.0,0.3,,0.16666666666666669,11.0,0.3641604167868594,[0. 0.],0.0,0.0,[0 1],0.5,0.25,0.0,-0.00035977651714347303,9.99883270263672,0.0005835784645190711,0.0,0.9994164215354816,8567.828156785252,0.0011666633546661607,0,0,1,1,0.04137080148881456
137,137,137,PMID: 33688654,RNAPS0000474,https://pubmed.ncbi.nlm.nih.gov/33688654,RNA + protein,-,-,SARS-CoV-2 virus RNA,211nt(84-294),CUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGA,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,LCD,-,-,P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,7.5µM [SARS-CoV-2];|30 µM [SARS-CoV-2 N protein],300 mM NaCl,"20 mM Tris, pH 8.0",37˚C,≤ 24 h,-,FRAP,"liquid, solid","The LCD segment, as opposed to the full length NCAP, form fibrils in lower protein:RNA ratios.  Whereas we observed no LLPS or amyloid formation of the LCD in the 40:1 protein: RNA (0.75  µM) molar ratio, ThS and PI positive LLPS droplets of roughly 3-10 µm in diameter appeared in  the 4:1 (7.5 µM RNA) molar ratio mixture during 17 h of incubation (Figure 4B & S4). 24 h of incubation led to the formation of gel particles of intense ThS signal",211,0.2132701421800948,0.2890995260663507,0.2559241706161137,0.2417061611374408,1.0588235294117647,0.7377049180327869,13.942857142857143,0.4636494338016554,"[1.49501492 2.47226479 2.47226479 1.49501492 2.72475733 2.72475733
 3.44951466 2.72475733 0.         0.         2.45948481 1.49501492
 2.47226479 2.47226479 0.         0.         0.         0.
 0.         0.         0.         2.72475733 1.72475733 0.74750746
 1.72475733 2.72475733 2.45948481 0.         0.         2.45948481
 0.         0.         1.22974241 2.45948481 2.72475733 3.44951466
 1.         1.         1.         1.22974241 2.72475733 1.72475733
 1.72475733 4.44951466 1.97724987 0.97724987 1.22974241 2.45948481
 1.22974241 0.97724987 0.25249254 1.         3.44951466 4.44951466
 2.47226479 1.49501492 2.72475733 1.         0.25249254 0.74750746
 1.72475733 1.72475733 2.47226479 1.97724987 1.72475733 2.72475733
 1.22974241 0.74750746 1.72475733]",1.6012281072412498,1.2891586098683052,"[1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1]",0.9047619047619048,0.08616780045351477,-79.0,-81.10690307617188,198.71128845214844,6.705912965097867,-79.0,0.03276080159293023,17.167108733706062,10.717864410290082,0,0,1,1,0.12967345312045786
138,138,138,PMID: 7816606,RNAPS0000481,https://pubmed.ncbi.nlm.nih.gov/7816606,Undefined,RNAcentral:URS000066A9F5_4113|URS00006A6BFA_4113|URS000072780D_4113|URS0000692EF9_4113|URS00006CA24C_4113|URS00006F92C1_4113|URS000072E50D_4113|URS00006C235B_4113,https://rnacentral.org/rna/URS000066A9F5/4113,U3,324nt(1-324),AUGGGCCCGCUUGAACAGGAUCUGUUCUAUAGGCUCGUACCACUGCAUCCUUGAUUUUUAAGGAGACAGGAAACCAAGUCUAGUGGAUGAUUCGUAGCCAUUAGACCGAUUUUUAAGGAGACAGGAAACCAAGUCUAGUGGAUGAUUCGUAGCCAUUAGACCGAUUUUUAAGGAGACAGGAAACCAAGUCUAGUGGAUGAUUCGUAGCCAUUAGACCAGAGCGUGAUUAAUAGCUUCCAUGAUCCUCGGGUCAUGGUGCCAUAGAUGAUCGUUCUUAACCUCGAUCAUGGGUGUUGAGAUGGUCUAAUGGUUGUCUGACAGACU,snoRNA,Solanum tuberosum,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Leaf|Ovule|Silk,"ISH,Epifluorescence microscopy",-,Control in situ hybridisations were carried out using oligonucleotides complementary to plant Ul snRNA and U3 snoRNA sequences and showed specific labelling to the nucleoplasm and nucleoli respectively.,324,0.2716049382716049,0.2808641975308642,0.2561728395061729,0.191358024691358,1.338709677419355,0.9670329670329668,13.870370370370367,0.462346142307193,"[1.97724987 6.42676453 1.97724987 0.97724987 1.22974241 1.22974241
 1.22974241 1.22974241 0.         0.         2.72475733 1.22974241
 1.72475733 2.72475733 1.22974241 1.72475733 1.72475733 0.
 0.         0.         1.72475733 1.49501492 1.22974241 1.
 1.72475733 0.74750746 0.97724987 1.72475733 1.72475733 0.74750746
 0.25249254 1.97724987 0.         0.         2.47226479 0.
 0.         0.         1.22974241 1.49501492 1.72475733 1.
 0.25249254 1.22974241 1.22974241 1.72475733 1.72475733 0.
 0.         2.72475733 1.         0.25249254 1.72475733 1.
 0.         0.         0.         2.72475733 2.72475733 0.
 0.         1.72475733 0.74750746 1.22974241 1.22974241 0.97724987
 1.         1.72475733 1.         0.         0.         2.45948481
 2.72475733 2.72475733 0.         0.         0.         1.72475733
 0.25249254 0.97724987 1.72475733 4.44951466 3.95449974 1.22974241
 1.22974241 2.72475733 1.         0.97724987 0.97724987 0.25249254
 0.97724987 0.25249254 1.22974241 1.22974241 0.97724987 1.97724987
 2.47226479 0.97724987 0.74750746 1.72475733 1.72475733 0.25249254
 0.25249254 1.22974241 1.49501492 1.49501492 1.49501492]",1.21914617327553,1.091634072673682,"[1 1 1 1 1 0 1 1 1 1 0 0 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 0 1 1 1 0 0 1 1 1
 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1]",0.796875,0.161865234375,-106.6999969482422,-113.75367736816406,228.91661071777344,65.94697991068674,-94.1999969482422,1.0704734105914423e-05,3.1966336020112966,89.57569765888607,0,0,1,1,0.061572633418431555
139,139,139,PMID: 7816606,RNAPS0000482,https://pubmed.ncbi.nlm.nih.gov/7816606,Undefined,RNAcentral:URS0000C51A3D_4577|URS0000C799C9_4577|URS0000C858BF_4577|URS0000C24973_4577|URS0000C1B330_4577|URS0000C7B170_4577|URS0000C11395_4577|URS0000C12A1A_4577|URS0000C437FE_4577|URS0000C56791_4577|URS0000C46268_4577|URS0000C51E36_4577|URS0000C62A71_4577|URS0000C364E6_4577|URS0000C5D392_4577|URS0000D72DCC_4577|URS0000C4B992_4577|URS0000D72ED8_4577|URS0000D745C3_4577|URS0000C328E5_4577|URS0000D744FD_4577|URS0000D74B79_4577,https://rnacentral.org/rna/URS0000C51A3D/4577,U3,269nt(1-269),ACGACCUUACUUGAACAGGAUCUGUUCUAUAGGAUCGUACCGUUGCAUCCUUGAUUAAUAAGGAGGCAAGCACUUAAGCCUGGUUGAUGUGUCAUGACCUUUGGGCCAGAGCGUGAUUAACGGCUAGGAUUGGCUCUGAUGUCAUGACCUUUGGGCCAGAGCGUGAUUAACGGCUAGGAUUGGCUCUGAUGCUUUGUCCUUAAGCUGUAGAGGAUCGUUCCCGUCAGGCUUGCUUGACUCGGGGUGGCCCAUAGGUUGUCUGACAGGCU,snoRNA,Zea mays,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Leaf|Ovule|Silk,"ISH,Epifluorescence microscopy",-,Control in situ hybridisations were carried out using oligonucleotides complementary to plant Ul snRNA and U3 snoRNA sequences and showed specific labelling to the nucleoplasm and nucleoli respectively.,269,0.20446096654275087,0.2936802973977695,0.2899628252788104,0.2118959107806692,1.368421052631579,0.6962025316455696,14.295454545454545,0.4662670140473233,"[3.44951466 1.         0.97724987 0.97724987 1.72475733 1.72475733
 0.74750746 0.97724987 0.         0.         2.72475733 1.72475733
 1.         2.72475733 1.72475733 0.25249254 0.97724987 0.
 0.         0.         4.44951466 1.97724987 1.22974241 0.
 0.         2.72475733 1.22974241 0.97724987 1.22974241 1.49501492
 0.97724987 1.72475733 1.         1.97724987 3.95449974 2.72475733
 2.72475733 0.         0.         1.97724987 1.97724987 0.25249254
 1.         2.72475733 1.49501492 0.97724987 0.74750746 1.22974241
 1.22974241 1.         4.44951466 2.47226479 2.47226479 2.47226479
 0.         0.         2.72475733 2.72475733 0.         0.
 2.47226479 0.74750746 1.72475733 1.         1.72475733 0.
 0.         1.72475733 0.97724987 1.72475733 2.72475733 1.72475733
 1.97724987 2.47226479 2.47226479 1.97724987 0.25249254 1.22974241
 2.72475733 4.44951466 4.44951466 4.44951466 0.         0.
 1.72475733 1.49501492 1.49501492 2.47226479]",1.5365608804478823,1.4259936628577143,"[1 0 1 1 1 0 1 1 1 1 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1]",0.8867924528301887,0.10039159843360627,-99.1999969482422,-104.56279754638672,243.96566772460938,15.925050600775846,-98.9000015258789,0.0001663671313297275,10.55475156501454,24.090416245922352,0,0,1,1,0.09320554897751837
140,140,140,PMID: 17135348,RNAPS0000485,https://pubmed.ncbi.nlm.nih.gov/17135348,Undefined,NCBI ID:100314052,https://www.ncbi.nlm.nih.gov/gene/100314052,rno-miR-206-3p,22nt(1-22),UGGAAUGUAAGGAAGUGUGUGG,miRNA,Rattus norvegicus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Myogenic cells,"ISH,Immunostaining",-,"However, to our surprise, we also observed miR-206 to be concentrated in nucleoli.",22,0.2727272727272727,0.2727272727272727,0.4545454545454545,0.0,,1.0,18.0,0.4635707109327871,[0.         0.         1.         1.72475733 0.74750746 1.49501492],0.8278799529773547,0.442718930332475,[1 1 1 1],1.0,0.0,0.0,-0.042063169181346886,21.73607635498047,0.13200342574344626,0.0,0.9340280327182541,83.33117067263787,0.26221008689569825,0,0,1,1,0.16539918375491747
141,141,141,PMID: 18204908,RNAPS0000486,https://pubmed.ncbi.nlm.nih.gov/18204908,Undefined,NCBI ID:387198,https://www.ncbi.nlm.nih.gov/gene/387198,mmu-miR-202-3p,22nt(1-22),AGAGGUAUAGCGCAUGGGAAGA,miRNA,Mus musculus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Spermatocytes,"ISH,Microarray,Northern blot",-,"This round mass contained little DNA and appeared in the surrounding DNA as a darker structure resembling the nucleolus. Other miRNAs tested miR-320, 20 and 202 exhibited similar patterns except that miR-320 localized to the Sertoli cell nucleolus and also displayed a diffuse pattern in the nucleus but not in the cytoplasm of germ cells (data not shown).",22,0.3636363636363637,0.13636363636363635,0.4090909090909091,0.09090909090909093,4.5,2.666666666666667,18.0,0.4537667893641595,[1.72475733 0.         0.         1.97724987 1.97724987 1.97724987],1.27608448911006,0.822164871863252,[1 1 1 1],1.0,0.0,0.0,-0.28713250160217285,20.81122589111328,0.5943869923363619,0.0,0.627581595285405,18.50646151720484,1.1270781290502083,0,0,1,1,0.16459794965489533
142,142,142,PMID: 18204908,RNAPS0000487,https://pubmed.ncbi.nlm.nih.gov/18204908,Undefined,NCBI ID:723838,https://www.ncbi.nlm.nih.gov/gene/723838,mmu-miR-320-3p,22nt(1-22),AAAAGCUGGGUUGAGAGGGCGA,miRNA,Mus musculus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Spermatocytes,"ISH,Microarray,Northern blot",-,"This round mass contained little DNA and appeared in the surrounding DNA as a darker structure resembling the nucleolus. Other miRNAs tested miR-320, 20 and 202 exhibited similar patterns except that miR-320 localized to the Sertoli cell nucleolus and also displayed a diffuse pattern in the nucleus but not in the cytoplasm of germ cells (data not shown).",22,0.3181818181818182,0.13636363636363635,0.4545454545454545,0.09090909090909093,5.0,2.333333333333333,18.0,0.4341589462269045,[0.         3.44951466 1.         1.22974241 2.72475733 4.44951466],2.1422548430205386,2.349727689110148,[1 1 1 1],1.0,0.0,-1.5,-1.6866358518600464,20.088668823242188,1.1558699702397977,-1.5,0.7387301399019338,11.509416157181619,1.9272346307250936,0,0,1,1,0.12357100518315234
143,143,143,PMID: 18204908,RNAPS0000488,https://pubmed.ncbi.nlm.nih.gov/18204908,Undefined,NCBI ID:DQ548931,https://www.ncbi.nlm.nih.gov/nuccore/DQ548931,piR-mmu-48,30nt(1-30),UGCAAGUGUUCGGGUUGCUGACCGCAGAGG,piRNA,Mus musculus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Sertoli cells,"ISH,Northern blot",-,"FISH analysis on testicular sections. piR-7 and piR-17080 are shown but the same pattern is apparent for piR-17005 and piR-17043. Similarly to miRNAs, piRNAs localize to the nucleolus of Sertoli cells (yellow arrow) as well as to the cytoplasm of spermatocytes.",30,0.16666666666666666,0.2333333333333333,0.4,0.2,2.0,0.7142857142857142,14.0,0.4519599167964748,"[1.72475733 0.74750746 1.72475733 2.72475733 2.72475733 1.72475733
 2.47226479 3.95449974 2.72475733]",2.280312886060453,0.7453064587308704,[1 1 1 1 1 1],1.0,0.0,-6.699999809265138,-6.811158657073975,28.583404541015625,0.8701993696641531,-6.699999809265138,0.834970599671598,21.16479485738995,1.6602053403246428,0,0,1,1,0.15659742474527044
144,144,144,PMID: 18204908,RNAPS0000489,https://pubmed.ncbi.nlm.nih.gov/18204908,Undefined,NCBI ID:DQ548893,https://www.ncbi.nlm.nih.gov/nuccore/DQ548893,piR-mmu-6,30nt(1-30),UGCAAGGUCGCAAGGUCGCAAGGUCGAGGU,piRNA,Mus musculus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Sertoli cells,"ISH,Northern blot",-,"FISH analysis on testicular sections. piR-7 and piR-17080 are shown but the same pattern is apparent for piR-17005 and piR-17043. Similarly to miRNAs, piRNAs localize to the nucleolus of Sertoli cells (yellow arrow) as well as to the cytoplasm of spermatocytes.",30,0.2333333333333333,0.16666666666666666,0.4,0.2,2.0,1.4,14.0,0.4525915001634619,"[1.72475733 1.22974241 2.72475733 2.72475733 3.44951466 1.
 1.72475733 3.44951466 3.44951466]",2.386368412294192,0.8616792777193315,[1 1 1 1 1 1],1.0,0.0,-2.0999999046325684,-3.1994311809539795,22.53745460510254,4.038583397879068,-1.8999999761581416,0.1679880997812823,3.549380945585452,6.345406039418083,0,0,1,1,0.14541025051623246
145,145,145,PMID: 18204908,RNAPS0000490,https://pubmed.ncbi.nlm.nih.gov/18204908,Undefined,NCBI ID:DQ539895,https://www.ncbi.nlm.nih.gov/nuccore/DQ539895,piR-mmu-67,32nt(1-32),AAAAAAAUGUACAGUGGUGACUACAUACUUGC,piRNA,Mus musculus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Sertoli cells,"ISH,Northern blot",-,"FISH analysis on testicular sections. piR-7 and piR-17080 are shown but the same pattern is apparent for piR-17005 and piR-17043. Similarly to miRNAs, piRNAs localize to the nucleolus of Sertoli cells (yellow arrow) as well as to the cytoplasm of spermatocytes.",32,0.40625,0.25,0.1875,0.15625,1.2,1.625,15.4,0.39740092605057015,"[0.         0.         0.97724987 1.49501492 2.45948481 1.49501492
 0.97724987 0.74750746 0.97724987]",1.0143079697353707,0.5204042434357983,[0 0 1 1 0 1],0.5,0.25,-2.299999952316284,-3.3536269664764404,21.60204124450684,6.370869545558039,2.0,0.18094839382806124,3.0566148063293284,8.996393788496663,0,0,1,1,0.12912334804229642
146,146,146,PMID: 18204908,RNAPS0000491,https://pubmed.ncbi.nlm.nih.gov/18204908,Undefined,NCBI ID:DQ723466,https://www.ncbi.nlm.nih.gov/nuccore/DQ723466,piR-mmu-88,31nt(1-31),UGCAAUCUAUUGGAGAGAAAGUUUCAGUUGC,piRNA,Mus musculus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:Sertoli cells,"ISH,Northern blot",-,"FISH analysis on testicular sections. piR-7 and piR-17080 are shown but the same pattern is apparent for piR-17005 and piR-17043. Similarly to miRNAs, piRNAs localize to the nucleolus of Sertoli cells (yellow arrow) as well as to the cytoplasm of spermatocytes.",31,0.2903225806451613,0.3225806451612903,0.25806451612903225,0.12903225806451613,2.0,0.9000000000000001,13.6,0.4555041668330873,"[0.         0.         0.25249254 1.22974241 1.49501492 0.74750746
 0.         0.         1.22974241]",0.5504999706781823,0.3505189247152811,[1 0 1 0 1 1],0.6666666666666666,0.22222222222222224,-3.5999999046325684,-4.469193935394287,25.32048225402832,3.617109972014537,-1.0,0.24407139458289115,5.442005141538634,5.290438150482709,0,0,1,1,0.16706228433352038
147,147,147,PMID: 19628621,RNAPS0000492,https://pubmed.ncbi.nlm.nih.gov/19628621,Undefined,RNAcentral:URS00003DD6A1_10116,https://rnacentral.org/rna/URS00003DD6A1/10116,E2,64nt(1-64),AGUUGAGGUCACACGCUGGUCGAUGAACUCCUAAGUGUAGGUAGUGUGCUAAACGAGCGGCAAG,snoRNA,Rattus norvegicus,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,organelle:Nucleolus;cell:L6 myoblasts,qRT-PCR,-,"Thus, a known snoRNA, E2, was present at highest levels in the nucleolus-enriched fraction, while a Ro small RNA family member, Y1 RNA, was detected at highest levels in the cytoplasmic fraction, as expected for this known cytoplasm-concentrated RNA species.",64,0.265625,0.21875,0.328125,0.1875,1.75,1.2142857142857142,15.0,0.4556136300942529,"[0.97724987 1.72475733 2.72475733 2.72475733 2.72475733 2.45948481
 1.22974241 0.97724987 1.22974241 1.22974241 0.74750746 0.74750746
 1.72475733 1.72475733 1.49501492 1.22974241 0.25249254 1.22974241
 3.95449974 1.97724987]",1.6542756274919466,0.7474544116754356,[1 1 1 1 0 1 1 1 1 1 1 1],0.9166666666666666,0.07638888888888888,-14.100000381469727,-15.290371894836426,55.097633361816406,5.743446562606278,-14.100000381469727,0.14494297450593746,7.187001286970703,8.859643032703188,0,0,1,1,0.18210330076974612
148,148,148,PMID: 23940654,RNAPS0000494,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:406910,https://www.ncbi.nlm.nih.gov/gene/406910,hsa-miR-125a-5p,24nt(1-24),UCCCUGAGACCCUUUAACCUGUGA,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",24,0.2083333333333333,0.2916666666666667,0.16666666666666666,0.3333333333333333,0.5,0.7142857142857143,14.0,0.4513520834788297,"[2.72475733 1.49501492 2.47226479 0.         0.         1.22974241
 1.49501492]",1.3452563398391322,0.9786855732871657,[1 1 0 1],0.75,0.1875,0.0,-0.22493334114551544,22.48415946960449,0.7579895641844047,0.0,0.6942233934718112,15.831352523846393,1.450495293547391,0,0,1,1,0.17294926068755756
149,149,149,PMID: 23940654,RNAPS0000495,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:100302236,https://www.ncbi.nlm.nih.gov/gene/100302236,hsa-miR-1260a,73nt(1-73),ACCUUUCCAGCUCAUCCCACCUCUGCCACCAAAACACUCAUCGCGGGGUCAGAGGGAGUGCCAAAAAAGGUAA,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",73,0.3013698630136986,0.1643835616438356,0.2054794520547945,0.3287671232876712,0.625,1.8333333333333333,13.666666666666664,0.436781641156641,"[0.         0.         3.44951466 1.72475733 1.97724987 4.44951466
 1.72475733 2.47226479 4.44951466 0.         0.         1.49501492
 1.22974241 1.97724987 6.42676453 2.47226479 1.49501492 2.72475733
 2.72475733 2.72475733 0.         0.         0.25249254]",1.9030604034605685,2.7744774914648302,[1 1 1 1 1 1 0 1 1 1 1 1 0 1],0.8571428571428571,0.12244897959183675,-20.200000762939453,-21.3792724609375,63.83861923217773,6.022196924411973,-19.200000762939453,0.14757687785306076,7.8103996256228365,9.016484108683226,0,0,1,1,0.15190200577696084
150,150,150,PMID: 23940654,RNAPS0000496,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:100302123,https://www.ncbi.nlm.nih.gov/gene/100302123,hsa-miR-1275,80nt(1-80),CCUCUGUGAGAAAGGGUGUGGGGGAGAGGCUGUCUUGUGUCUGUAAGUAUGCCAAACUUAUUUUCCCCAAGGCAGAGGGA,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",80,0.225,0.2625,0.3375,0.175,1.9285714285714288,0.8571428571428571,14.538461538461535,0.4651582157902479,"[1.49501492 1.49501492 0.         0.         2.47226479 2.47226479
 4.44951466 2.72475733 2.72475733 2.72475733 1.22974241 0.74750746
 1.49501492 0.         0.         1.         1.         0.74750746
 0.         0.         0.         1.97724987 1.97724987 2.47226479
 2.47226479]",1.4270859066273358,1.390366024322916,[1 1 1 1 1 1 1 1 1 0 1 0 0 1 1 1],0.8125,0.15234375,-26.60000038146973,-27.26667022705078,69.38255310058594,7.006486765599598,-26.60000038146973,0.3390212454938042,7.532691676215795,11.017594424473247,0,0,1,1,0.1575732496079656
151,151,151,PMID: 23940654,RNAPS0000497,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:406966,https://www.ncbi.nlm.nih.gov/gene/406966,hsa-miR-191-5p,23nt(1-23),CAACGGAAUCCCAAAAGCAGCUG,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,"ISH,qRT-PCR,Confocal microscopy",-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”. Four nucleolar miRNAs; miR191, miR-484, miR-574-3p and miR-193b, were tested in our ISH experiments, and all four miRNAs exhibit strong nucleolar localisation (Figure 2A).",23,0.39130434782608703,0.08695652173913042,0.21739130434782608,0.3043478260869565,0.7142857142857142,4.5,18.33333333333333,0.4486494214498758,[1.         1.         1.         0.         0.         3.44951466],1.074919110168299,1.3277408060152462,[1 1 0 1],0.75,0.1875,-0.699999988079071,-0.957714021205902,21.348447799682614,0.9481163515485898,-0.699999988079071,0.658263987826465,13.92229425928488,1.4558684710679284,0,0,1,1,0.16824586370820566
152,152,152,PMID: 23940654,RNAPS0000498,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:574455,https://www.ncbi.nlm.nih.gov/gene/574455,hsa-miR-193b-3p,22nt(1-22),AACUGGCCCUCAAAGUCCCGCU,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,"ISH,qRT-PCR,Confocal microscopy",-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”. Four nucleolar miRNAs; miR191, miR-484, miR-574-3p and miR-193b, were tested in our ISH experiments, and all four miRNAs exhibit strong nucleolar localisation (Figure 2A).",22,0.2272727272727273,0.18181818181818185,0.18181818181818185,0.4090909090909091,0.4444444444444444,1.25,18.0,0.4504349265907809,[1.72475733 4.44951466 2.47226479 0.74750746 1.72475733 4.44951466],2.594719373073407,1.9702309997084777,[1 1 0 1],0.75,0.1875,-0.10000000149011612,-1.260175347328186,15.961810111999512,3.114477985893477,0.0,0.152221093842885,2.8715111945401635,4.669378054498137,0,0,1,1,0.14373671655414516
153,153,153,PMID: 23940654,RNAPS0000499,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:442920,https://www.ncbi.nlm.nih.gov/gene/442920,hsa-miR-196b-5p,22nt(1-22),UAGGUAGUUUCCUGUUGUUGGG,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",22,0.09090909090909093,0.4545454545454545,0.3636363636363637,0.09090909090909093,4.0,0.2,18.0,0.4415598040912523,[0.25249254 0.97724987 1.         1.72475733 0.97724987 1.72475733],1.1094178224433933,0.2564192267436676,[1 1 1 1],1.0,0.0,-2.700000047683716,-2.944643497467041,20.292844772338867,0.9931911402419848,-2.700000047683716,0.6723730709314109,12.879811855226958,1.6664528272280046,0,0,1,1,0.1501605174434923
154,154,154,PMID: 23940654,RNAPS0000500,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:442909,https://www.ncbi.nlm.nih.gov/gene/442909,hsa-miR-342-3p,23nt(1-23),UCUCACACAGAAAUCGCACCCGU,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",23,0.3043478260869565,0.17391304347826084,0.13043478260869565,0.39130434782608703,0.3333333333333333,1.7500000000000002,18.33333333333333,0.4215678241942665,[1.49501492 1.49501492 0.         0.         2.72475733 3.95449974],1.6115478194034747,1.9916652798372825,[1 1 1 1],1.0,0.0,0.0,-0.34091171622276306,20.89936828613281,1.05059469626686,0.0,0.5751409915559778,10.946181282718847,1.7966821989327648,0,0,1,1,0.1516029813204483
155,155,155,PMID: 23940654,RNAPS0000501,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:768216,https://www.ncbi.nlm.nih.gov/gene/768216,hsa-miR-454-3p,23nt(1-23),UAGUGCAAUAUUGCUUAUAGGGU,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",23,0.2608695652173913,0.39130434782608703,0.2608695652173913,0.08695652173913042,3.0,0.6666666666666666,18.33333333333333,0.4416597223557696,[1.72475733 0.         0.         0.25249254 0.         0.        ],0.3295416446753035,0.3978256928659072,[1 0 1 1],0.75,0.1875,-1.600000023841858,-2.077487707138061,19.915491104125977,1.641519554654754,-1.600000023841858,0.4608240297627178,7.454982432337649,2.8245372312709702,0,0,1,1,0.1591081818086465
156,156,156,PMID: 23940654,RNAPS0000502,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:619553,https://www.ncbi.nlm.nih.gov/gene/619553,hsa-miR-484,79nt(1-79),AGCCUCGUCAGGCUCAGUCCCCUCCCGAUAAACCCCUAAAUAGGGACUUUCCCGGGGGGUGACCCUGGCUUUUUUGGCG,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,"ISH,qRT-PCR,Confocal microscopy",-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”. Four nucleolar miRNAs; miR191, miR-484, miR-574-3p and miR-193b, were tested in our ISH experiments, and all four miRNAs exhibit strong nucleolar localisation (Figure 2A).",79,0.16455696202531644,0.2405063291139241,0.26582278481012656,0.3291139240506329,0.8076923076923077,0.6842105263157894,13.692307692307693,0.4309733257199014,"[2.72475733 2.45948481 2.72475733 2.72475733 1.49501492 2.47226479
 3.95449974 3.95449974 0.         0.         1.97724987 0.
 0.         0.         2.47226479 0.74750746 1.97724987 6.42676453
 4.44951466 2.72475733 2.72475733 4.44951466 0.         0.
 0.        ]",2.018384659855572,3.05346079240061,[1 1 1 1 1 0 1 0 1 1 1 1 1 1 1],0.8666666666666667,0.11555555555555552,-32.5,-33.427440643310554,68.48793792724611,7.492543529363267,-32.5,0.22206153114799296,7.514623543320187,11.830650709781866,0,0,1,1,0.1467333624793929
157,157,157,PMID: 23940654,RNAPS0000503,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:693159,https://www.ncbi.nlm.nih.gov/gene/693159,hsa-miR-574-3p,22nt(1-22),CACGCUCAUGCACACACCCACA,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:HeLa cells,"ISH,qRT-PCR,Confocal microscopy",-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”. Four nucleolar miRNAs; miR191, miR-484, miR-574-3p and miR-193b, were tested in our ISH experiments, and all four miRNAs exhibit strong nucleolar localisation (Figure 2A).",22,0.3181818181818182,0.09090909090909093,0.09090909090909093,0.5,0.18181818181818185,3.5,18.0,0.4374908090002833,[2.72475733 1.72475733 1.72475733 2.72475733 2.72475733 2.72475733],2.391423997171565,0.22222222222222224,[1 1 1 1],1.0,0.0,-1.399999976158142,-1.4686340093612669,21.56290626525879,0.22422125690324574,-1.399999976158142,0.8946157632428898,50.30361831931192,0.40518502629732017,0,0,1,1,0.13517338267237905
158,158,158,PMID: 23940654,RNAPS0000504,https://pubmed.ncbi.nlm.nih.gov/23940654,Undefined,NCBI ID:407050,https://www.ncbi.nlm.nih.gov/gene/407050,hsa-miR-93-3p,80nt(1-80),CUGGGGGCUCCAAAGUGCUGUUCGUGCAGGUAGUGUGAUUACCCAACCUACUGCUGAGCUAGCACUUCCCGAGCCCCCGG,miRNA,Homo sapiens,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,"crowding agent:16%dextran 9-11 kDa,10%PEG 8 kDa",qRT-PCR,-,"Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.",80,0.175,0.225,0.2875,0.3125,0.92,0.7777777777777777,14.384615384615385,0.4433824036023968,"[4.44951466 3.95449974 1.22974241 0.74750746 1.72475733 1.72475733
 1.72475733 3.44951466 3.44951466 1.72475733 1.49501492 0.
 0.         1.         1.72475733 1.72475733 1.72475733 2.72475733
 1.22974241 1.72475733 1.72475733 1.97724987 3.95449974 3.95449974
 6.42676453]",2.2226255236823778,2.1295065936962505,[1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1],0.9375,0.05859375,-43.79999923706055,-45.17121505737305,74.00713348388672,3.57352461621677,-43.79999923706055,0.10808471558767176,13.00224819020652,4.849228462235961,0,0,1,1,0.14942255162515083
159,159,159,PMID: 26979837,RNAPS0000509,https://pubmed.ncbi.nlm.nih.gov/26979837,Undefined,RNAcentral:URS0000D656E9_4896,https://rnacentral.org/rna/URS0000D656E9/4896,U3,256nt(1-256),AAUUCUUUGAAGGCAUGCUUUUCGAUUAGGUUUUUUACCUAAUUGUUUUGCUGUCUUUCUAUGCGAUGAUCUCUUACAUGAUAUGUUUCCUUUUGGUCGUAUUAUGUAGGGCAGCUGGUGUUUUCUGACGUGUUUAAUUUCAUCUAUUAUAUUACAACUGUGGUGUCGUUUGAUGACAUAGAUGUAAUUUCUAGAUGAAGUUGUGUCAUGUUUUAGCGUAGAUUUUAGUGAAUAAAUGAAACGAUUUCAAAUUCCG,snoRNA,Schizosaccharomyces pombe,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,26˚C,-,organelle:Nucleolus;cell:S. pombe strains (UR471),"Fluorescence microscopy,RT-PCR",-,Visualization of U3 snoRNA localized in the nucleolus and F732 using the U1A-tag-GFP system.,256,0.23046875,0.4375,0.203125,0.12890625,1.5757575757575757,0.5267857142857143,14.214285714285715,0.4562967279320762,"[0.         0.74750746 0.97724987 1.         2.72475733 0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         1.72475733 0.74750746
 0.74750746 0.74750746 1.         1.72475733 0.97724987 0.74750746
 0.74750746 0.97724987 0.         0.         1.         0.
 0.         3.44951466 0.         0.         0.         1.97724987
 3.95449974 2.45948481 2.45948481 0.         0.         1.49501492
 2.45948481 0.         0.         0.         0.97724987 0.
 0.         0.         0.         0.97724987 1.49501492 2.45948481
 2.72475733 0.         0.         1.22974241 0.         0.
 0.97724987 0.         0.         0.97724987 0.97724987 0.97724987
 0.97724987 1.49501492 1.22974241 0.         0.         1.
 1.72475733 0.         0.         0.74750746 0.         0.
 0.         1.         0.         0.         0.         0.        ]",0.6761020317391119,0.823924778989657,"[0 0 1 1 1 1 0 1 0 0 1 0 1 0 1 1 0 1 0 1 0 1 1 1 0 1 0 0 1 0 0 1 1 1 1 0 1
 0 1 1 1 1 0 1 0 1 0 0 1 0 1]",0.5686274509803921,0.24529027297193384,-75.80000305175781,-79.57212829589844,235.33018493652344,11.583839389374713,-74.4000015258789,0.002197582563764946,11.481625375928646,18.474248759355987,0,0,1,1,0.10219021168289105
160,160,160,PMID: 27590598,RNAPS0000512,https://pubmed.ncbi.nlm.nih.gov/27590598,Undefined,RNAcentral:URS00003DD719_4577|URS0000135BDD_4577,https://rnacentral.org/rna/URS0000135BDD/4577,18S,111nt(1-111),CUCCUACCGAUUGAAUGGUCCGGUGAAGUGUUCGGAUCGCGGCGACGGGGGCGGUUCGCCGCCCCCGACGUCGCGAGAAGUCCAUUGAACCUUAUCAUUUAGAGGAAGGAG,rRNA,Zea mays,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:Leaves,FISH,-,"RNA-FISH was first performed to detect the transcripts derived from the 18S ribosomal RNA (rRNA) genes in maize. As expected, the 18S rRNA transcripts were localized exclusively in the nucleolus (Fig. 2a) and were co-localized with the 5S rRNA transcripts (Fig. 2b).",111,0.1981981981981982,0.2072072072072072,0.3333333333333333,0.2612612612612613,1.2758620689655171,0.9565217391304348,14.444444444444445,0.4576894758669297,"[1.22974241 1.97724987 0.         0.         1.         3.44951466
 2.72475733 1.72475733 1.22974241 1.22974241 1.         2.72475733
 4.44951466 4.44951466 4.44951466 6.42676453 6.42676453 1.97724987
 1.97724987 6.42676453 6.42676453 3.95449974 2.45948481 3.95449974
 2.47226479 0.97724987 1.72475733 1.         0.97724987 0.25249254
 0.25249254 0.         0.         1.72475733 1.72475733 1.22974241]",2.3334614960396025,3.707932738627163,[1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1],0.8636363636363636,0.11776859504132232,-63.29999923706055,-63.54814147949219,110.09133911132812,0.4704795101518757,-63.29999923706055,0.6685662834575352,122.07720073300716,0.8913974977827153,0,0,1,1,0.07185009068968495
161,161,161,PMID: 27590598,RNAPS0000513,https://pubmed.ncbi.nlm.nih.gov/27590598,Undefined,RNAcentral:URS000056EA56_4577,https://rnacentral.org/rna/URS000056EA56/4577,5S,119nt(1-119),GGAUGCGAUCAUACCAGCACUAAAGCACCGGAUCCCAUCAGAACUCCGAAGUUAAGCGUGCUUGGGCGAGAGUAGUACUAGGAUGGGUGACCUCCUGGGAAGUCCUCGUGUUGCAUUCC,rRNA,Zea mays,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,organelle:Nucleolus;cell:Leaves,FISH,-,"RNA-FISH was first performed to detect the transcripts derived from the 18S ribosomal RNA (rRNA) genes in maize. As expected, the 18S rRNA transcripts were localized exclusively in the nucleolus (Fig. 2a) and were co-localized with the 5S rRNA transcripts (Fig. 2b).",119,0.24369747899159666,0.2184873949579832,0.2857142857142857,0.25210084033613445,1.1333333333333333,1.1153846153846154,14.578947368421053,0.4595172333336854,"[1.97724987 1.97724987 0.         0.         3.44951466 1.72475733
 0.25249254 1.22974241 3.95449974 1.97724987 1.         1.72475733
 0.74750746 1.22974241 2.72475733 1.72475733 0.         0.
 4.44951466 1.72475733 1.97724987 3.95449974 1.49501492 0.97724987
 0.97724987 1.72475733 1.72475733 1.         2.72475733 2.45948481
 2.45948481 2.72475733 1.72475733 1.72475733 3.44951466 1.72475733
 1.72475733 1.        ]",1.7741146662792076,1.2057214136815524,[1 0 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1],0.9130434782608696,0.07939508506616258,-39.400001525878906,-41.15565872192383,111.3625946044922,4.579269681751164,-36.70000076293945,0.05792471653948144,15.554331254676724,6.898153868460431,0,0,1,1,0.16851329341304228
162,162,162,PMID: 27707420,RNAPS0000514,https://pubmed.ncbi.nlm.nih.gov/27707420,Undefined,RNAcentral:URS00000FEF50_347515,https://rnacentral.org/rna/URS00000FEF50/347515,5S,123nt(1-123),CUUCGAGUACGACCACACUUGAGUGAAAACACCAUAUCCCGUCCGAUUUGUGAAGUUAAGCACUCACAGGCUCAGUUAGUACUGAGGUCAGUGAUGACUCGGGAACCCUGAGUGCCGUACUCC,rRNA,Leishmania major,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,RT,-,other_molecular:0.5% BSA;organelle:Nucleolus;cell:Promastigotes,FISH,-,"In contrast, 5S rRNA transcripts in L. major were localized within the nucleolus, and scattered throughout the cytoplasm, where mature ribosomes are located.",123,0.2601626016260163,0.23577235772357724,0.23577235772357724,0.2682926829268293,0.8787878787878788,1.1034482758620692,14.35,0.4607833334800097,"[1.72475733 1.72475733 1.72475733 3.44951466 2.72475733 1.22974241
 0.74750746 0.74750746 0.25249254 1.72475733 0.         0.
 2.72475733 4.44951466 0.         0.         0.74750746 0.97724987
 0.25249254 1.22974241 1.49501492 1.49501492 2.72475733 2.72475733
 0.         0.         1.22974241 2.72475733 1.72475733 1.49501492
 1.22974241 0.74750746 2.47226479 1.97724987 1.97724987 2.47226479
 1.49501492 3.95449974 1.97724987 1.72475733]",1.5518358249681523,1.2059384071237764,[1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1],0.875,0.109375,-37.099998474121094,-39.76159286499024,92.7317886352539,19.95143062764807,-33.5,0.01331959323797178,3.6348034407641436,30.293560472034674,0,0,1,1,0.14989223376351618
163,163,163,PMID: 27708161,RNAPS0000515,https://pubmed.ncbi.nlm.nih.gov/27708161,Undefined,-,-,HID2,103nt(1-103),UUUGAGGAAAGUGAUGAUAUGAAAUUGUCGCCCCAGGCUUAAUCUGCAUCCAUUACGAUGGUUGUAACAUGGUGAUUGACUAUUUUUGUCUGAUUCUCUCAAA,snoRNA,Arabidopsis thaliana,-,-,-,-,-,-,-,-,-,-,In vivo,-,-,-,-,-,other_molecular:Digoxigenin;organelle:Nucleolus;cell:Proliferative tissue,ISH,-,"Nucleolus-localized HID2 is actively expressed in Arabidopsis proliferative tissues, whereas defects in HID2 cause a series of developmental defects reminiscent of ribosomal protein mutants.",103,0.2621359223300971,0.3592233009708738,0.21359223300970875,0.1650485436893204,1.2941176470588234,0.7297297297297297,14.0,0.4574845188969065,"[0.         1.22974241 0.74750746 0.74750746 0.97724987 0.25249254
 0.         0.         1.72475733 4.44951466 3.95449974 2.72475733
 0.         0.         1.72475733 2.72475733 0.         0.
 1.72475733 0.25249254 0.97724987 0.74750746 1.72475733 1.72475733
 0.74750746 0.74750746 0.         0.         0.         1.49501492
 0.74750746 0.74750746 0.74750746]",1.0194429561204463,1.246002967724581,[1 1 1 0 0 1 1 1 1 1 0 1 0 1 1 1 0 1 1 1],0.75,0.1875,-23.79999923706055,-25.80704689025879,85.12922668457031,11.127300704480731,-23.79999923706055,0.038523072925297074,5.761940570899526,16.983863895761033,0,0,1,1,0.1527712017619247
164,164,164,PMID: 32234784,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/32234784,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1|residue=RGG 90-137
RGYRGGSAGGRGFFRGGRGRGRGFSRGGGDRGYGGNRFESRSGGYGG",CIRBP,RGG,-,47aa(90-137),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[90-137],"[90-125],[130-137]",In vitro,30 µM [CIRBP];|10 µM (UG)12 RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4 pH 7.5,1 mM DTT,2.5% glycerol",25℃,≤ 30 min,-,Differential interference contrast microscopy,liquid,DIC microscopy showed that CIRBPRGG formed liquid-like condensates in the presence of RNA similar to the full-length protein.,24,0.0,0.5,0.5,0.0,,,12.0,0.4736842105263158,"[1.49501492 1.49501492 1.49501492 1.49501492 1.49501492 1.49501492
 1.49501492]",1.4950149249061544,4.930380657631324e-32,[1 1 1 1],1.0,0.0,0.0,-0.01240577083081007,23.94452476501465,0.028043499427562384,0.0,0.9800724740111452,427.9066537682479,0.056064507453878816,0,1,0,1,0.09885836904341588
165,165,165,PMID: 32328638,RNAPS0000527,https://pubmed.ncbi.nlm.nih.gov/32328638,RNA + protein,-,-,luciferase siRNA,24nt,GCACUCUGAUUGACAAAUACGAUU,siRNA,Xenopus tropicalis,-,fxr1,-,-,539aa(isofromA),Q5BJ56,PhaSepDB,http://db.phasep.pro/browse/,-,"[404-421],[461-496],[523-539]",In vitro,4 µM [FXR1];|10 nM luciferase RNA,150 mM KCl,"20 mM Hepes and 1 mM β-mercaptoethanol, pH 7.4",RT,> 3 h,-,Fluorescence microscopy,liquid,"We observed that in the presence of luciferase RNA, both isoforms E and A had the tendency to slowly aggregate (Fig. 6 A; and Fig. S4 A).",24,0.3333333333333333,0.2916666666666667,0.16666666666666666,0.2083333333333333,0.7999999999999999,1.1428571428571428,14.0,0.418414473810729,"[2.72475733 1.49501492 0.74750746 0.74750746 0.         0.
 0.        ]",0.8163981686167439,0.8730521658047141,[1 1 0 1],0.75,0.1875,0.0,-0.7057041525840759,18.451141357421875,2.7747143467366384,0.0,0.31821519859729425,4.324769507936298,4.056827182105375,0,0,1,1,0.17037422663471552
166,166,166,PMID: 34159327,RNAPS0000532,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA,267nt (5′UTR),GGGUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAG,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15-50nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,20h,-,Fluorescence microscopy,liquid,"We tested 1-1000nt, 1-267nt (the 5′UTR), 1-500nt, and 500-1000nt fragments at either 15, 25, or 50nM RNA and 3.6µM protein. All tested fragments could drive N-protein LLPS, however some fragments drove LLPS more readily (1-500 or 1-1000).",267,0.24719101123595505,0.299625468164794,0.2172284644194757,0.2359550561797753,0.9206349206349208,0.825,14.204545454545455,0.4646521073337179,"[0.         0.         0.25249254 0.         0.         1.72475733
 1.         3.44951466 1.         0.         0.         2.72475733
 1.72475733 0.         0.         1.72475733 0.74750746 0.97724987
 0.97724987 1.22974241 1.22974241 0.74750746 0.         0.
 1.72475733 0.         0.         0.         1.49501492 2.72475733
 2.72475733 1.49501492 1.49501492 3.95449974 4.44951466 1.72475733
 0.25249254 0.74750746 1.72475733 2.72475733 2.72475733 2.72475733
 0.         0.         0.         0.         0.         0.
 0.         1.49501492 1.22974241 1.22974241 2.72475733 1.72475733
 1.72475733 1.72475733 0.74750746 1.72475733 1.72475733 0.74750746
 0.97724987 1.72475733 4.44951466 4.44951466 0.         0.
 0.         0.         4.44951466 2.47226479 1.72475733 3.44951466
 2.72475733 1.72475733 0.97724987 1.72475733 1.72475733 0.97724987
 1.72475733 1.         1.22974241 3.95449974 3.95449974 1.49501492
 2.47226479 0.         0.         1.        ]",1.3565523682164875,1.5975877024267044,"[1 1 0 1 1 0 1 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 1
 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1]",0.8113207547169812,0.1530793876824493,-84.69999694824219,-87.59088134765625,237.411865234375,18.362951961016734,-84.69999694824219,0.009181592370277498,9.019825739312244,30.113002611120766,0,0,1,1,0.11909999400258198
167,167,167,PMID: 34159327,RNAPS0000534,https://pubmed.ncbi.nlm.nih.gov/34159327,RNA + protein,-,-,SARS-CoV-2 virus RNA,500nt(1-500),GGGUUAAAGGUUUAUACCUUCCCAGGUAACAAACCAACCAACUUUCGAUCUCUUGUAGAUCUGUUCUCUAAACGAACUUUAAAAUCUGUGUGGCUGUCACUCGGCUGCAUGCUUAGUGCACUCACGCAGUAUAAUUAAUAACUAAUUACUGUCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGAGAAAACACACGUCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUCCGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUAGAAGUUGAAAAAGGCGUUUUGCCUCAACUUGAACAGCCCUAUGUGUUCAUCAAACGUUCGGAUGCUCGAACUGC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=45-364
LPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFP",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,15-50nM [SARS-CoV-2];|3.6 µM [SARS-CoV-2 N protein],150 mM NaCl,20 mM Tris pH 7.5,37°C,20h,-,Fluorescence microscopy,liquid,"We tested 1-1000nt, 1-267nt (the 5′UTR), 1-500nt, and 500-1000nt fragments at either 15, 25, or 50nM RNA and 3.6µM protein. All tested fragments could drive N-protein LLPS, however some fragments drove LLPS more readily (1-500 or 1-1000).",500,0.2445328031809145,0.28628230616302186,0.23658051689860835,0.2326043737574553,1.017094017094017,0.8541666666666667,14.060240963855419,0.4644651932646729,"[0.         0.         0.         0.         0.         2.72475733
 2.72475733 1.22974241 0.74750746 0.74750746 0.25249254 1.72475733
 1.72475733 0.74750746 0.25249254 1.22974241 1.22974241 0.97724987
 0.97724987 0.74750746 0.97724987 0.74750746 0.25249254 0.25249254
 0.97724987 0.         0.         0.         1.49501492 2.47226479
 2.47226479 1.49501492 2.72475733 2.72475733 3.44951466 2.72475733
 0.         0.         2.45948481 1.49501492 2.47226479 2.47226479
 0.         0.         0.         0.         0.         0.
 0.         2.72475733 1.72475733 0.74750746 1.72475733 2.72475733
 2.45948481 0.         0.         2.45948481 0.         0.
 1.22974241 2.45948481 2.72475733 3.44951466 1.         1.
 1.         1.22974241 2.72475733 1.72475733 1.72475733 4.44951466
 1.97724987 0.97724987 1.22974241 2.45948481 1.22974241 0.97724987
 0.25249254 1.         3.44951466 4.44951466 2.47226479 1.49501492
 2.72475733 1.         0.25249254 0.74750746 1.72475733 1.72475733
 2.47226479 1.97724987 1.72475733 2.72475733 1.22974241 0.74750746
 1.72475733 1.72475733 0.         0.         2.72475733 3.44951466
 1.72475733 0.74750746 0.74750746 1.         2.72475733 0.
 0.         1.72475733 1.72475733 1.97724987 4.44951466 3.44951466
 3.44951466 1.72475733 1.22974241 2.72475733 1.         1.22974241
 1.49501492 2.47226479 4.44951466 3.44951466 3.44951466 1.72475733
 0.         0.         2.72475733 2.72475733 2.45948481 1.22974241
 0.97724987 0.         0.         0.97724987 1.         1.72475733
 1.22974241 2.72475733 1.         0.97724987 0.97724987 0.97724987
 0.         0.         1.97724987 0.         0.         2.72475733
 1.22974241 0.97724987 0.97724987 1.72475733 2.72475733 1.
 0.74750746 0.97724987 0.97724987 0.74750746 0.25249254 1.97724987
 1.97724987 1.22974241 1.22974241 1.22974241]",1.413757212253939,1.2445336593992833,"[1 1 0 1 1 0 1 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 1
 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1
 1 1 0 1 1 1 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1]",0.84,0.13440000000000005,-168.8000030517578,-176.64453125,450.4440612792969,33.921734985958736,-165.39999389648438,2.966857798111416e-06,9.16845236989866,53.323388979318246,0,0,1,-1,-0.020449455907317837
168,168,168,PMID: 32637943,RNAPS0000538,https://pubmed.ncbi.nlm.nih.gov/32637943,RNA + protein,-,-,SARS-CoV-2 virus RNA,61nt(Rsndom-10),UCCAACUCAGUUUGCCUGUUUUACAGGUUCGCGACGUGCUCGUACGUGGCUUUGGAGACUC,virus RNA,SARS-CoV-2 virus,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10 µM [SARS-CoV-2 N protein];|1.25-20 µM [Rsndom-10],70 mM KCl,25 mM HEPES pH 7.5,RT,> 30 min,-,Light microscopy,liquid,"We analyzed the formation and morphology of condensates over a wide range of N protein and 5′-400 RNA concentrations (Figures S3 and ​and1C,1C, top row). At low RNA concentrations, small spherical droplets were seen at multiple N protein concentrations. Higher RNA and protein concentrations led to filamentous structures. Interestingly, at RNA concentrations approaching those of N protein, no structures were formed. Droplets formed when TRS RNA was equimolar with or in excess of N protein (Figure 1C), suggesting that these droplets depend on the binding of a single TRS RNA to each N protein. A 10-nt RNA with a random sequence displayed similar behavior but at higher concentrations, suggesting that specific binding is not entirely responsible for the effects of TRS RNA (Figure 1C).",61,0.14754098360655735,0.3278688524590164,0.26229508196721313,0.26229508196721313,1.0,0.45,14.0,0.4559300224652305,"[1.72475733 0.74750746 0.74750746 1.         2.72475733 0.
 0.         1.72475733 1.72475733 1.97724987 4.44951466 3.44951466
 3.44951466 1.72475733 1.22974241 2.72475733 1.         1.22974241
 1.49501492]",1.7433606576379153,1.3096880477103372,[1 1 1 1 0 1 1 1 1 1 1 1],0.9166666666666666,0.07638888888888888,-17.399999618530273,-18.359424591064453,53.78996276855469,4.700954839519509,-17.399999618530273,0.2108313803121484,8.458289979932415,7.445399030026381,0,0,1,1,0.18354326151541617
169,169,169,PMID: 33479198,RNAPS0000539,https://pubmed.ncbi.nlm.nih.gov/33479198,RNA + protein,-,-,"17-mer ssRNA (Lu,2021)",34nt,CGUGGAGGAGGUCUUAUCAGAGGCACGUCAACAUCUUAAAGAUGGCACUUGUGGCUUAGUA,irregular RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10µM [SARS-CoV-2 N protein];|0-10µM [17 mer RNA-3'-6-FAM],80 mM KCl,5 mM HEPES pH 7.5,20 °C,≥ 10 min,-,"Fluorescence microscopy,Differential interference contrast microscopy","liquid, solute","We generated a variant N protein with an N-terminal cysteine for specific labeling, then mixed Cy5-labeled full-length N protein with a nonspecific 17-mer ssRNA labeled with fluorescein (6-FAM). After mixing, we observed formation of spherical phase-separated condensates containing both components (Fig. 1a). Condensates formed in a specific range of RNA concentration, above which phase separation was inhibited (Fig. 1a). This so-called reentrant phase separation behavior is commonly observed in two-component systems, including RNA–protein mixtures, and is related to the ratio of binding sites in the two components in the mixture. With 10 µM N protein, maximal phase separation occurred in the presence of 5 µM 17-mer RNA (85 µM nucleotide), above which phase separation was inhibited (Fig.1a).",34,0.26229508196721313,0.26229508196721313,0.29508196721311475,0.18032786885245905,1.6363636363636362,1.0,14.0,0.4459899926947405,"[3.44951466 3.44951466 3.44951466 1.72475733 0.25249254 0.74750746
 2.47226479 4.44951466 1.72475733 0.97724987 0.97724987 0.
 0.         1.72475733 2.72475733 1.22974241 1.72475733 1.
 0.74750746]",1.7276768259830058,1.5695943801703545,[1 1 1 1 1 1 1 0 1 1 1 0],0.8333333333333334,0.13888888888888892,-11.600000381469727,-13.231435775756836,51.01827621459961,5.371393514293059,-11.600000381469727,0.07085955845353961,6.100489101532101,9.189199932021307,0,0,1,1,0.16726119376970922
170,170,170,PMID: 33650968,RNAPS0000563,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:2857,https://www.ncbi.nlm.nih.gov/gene/2857,GPR34,496nt(3'UTR),GGUAAACAUACUAAAAUGAAUUAUAUAAUGCAGCCUCUUAAUUCUUUGAAGAACUAAAAAAUUAGGAAACAAAGUUCUAGCAUUUACAAAACUCAGAUCUCAAAGCUCUGCUUGUAUUUGUGAUAUUUCAUUUGCUUAACUGUAAACCAUUUCAAGGUACUAACUUUUAAAUCUGUAUGUAAAAUCUUUUCAAAAUACAUUUUUAAGCUAAUACUCUUAACAUAGAUUAUGAAGUUAAGUGAAAUUUAUGGCUCUAACAGCAAAAUAAUUAAAGUGCCAUAGUUUCUCAAGUGACUAAAGUAGUUAUUAAAAUCAAGCACUUGAUACUAAUUUGAAGUGUGUUUAAAAGUAAAUGAUUUGGGAACUGACAAUGUGUCAGAAAAUAUAUGUUCAUUUAUCAUUUUAAAAUCUUGUAUAAUUUGCCACUGUAUUCAUUUAUGCCUAAAUCUCUAUAACAGAUGAAAAGAUAAUUAAUAAAAUCCUAAUUAAAAAAUGA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[GPR34 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",496,0.3911290322580645,0.35080645161290325,0.12701612903225806,0.1310483870967742,0.9692307692307692,1.114942528735632,13.865853658536587,0.4534002050372271,"[0.         0.         0.74750746 0.         0.         0.
 0.         0.         0.         1.22974241 2.72475733 1.72475733
 0.         0.         0.74750746 0.97724987 0.97724987 0.
 0.         0.         0.         0.         0.         0.74750746
 0.97724987 1.72475733 0.         0.         0.         0.
 1.49501492 1.22974241 0.74750746 0.74750746 1.22974241 2.72475733
 1.72475733 0.         0.         0.74750746 0.         0.
 0.         0.         0.         0.         0.74750746 0.25249254
 0.25249254 0.25249254 0.97724987 0.25249254 0.97724987 0.74750746
 0.         0.         0.         0.74750746 0.74750746 0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.25249254 0.         0.         0.
 0.         0.74750746 0.         0.         0.97724987 0.
 0.         0.74750746 0.         0.         0.         2.47226479
 0.74750746 1.72475733 0.         0.         0.         0.
 0.         2.72475733 1.         0.         0.         1.22974241
 0.74750746 0.74750746 0.25249254 0.97724987 0.         0.
 0.         0.         1.72475733 1.72475733 0.97724987 0.74750746
 0.         0.         0.         1.22974241 1.49501492 0.
 0.         0.         0.         0.         0.25249254 1.
 1.72475733 1.49501492 0.         0.         1.49501492 0.74750746
 0.         0.         0.         0.97724987 0.         0.
 0.         0.         0.         0.         0.97724987 0.
 0.         0.         2.72475733 1.49501492 0.         0.
 0.         0.         1.         0.         0.         0.
 0.         0.74750746 0.97724987 0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.        ]",0.4148823946133549,0.43384070398736296,"[1 0 0 0 0 0 1 0 0 0 1 0 0 1 0 1 0 0 1 1 1 1 1 0 0 0 1 0 0 1 0 1 0 0 1 0 0
 0 0 0 0 1 0 0 1 0 1 0 0 0 1 1 0 0 0 1 0 1 1 0 0 0 0 1 0 0 0 1 0 0 0 0 1 1
 1 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1 0 1 0 0 0 0 1 0 0]",0.3434343434343434,0.2254871951841649,-79.5999984741211,-92.59757232666016,358.08380126953125,82.84596671766789,-58.86999893188477,6.937070946744572e-10,3.28048594080242,118.30143401871666,0,0,1,1,0.0033245182290528863
171,171,171,PMID: 33650968,RNAPS0000564,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:51699,https://www.ncbi.nlm.nih.gov/gene/51699,VPS29,482nt(3'UTR),AGCCAGGCCUGUCUUGAUGAUUUUUGGUUUUUUUUCAUUGUCCUGUUGAAAUCAAGUAAUUAAACAUUUAAGAGCCACAAAAUUGUAUCACUUUUAUAAUAUUUUGCAGUAAAAUAUAAUACCAUCUUCUCUGUUAAUACAUAAUUGCUCCAAGCUUCCUGUAAACUAUAAGAAUAUAUUUAGUUUACAGUAUAUGGAUUCUAUGAAAAAAUGUCCACAACACAGUAAUUGGUCACUUGUUAAGAAAAAUUUAUCCUUGUAAGUAUCUUCAAAGUUGAUAUUUGGAACUUUAUUCCAAAAGUAGUGCAUGUGGAGAAAGAAUCUAGACUUUCUUGUAUACAUUUUUCUCUUCUCCAGUAAUAAACAAUUACCUUUCAUUUAUACUUUGAUAACCUGUAUUUAAUUUAAAAAAAAACAUAAAAAUGAGGAACCAAGUGAAACUACGGAUAUAAAUAUUAAAGUGGACGAGAUGACCUUUCAGA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[VPS29 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,"liquid, gel","We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",482,0.35684647302904565,0.3589211618257261,0.13692946058091288,0.14730290456431536,0.9295774647887324,0.9942196531791908,13.9,0.4537382047994948,"[4.44951466 2.72475733 2.72475733 1.22974241 0.97724987 0.
 0.         0.         0.         0.         0.         0.74750746
 1.72475733 1.72475733 0.97724987 0.         0.         0.97724987
 0.         0.         0.         0.         0.         2.47226479
 2.47226479 0.         0.         0.         0.         0.
 0.         0.         0.         0.         1.22974241 0.
 0.         0.         0.         0.         1.72475733 0.97724987
 1.49501492 0.         0.         0.         0.         0.
 3.44951466 1.72475733 0.25249254 1.72475733 1.72475733 0.25249254
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.25249254 0.74750746
 0.74750746 0.         0.         0.         1.72475733 1.72475733
 1.22974241 1.49501492 0.         0.         1.72475733 0.74750746
 0.97724987 0.25249254 0.         0.         0.         0.
 1.72475733 0.         0.         0.74750746 0.97724987 0.74750746
 0.97724987 0.         0.         0.         1.72475733 0.
 0.         0.25249254 0.25249254 0.97724987 1.72475733 1.72475733
 1.72475733 1.72475733 0.74750746 0.         0.         1.22974241
 0.         0.         0.97724987 0.25249254 0.         0.
 0.         1.22974241 1.72475733 1.72475733 0.         0.
 0.         0.         0.         1.         0.         0.
 0.         0.74750746 0.         0.         1.72475733 0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         1.22974241 1.72475733 1.72475733
 0.74750746 0.74750746 1.72475733 1.         0.         0.
 0.         0.         0.         2.45948481 2.45948481 1.22974241
 1.72475733 0.         0.        ]",0.5836019015803597,0.7160043451184914,"[1 1 1 0 0 0 0 0 1 0 1 0 0 0 1 0 0 1 0 0 0 1 0 0 1 1 0 0 0 1 1 1 0 0 0 0 0
 1 0 1 0 0 1 1 1 0 1 0 0 0 1 0 0 1 0 0 1 0 1 0 1 1 1 0 1 0 1 0 0 1 1 0 0 0
 1 0 0 0 1 0 0 0 0 0 0 1 1 1 1 0 0 0 1 1 1 1]",0.4166666666666667,0.24305555555555555,-75.19999694824219,-87.6828384399414,290.6227111816406,104.86771902419164,-26.70000076293945,1.5991252637894195e-09,2.2880305548326274,164.91222667016368,0,0,1,-1,-0.0007170668179803386
172,172,172,PMID: 33650968,RNAPS0000565,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:4609,https://www.ncbi.nlm.nih.gov/gene/4609,MYC,476nt(3'UTR),GGAAAAGUAAGGAAAACGAUUCCUUCUAACAGAAAUGUCCUGAGCAAUCACCUAUGAACUUGUUUCAAAUGCAUGAUCAAAUGCAACCUCACAACCUUGGCUGAGUCUUGAGACUGAAAGAUUUAGCCAUAAUGUAAACUGCCUCAAAUUGGACUUUGGGCAUAAAAGAACUUUUUUAUGCUUACCAUCUUUUUUUUUUCUUUAACAGAUUUGUAUUUAAGAAUUGUUUUUAAAAAAUUUUAAGAUUUACACAAUGUUUCUCUGUAAAUAUUGCCAUUAAAUGUAAAUAACUUUAAUAAAACGUUUAUAGCAGUUACACAGAAUUUCAAUCCUAGUAUAUAGUACCUAGUAUUAUAGGUACUAUAAACCCUAAUUUUUUUUAUUUAAGUACAUUUUGCUUUUUAAAGUUGAUUUUUUUCUAUUGUUUUUAGAAAAAAUAAAAUAACUGGCAAAUAUAUCAUUGAGCCAAAUCUUAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[MYC 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",476,0.35084033613445376,0.3760504201680672,0.12815126050420167,0.14495798319327732,0.8840579710144926,0.9329608938547486,13.924050632911394,0.4415201162988669,"[0.25249254 0.         0.         0.         0.         1.
 0.25249254 0.97724987 0.74750746 0.74750746 0.25249254 1.72475733
 1.72475733 1.72475733 1.         1.72475733 0.         0.
 0.97724987 0.97724987 0.74750746 0.         0.         1.72475733
 0.97724987 0.         0.         2.72475733 1.72475733 0.74750746
 1.72475733 2.72475733 2.72475733 1.49501492 0.74750746 1.22974241
 1.49501492 0.74750746 0.74750746 0.         0.         1.
 0.         0.         0.25249254 1.72475733 2.72475733 0.
 0.         1.22974241 0.         0.         1.97724987 0.
 0.         0.97724987 0.         0.         0.         0.
 0.         1.72475733 0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.25249254 0.         0.         0.         0.
 0.         0.         0.         0.         0.74750746 0.74750746
 0.         0.         1.49501492 0.         0.         0.
 1.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 1.22974241 0.         0.         1.49501492 0.         0.
 0.74750746 0.25249254 0.97724987 0.         0.         1.72475733
 1.72475733 0.         0.         0.         1.72475733 0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.97724987 0.         0.         0.25249254
 0.         0.         0.         0.97724987 0.         0.
 0.         0.25249254 0.         0.         0.         0.
 0.         0.         0.         0.         2.72475733 0.
 0.         0.         0.74750746 1.72475733 1.         0.25249254
 0.        ]",0.45226230957249397,0.5122785582855203,"[1 0 1 1 1 1 0 1 1 0 1 1 0 0 1 0 1 1 1 1 1 1 1 1 0 1 0 0 1 0 1 1 0 0 0 0 1
 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 1 0 1 1 0 0 1 0 1 1 0 1 0 1
 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 0 1 1 0]",0.43157894736842106,0.2453185595567867,-98.3000030517578,-107.8536376953125,352.2078552246094,70.58541499601453,-73.0999984741211,1.8533988407433878e-07,3.4373414094460943,104.73862738131672,0,0,1,1,0.009340826122795187
173,173,173,PMID: 33650968,RNAPS0000566,https://pubmed.ncbi.nlm.nih.gov/33650968,RNA + protein,NCBI ID:5321,https://www.ncbi.nlm.nih.gov/gene/5321,PLA2G4A,473nt(3'UTR),UUCAUGUACUGGAAAUGGCAGCAGUUUCUGAUGCUGAGGCAGUUUGCAAUCCCAUGACAACUGGAUUUAAAAGUACAGUACAGAUAGUCGUACUGAUCAUGAGAGACUGGCUGAUACUCAAAGUUGCAGUUACUUAGCUGCAUGAGAAUAAUACUAUUAUAAGUUAGGUUGACAAAUGAUGUUGAUUAUGUAAGGAUAUACUUAGCUACAUUUUCAGUCAGUAUGAACUUCCUGAUACAAAUGUAGGGAUAUAUACUGUAUUUUUAAACAUUUCUCACCAACUUUCUUAUGUGUGUUCUUUUUAAAAAUUUUUUUUCUUUUAAAAUAUUUAACAGUUCAAUCUCAAUAAGACCUCGCAUUAUGUAUGAAUGUUAUUCACUGACUAGAUUUAUUCAUACCAUGAGACAACACUAUUUUUAUUUAUAUAUGCAUAUAUAUACAUACAUGAAAUAAAUACAUCAAUAUAAAAAUAA,mRNA,Homo sapiens,"A fusion protein construct[TIS11B RBD]-[FUS IDR]with RBD residues 114-181fused to FUS residues 1-214|length=282aa|residues=114-181/1-214
RYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEE|
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG",TIS11B-FUS,RBD;IDR,-,"282aa(1-214,114-181)","Q07352,P35637","TIS11B:PhaSePro,
FUS:PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q07352;https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[93-113];[114-181],"[80-92],[201-214];|[114-181]",In vitro,10µM[mGFP-FUS-TIS];|100-750nM[PLA2G4A 3'UTR],"150 mM NaCl,  200 mM ZnCl2","25 mM Tris-Cl, pH 7.4, 1 mM DTT, 2.5% glycerol",RT,16 h,crowding agent:5% dextran T500 [Pharmacosmos],FRAP,liquid,"We observed a strong association between the propensity of an RNA to induce network formation and the predicted ‘unstructured-ness’ of the RNA. For sphere-inducing RNAs, the majority of their nucleotides are predicted to form strong local structures, whereas RNAs with a high propensity for network",473,0.34249471458773784,0.3615221987315009,0.15010570824524316,0.14587737843551796,1.028985507246377,0.9473684210526316,14.012820512820511,0.4532123958588492,"[0.97724987 0.97724987 1.72475733 0.         0.         4.44951466
 1.72475733 0.74750746 0.74750746 1.72475733 1.72475733 2.47226479
 2.47226479 0.74750746 0.25249254 1.         1.         1.22974241
 1.22974241 1.72475733 0.         0.         0.         0.97724987
 0.74750746 0.97724987 0.74750746 0.74750746 1.72475733 1.72475733
 0.74750746 0.97724987 1.22974241 1.49501492 1.49501492 2.72475733
 1.72475733 0.74750746 0.74750746 0.74750746 1.72475733 1.72475733
 0.74750746 0.         0.         3.44951466 1.72475733 0.74750746
 0.         0.         0.         0.         0.         0.
 0.         1.72475733 0.74750746 0.25249254 0.97724987 0.97724987
 0.         0.         0.         0.         0.         0.
 0.74750746 0.25249254 0.97724987 0.         0.         1.49501492
 0.74750746 0.74750746 0.97724987 1.72475733 1.72475733 0.74750746
 0.         0.         1.72475733 1.         0.         0.
 0.74750746 0.         0.         0.         0.         0.25249254
 0.74750746 1.72475733 1.72475733 0.74750746 0.         0.
 1.49501492 1.22974241 0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.74750746 0.97724987 0.74750746 0.74750746
 0.         0.         2.45948481 2.72475733 0.         0.
 0.74750746 0.         0.         0.         0.         1.49501492
 0.74750746 0.97724987 0.         0.         0.         0.
 1.72475733 1.49501492 1.22974241 0.74750746 0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.74750746 0.97724987 0.         0.
 0.         0.97724987 0.         0.         0.         0.        ]",0.6654737937676671,0.6474912638044711,"[1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 0 1 1 1 0 1 1 0 0 0 0 1 0 1 0
 0 1 0 1 0 0 1 0 1 1 0 1 1 0 0 0 0 1 1 1 0 1 0 0 0 0 0 0 0 1 0 1 0 1 0 0 1
 0 1 1 0 0 1 1 1 0 0 0 1 0 0 0 0 0 1 0 0]",0.5106382978723404,0.2498868266183793,-98.4000015258789,-107.62892150878906,360.81427001953125,70.37036839513094,-86.80000305175781,3.138944330472523e-07,3.9863620029002296,111.29821761568974,0,0,1,1,0.02778728468649383
174,174,174,PMID: 34267352,RNAPS0000624,https://pubmed.ncbi.nlm.nih.gov/34267352,Undefined,NCBI ID:735301,https://www.ncbi.nlm.nih.gov/gene/735301,SNHG9,345nt(1-345),GCGGCCCGGGAAUCUACGUCACCCGAAAAGCGACUAUAAACGCCGGCGCCUCCGUCCCCAGCCGCGGCUCGGGAAUCCACCCGAAGAGUGGCUAUAAACGUCCGCGCCUCCAUUGCGCUCUCCUCUUCACUUAGGACACUGGUCCUCCCACGCCUGACACCGACGUCGCCAGGACCGCGGGGUUGGGGGAACUUGGCUGUCCCACGUCUUUCAAAUAAAGCUGUUUUGUCUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1
MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTE
DPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVI
QALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKG
SKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPP
QVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGY
PPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQ
NVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNME
LYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQ
PSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNV
TVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENV
DSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHR
KKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVC
LARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF
VMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG
HIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAAR
QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQM
KVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLR
QQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTF
RRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV",LATS1,-,-,1130aa(1-1130),O95835,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1421,http://db.phasep.pro/browse/","[1-68],[149-276],[294-321],[365-405],[432-484],[515-601],[1104-1130]","[228-267],[301-314],[434-447],[483-494],[555-560],[1104-1116]",In vivo,-,-,-,-,-,cell:MDA-MB-231 cells;other_molecular:phosphatidic acids,"FISH,Confocal microscopy",-,"Next, we conducted RNA fluorescence in situ hybridization (FISH) and qRT-PCR analyses to examine SNHG9 expression in MDA-MB-231 cells. We found that SNHG9 was mainly localized in the cytoplasm (Fig. 1h, i) and colocalized with PA",345,0.4579710144927536,0.13333333333333333,0.17391304347826084,0.2347826086956521,0.7407407407407407,3.4347826086956523,13.140350877192983,0.3133578035582442,"[6.42676453 6.42676453 1.97724987 0.74750746 1.72475733 1.72475733
 2.47226479 1.97724987 0.25249254 1.         1.72475733 0.
 0.         4.44951466 6.42676453 4.44951466 4.44951466 4.44951466
 2.72475733 4.44951466 6.42676453 4.44951466 4.44951466 1.97724987
 1.         3.44951466 2.72475733 1.72475733 1.49501492 2.72475733
 0.         0.         1.22974241 3.95449974 6.42676453 4.44951466
 0.         0.         3.95449974 2.72475733 1.72475733 0.97724987
 0.74750746 1.         1.72475733 1.49501492 2.45948481 2.45948481
 2.72475733 4.44951466 3.95449974 1.49501492 2.47226479 4.44951466
 3.44951466 2.72475733 3.44951466 4.44951466 6.42676453 4.44951466
 2.72475733 4.44951466 1.97724987 0.97724987 1.         2.72475733
 2.72475733 3.44951466 1.72475733 0.74750746 0.         0.
 0.         1.72475733 0.25249254 0.74750746 0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.        ]",1.6958202698269793,3.6748468473561786,"[1 1 0 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]",0.5942028985507246,0.2411258139046419,-72.5999984741211,-77.16857147216797,304.73199462890625,25.191447871821985,-66.59999847412111,0.0006035641075391138,8.474151205032943,39.83891944702489,0,0,1,1,0.032423920377870896
175,175,175,PMID: 34267352,RNAPS0000625,https://pubmed.ncbi.nlm.nih.gov/34267352,RNA + protein,NCBI ID:735301,https://www.ncbi.nlm.nih.gov/gene/735301,SNHG9,345nt(1-345),GCGGCCCGGGAAUCUACGUCACCCGAAAAGCGACUAUAAACGCCGGCGCCUCCGUCCCCAGCCGCGGCUCGGGAAUCCACCCGAAGAGUGGCUAUAAACGUCCGCGCCUCCAUUGCGCUCUCCUCUUCACUUAGGACACUGGUCCUCCCACGCCUGACACCGACGUCGCCAGGACCGCGGGGUUGGGGGAACUUGGCUGUCCCACGUCUUUCAAAUAAAGCUGUUUUGUCUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1
MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTE
DPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVI
QALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKG
SKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPP
QVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGY
PPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQ
NVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNME
LYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQ
PSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNV
TVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENV
DSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHR
KKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVC
LARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF
VMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG
HIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAAR
QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQM
KVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLR
QQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTF
RRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV",LATS1,-,-,1130aa(1-1130),O95835,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1421,http://db.phasep.pro/browse/","[1-68],[149-276],[294-321],[365-405],[432-484],[515-601],[1104-1130]","[228-267],[301-314],[434-447],[483-494],[555-560],[1104-1116]",In vitro,-,"15 mM NaCl, 130 mM KCl, 5 mM KH2PO4, 1.5 mM MgCl2","20 mM Tris-HCl, pH 7.5",25˚C,2 h,other_molecular:1 mg/mL BSA,"Differential interference contrast microscopy,Fluorescence microscopy",liquid," To test whether the interaction with SNHG9 induces LATS1 phase separation in vitro, we incubated LATS1-GFP protein with fluorescein-labeled SNHG9 (red). Upon mixing, LATS1 and SNHG9 formed micrometer-sized liquid droplets",345,0.4579710144927536,0.13333333333333333,0.17391304347826084,0.2347826086956521,0.7407407407407407,3.4347826086956523,13.140350877192983,0.3133578035582442,"[6.42676453 6.42676453 1.97724987 0.74750746 1.72475733 1.72475733
 2.47226479 1.97724987 0.25249254 1.         1.72475733 0.
 0.         4.44951466 6.42676453 4.44951466 4.44951466 4.44951466
 2.72475733 4.44951466 6.42676453 4.44951466 4.44951466 1.97724987
 1.         3.44951466 2.72475733 1.72475733 1.49501492 2.72475733
 0.         0.         1.22974241 3.95449974 6.42676453 4.44951466
 0.         0.         3.95449974 2.72475733 1.72475733 0.97724987
 0.74750746 1.         1.72475733 1.49501492 2.45948481 2.45948481
 2.72475733 4.44951466 3.95449974 1.49501492 2.47226479 4.44951466
 3.44951466 2.72475733 3.44951466 4.44951466 6.42676453 4.44951466
 2.72475733 4.44951466 1.97724987 0.97724987 1.         2.72475733
 2.72475733 3.44951466 1.72475733 0.74750746 0.         0.
 0.         1.72475733 0.25249254 0.74750746 0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.        ]",1.6958202698269793,3.6748468473561786,"[1 1 0 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]",0.5942028985507246,0.2411258139046419,-72.5999984741211,-77.16857147216797,304.73199462890625,25.191447871821985,-66.59999847412111,0.0006035641075391138,8.474151205032943,39.83891944702489,0,0,1,1,0.032423920377870896
176,176,176,PMID: 34267352,RNAPS0000626,https://pubmed.ncbi.nlm.nih.gov/34267352,RNA + protein,NCBI ID:735301,https://www.ncbi.nlm.nih.gov/gene/735301,SNHG9-antisense,345nt(1-345),AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUCUGUUUUGUCGAAAUAAACUUUCUGCACCCUGUCGGUUCAAGGGGGUUGGGGCGCCAGGACCGCUGCAGCCACAGUCCGCACCCUCCUGGUCACAGGAUUCACUUCUCCUCUCGCGUUACCUCCGCGCCUGCAAAUAUCGGUGAGAAGCCCACCUAAGGGCUCGGCGCCGACCCCUGCCUCCGCGGCCGCAAAUAUCAGCGAAAAGCCCACUGCAUCUAAGGGCCCGGCG,lncRNA,Homo sapiens,"sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1
MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTE
DPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVI
QALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKG
SKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPP
QVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGY
PPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQ
NVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNME
LYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQ
PSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNV
TVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENV
DSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHR
KKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVC
LARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF
VMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG
HIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAAR
QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQM
KVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLR
QQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTF
RRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV",LATS1,-,-,1130aa(1-1130),O95835,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1421,http://db.phasep.pro/browse/","[1-68],[149-276],[294-321],[365-405],[432-484],[515-601],[1104-1130]","[228-267],[301-314],[434-447],[483-494],[555-560],[1104-1116]",In vitro,100 nM [SNHG9-as];|0.01-2µM[LATS1-GFP],"15 mM NaCl, 130 mM KCl, 5 mM KH2PO4, 1.5 mM MgCl2","20 mM Tris-HCl, pH 7.5",25˚C,2 h,other_molecular:1 mg/mL BSA,Fluorescence microscopy,"solute, liquid","Droplet formation was observed when the protein concentration of LATS1-GFP was 0.1 µM in the presence of SNHG9-sense, while no droplet formed at the same protein concentration in the presence of SNHG9-antisense or in the absence of RNA",345,0.4579710144927536,0.13333333333333333,0.17391304347826084,0.2347826086956521,0.7407407407407407,3.4347826086956523,13.087719298245617,0.31425741285413616,"[0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.74750746 0.25249254 1.72475733 0.
 0.         0.         0.74750746 1.72475733 3.44951466 2.72475733
 2.72475733 1.         0.97724987 1.97724987 4.44951466 2.72475733
 4.44951466 6.42676453 4.44951466 3.44951466 2.72475733 3.44951466
 4.44951466 2.47226479 1.49501492 3.95449974 4.44951466 2.72475733
 2.45948481 2.45948481 1.49501492 1.72475733 1.         0.74750746
 0.97724987 1.72475733 2.72475733 3.95449974 0.         0.
 4.44951466 6.42676453 3.95449974 1.22974241 0.         0.
 2.72475733 1.49501492 1.72475733 2.72475733 3.44951466 1.
 1.97724987 4.44951466 4.44951466 6.42676453 4.44951466 2.72475733
 4.44951466 4.44951466 4.44951466 6.42676453 4.44951466 0.
 0.         1.72475733 1.         0.25249254 1.97724987 2.47226479
 1.72475733 1.72475733 0.74750746 1.97724987 6.42676453 6.42676453]",1.695820269826979,3.6748468473561786,"[0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 0 1 1]",0.5942028985507246,0.24112581390464186,-75.19999694824219,-79.27928924560547,290.431640625,37.629990089575344,-68.80000305175781,0.0013350541156987785,4.9206947332758935,55.53207556069566,0,0,1,1,0.0106472015759419
177,177,177,PMID: 34267352,RNAPS0000627,https://pubmed.ncbi.nlm.nih.gov/34267352,Undefined,NCBI ID:735301,https://www.ncbi.nlm.nih.gov/gene/735301,SNHG9,317nt(1-203+232-345),GCGGCCCGGGAAUCUACGUCACCCGAAAAGCGACUAUAAACGCCGGCGCCUCCGUCCCCAGCCGCGGCUCGGGAAUCCACCCGAAGAGUGGCUAUAAACGUCCGCGCCUCCAUUGCGCUCUCCUCUUCACUUAGGACACUGGUCCUCCCACGCCUGACACCGACGUCGCCAGGACCGCGGGGUUGGGGGAACUUGGCUGUCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,lncRNA,Homo sapiens,"sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1
MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTE
DPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVI
QALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKG
SKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPP
QVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGY
PPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQ
NVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNME
LYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQ
PSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNV
TVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENV
DSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHR
KKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVC
LARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF
VMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG
HIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAAR
QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQM
KVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLR
QQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTF
RRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV",LATS1,-,-,1130aa(1-1130),O95835,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1421,http://db.phasep.pro/browse/","[1-68],[149-276],[294-321],[365-405],[432-484],[515-601],[1104-1130]","[228-267],[301-314],[434-447],[483-494],[555-560],[1104-1116]",In vivo,-,-,-,-,-,cell:SNHG9 KD and LATS1 KO HEK293A cells;other_molecular:phosphatidic acids,Confocal microscopy,liquid,"Meanwhile, PA promoted LATS1 phase separation in both SNHG9FL- and SNHG9 mutants-expressing cells, although the promotion effect was stronger in SNHG9-FL-expressing group",317,0.4763406940063091,0.10725552050473186,0.17665615141955834,0.23974763406940064,0.736842105263158,4.441176470588236,13.096153846153848,0.30080987272246945,"[6.42676453 6.42676453 0.         0.         1.72475733 2.72475733
 3.95449974 0.         0.         2.72475733 0.         0.
 0.         6.42676453 6.42676453 3.95449974 2.72475733 4.44951466
 3.95449974 3.95449974 6.42676453 3.95449974 3.95449974 0.
 0.         4.44951466 1.97724987 1.22974241 2.72475733 1.
 0.         0.         3.44951466 4.44951466 4.44951466 3.44951466
 1.         1.97724987 2.47226479 1.72475733 1.72475733 1.22974241
 0.         0.         2.72475733 2.72475733 3.44951466 3.44951466
 2.72475733 3.95449974 2.47226479 1.49501492 2.72475733 3.44951466
 4.44951466 3.95449974 2.45948481 3.95449974 6.42676453 1.97724987
 1.97724987 4.44951466 1.72475733 1.72475733 2.72475733 2.72475733
 1.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.         0.         0.         0.         0.
 0.         0.        ]",1.6945636503212318,3.841292068517976,"[1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]",0.6031746031746031,0.2393550012597631,-71.19999694824219,-74.35984802246094,285.283447265625,20.962499141616547,-69.90000152587889,0.005934571048435859,9.77526128289278,33.88246831283137,0,0,1,-1,-0.00029827691160466685
